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IABSTRACT
This thesis describes a series of studies in mice infected with either 
Trypanosoma brucei brucei and Trypanosoma congolense, with the primary 
aim of identifying the pathogenic mechanism responsible for the acute phase 
response which occurs during African trypanosomiasis. The acute phase 
response was monitored by measuring the acute phase proteins, serum amyloid 
P-component (SAP) and haptoglobin (Hp) during a tissue invasive and non­
tissue invasive infection. The possible involvement of trypanosome endotoxin 
in the pathogenesis of trypanosomiasis was also investigated, by measuring the 
endotoxin levels and acute phase proteins in plasma of infected animals during 
treatment with either a general, systemic antibiotic (norfloxacin) or one that is 
restricted to the intestinal tract and binds to and neutralises the pathogenic 
effects of endotoxin (polymyxin-B). In addition, the endotoxin-like molecule(s) 
in trypanosome lysates or enriched protein membranes were examined to 
determine the presence of lipopolysaccharide or the active moiety, lipid-A, 
using polyacrylamide gel electrophoresis and the silver stain, or Western blot 
utilising a lipid-A specific monoclonal antibody.
Chapter I comprises an introduction and literature review on African 
trypanosomiasis with emphasis on endotoxin, cytokines and acute phase 
proteins.
Chapter II describes the general materials and methods used in these 
studies.
Chapter III describes the development of a direct antigen enzyme linked 
immunosorbent assay (ELISA) for the quantification of mouse serum amyloid 
P-component.
Chapter IV describes the acute phase response during chronic murine 
trypanosome infection with tissue invasive and non-invasive trypanosomes, and
II
the effect of subcurative treatment with the trypanocidal drug, diminazine 
aceturate. It was found that the acute phase proteins SAP and haptoglobin 
increased significantly after infection. Following infection with T. b. brucei, 
SAP increased in both infections to peak 7-10 days after infection (DAI), after 
which it declined to levels just above control values where it remained for the 
rest o f the infection period. In contrast, with T. congolense infection a second 
peak occurred around 34 DAI. The levels of SAP were not affected by the 
treatment with diminazine aceturate.
Haptoglobin (Hp) increased to peak at 7-10 DAI, and remained elevated 
throughout the infection in both experiments, but decreased significantly 
following treatment with diminazine aceturate in the T. congolense but not in 
the T. brucei infection where it remained elevated. The diminazine aceturate 
treatment in T. brucei infected mice resulted in severe cellular infiltration of 
mononuclear cells in the brains of these animals. As acute phase response 
occurs with both species of trypanosomes, it was concluded that tissue 
invasiveness is not the main means by which trypanosomes initiate tissue 
damage in infected hosts but that tissue pathology in the brain can cause 
synthesis of acute phase protein in the liver.
Chapter V describes the changes in plasma endotoxin-like activity, the 
concentration of the acute phase proteins, SAP and Hp, and tissue pathology 
during chronic T. b. brucei infections in mouse, the presence or absence of an 
antibiotic umbrella, with norfloxacin or polymyxin-B. The concentration of 
acute phase proteins and endotoxin-like activity increased significantly 
following infection. The animals also showed varying pathological changes 
during the different stages of infection. The spleen showed cellular activity, 
livers were markedly infiltrated with inflammatory cells with occasional 
necrosis, while the choroid plexus of the brains was infiltrated by trypanosome. 
Treatment with the antibiotic polymyxin-B, had no significant effect on any of
ill
the parameters examined, whereas in the norfloxacin-treated animals there was 
a small but significant decrease in the haptoglobin levels in the terminal stages 
of infection after 21 DAI. The norfloxacin-treated animals also showed reduced 
liver pathology but only in the early stages of infection, i.e., before 21 DAI.
Chapter VI describes the characterisation of trypanosome lysate and 
protein-enriched membrane proteins by the silver stain and by Western blot. 
The results showed that trypanosomes do not contain a gram negative bacteria­
like LPS molecule. On the other hand, the lipid-A monoclonal antibody (8A1) 
recognised epitopes on trypanosome lysate and protein-enriched membranes on 
Western blots; this were destroyed by pre-treatment of the samples with 
proteinase K, suggesting they are protein in nature or are associated with 
protein.
The general discussion and conclusions drawn from the study are 
presented in chapter VII. African trypanosomiasis causes an acute phase 
response and tissue damage probably by the production of pro-inflammatory 
cytokines which are induced probably by molecule(s) from trypanosomes with 
endotoxin-like activity. The molecule(s) responsible for the increased 
endotoxin-like activity is of trypanosome origin. Although this molecule(s) has 
lipid-A like activity and epitopes recognised by lipid-A monoclonal antibody, 
this trypanosome molecule(s), is dissimilar to the gram negative bacteria LPS.
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CHAPTER 1
INTRODUCTION AND GENERAL LITERATURE REVIEW
1.1. INTRODUCTION
African trypanosomiasis is an economically important haemoprotozoan 
disease affecting man and his domestic animals. In the animal infection, 
millions of dollars are lost annually through death, reduction in productivity of 
meat and milk, and reduced fertility (Luckins, 1992; Sekoni, 1992). In humans, 
infection reduces the productivity of individuals and also causes a great 
constraint on already limited health budgets of third world countries due to the 
high cost of drugs for treatment and control of the disease. The infestation of 
vast areas of land by tsetse flies, the principal vector, also limits the maximum 
utilisation of land in the tropics due to the risk of the infection both to man and 
his animals.
The development of an appropriate vaccine against the trypanosome 
parasite has remained elusive due to the parasite's ability to escape the host 
immune system by changing its surface coat by the phenomenon of antigenic 
variation (Vickerman, 1978; Nantulya, 1986). Control strategy of human 
African trypanosomiasis (HAT) is thus dependent on continuous surveillance, 
systematic case detection and treatment, and the control of the vectors, which 
are mainly of the Glossina species (de Raadt, 1984; Kuzoe, 1989). These 
control strategies however have several constraints. Few new drugs have been 
introduced over the last few decades due to the expense involved in drug 
development, registration and also a perceived small human commercial 
market. This has resulted in reluctance of the drug industry to invest in the 
development of new trypanocides, and has led to the widespread continuous use 
of the few available drugs in field clinics over many years, resulting in drug 
resistance (Anon, 1991; Bacchi, 1993). Most of the drugs available do not cross 
the blood-brain barrier (BBB) and can only be used in the treatment of the early 
stage trypanosomiasis. The available drugs that can cross the BBB, and thus 
used for the treatment of late stage trypanosomiasis, include the arsenicals,
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which are toxic and have adverse side effects (Adams, Haller, Boa, Doua, Dago 
and Konian, 1986). Another factor hindering effective treatment is the lack of 
easily affordable and sensitive diagnostic tests to enable early diagnosis and 
effective treatment before central nervous system (CNS) infection. This is 
compounded by the fact that the disease, being a rural condition, does not allow 
early reporting of cases. Thus most cases are diagnosed in the advanced stage 
with CNS involvement and are more difficult to treat. In human 
trypanosomiasis, painful diagnostic procedures, including lumber puncture, do 
not encourage the completion of therapeutic regimens and hinder the follow-up 
of patients after treatment (Anon, 1991).
Control of the tsetse fly is difficult due to the vast areas affected and lack 
of economically viable control methods. Also, effective control measures have 
been hampered by war and financial reasons, leading to re-invasion of areas that 
had been cleared of tsetse flies.
1.2. CLASSIFICATION OF TRYPANOSOMES
The pathogenic trypanosomes in the genus Trypanosoma, can be 
subdivided into two main groups, the stercorarian and salivarian (Table 1.1). 
This depends on the site of their development in the vector, and hence the mode 
of transmission. The stercorarian group develop in the alimentary tract, with the 
production of infective metacyclics occurring in the hind gut of the vector with 
the host infection either through skin contamination or by oral ingestion. 
Trypanosoma cruzi, the causative agent of Chagas' disease in South and Central 
America, is the most important pathogen of the group. On the other hand, the 
salivarian group complete their development in the anterior station, i.e., the 
salivary gland and the proboscis of tsetse fly, with the result that the parasites 
are transmitted by inoculation when the fly takes a blood meal on its host. The 
Brucei sub-group including T. brucei brucei, T. b. gambiense, and T. b.
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rhodesiense are among the important pathogens of the salivarian group 
affecting man and animals (Stephen, 1986).
1.3. DISEASE IN MAN
1.3.1. Pathogenesis And Pathology
Human African trypanosomiasis can be divided geographically into the 
west African (gambiense) and the east African form (rhodesiense), caused by 
Trypanosoma brucei gambiense and T. brucei rhodesiense respectively.
The disease affects all body systems, including the central nervous 
system (CNS). It is characterised by an initial trypanosome multiplication in the 
subcutaneous tissue at the point of tsetse fly bite (Fairbaim and Godfrey, 1957; 
1958). The tsetse fly inoculates the host with trypanosomes in saliva into the 
subcutaneous pool of blood during the process of feeding. Some of the 
organisms may enter directly into the blood stream (Willett and Gordon, 1957), 
but the majority get entangled in the extravascular tissue where they multiply 
by binary fission as long slender trypomastigotes, producing a local 
inflammatory reaction called a chancre (Fairbaim and Godfrey, 1957). The 
chancre is presented as a staphylococcal-like cellulitis characterised by a hard, 
painful, red nodule with marked oedema and erythema that can be several 
centimetres in diameter. It is more common in T. b. rhodesiense infections and 
in patients with a lighter skin (Molyneux, de Raadt and Seed, 1984). The 
trypanosomes then spread through the tissue spaces into the lymphatic system 
hence the local and general lymph nodes, where they continue to multiply. 
Once in the blood stream, the trypanosomes traverse the walls of blood and 
lymph capillaries and enter into tissues, including the CNS (Fairbaim and 
Godfrey, 1957; 1958).
For the tissue-invasive trypanosomes, i.e., the brucei group, invasion 
into most organs results in metabolic and biochemical changes, possibly caused
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by direct parasite action or indirectly by host immune response to the parasite. 
If  the human survives the acute phase of infection, the trypanosomes then 
progressively invade the CNS resulting in a meningoencephalitis accompanied 
by neurological signs. The severity and time course of the trypanosome 
infection varies with species of trypanosomes involved (Losos and Ikede, 
1973a). Typical T. b. rhodesiense infection, presents as an acute to subacute 
disease, accompanied by rapid development of severe parasitaemia, anaemia 
and acute cardiac abnormality leading to cardiac failure (Manson-Bahr and 
Charters, 1963; Manuelidis, Robertson, Amberson, Pola and Haymaker, 1965; 
Francis, 1972; Jones, Lowenthal and Buyst, 1975; Harries and Wirima, 1988). 
During this acute syndrome, neurological involvement is minimal since death 
occurs within weeks or a few months in untreated patients. On the other hand, 
T. b. gambiense infections present a subacute to chronic disease with slow heart 
involvement (Adams et al, 1986). It is characterised by low parasitaemia, 
marked progressive loss of body condition, and a predominant progressive 
neurological syndrome (Molyneux et al, 1984; Boa, Traore, Doua, Kouassi- 
Troure, Kouassi and Giodano, 1988). Atypical cases of chronic T. b. 
rhodesiense and acute T. b. gambiense infections have also been documented 
(Apted, 1970a).
The mechanisms that lead to the severe pathology of human African 
trypanosomiasis are still poorly understood, but appear to be related to the 
invasive capacity of the trypanosomes, their ability to generate biologically 
active mediators, and/or to stimulate immunological reactions by the host to this 
highly antigenic parasite which undergoes persistent antigenic variation (Borst 
and Cross, 1982; Steinert and Pays, 1985). The precise form of the human and 
animal trypanosomiasis, depends not only upon the host, and the species of 
infecting trypanosomes, but also upon the particular strain of the trypanosome 
involved (Losos and Ikede, 1973a; 1973b).
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1.3.2. Clinical Signs
Gambian human sleeping sickness is characterised by a relatively long 
incubation period followed by a gradual but progressive onset of irregular fever, 
anaemia, splenomegaly, hepatomegaly, lymphoadenopathy and cachexia 
(Apted, 1970a; Ormerod, 1970). Affected individuals eventually show 
neurological disturbances, including headache, changes in behaviour, and 
reversed sleep pattern manifested as somnolence during the day and insomnia at 
night (Greenwood and Whittle, 1980). Sensory symptoms are also frequent with 
cutaneous hyperaesthesia and deep hyperpathia (Boa et al, 1988), accompanied 
by changes in mental performance, lassitude, and general weakness. As the 
disease progresses, there is wasting and a gradual loss in the control of limbs, 
abdominal, and thoracic muscle, leading to coma, and death in untreated cases 
(Haller, Adams, Merouze and Dago, 1986). Signs of cardiac involvement are 
also encountered (Adams et al, 1986), but the disease is mainly associated with 
central CNS involvement (Molyneux et al, 1984; Boa et al, 1988). In its milder 
form, the progression of this disease may be extremely slow, and mortality may 
be correspondingly slow (Tizard, Nielsen, Seed and Hall, 1978).
In contrast T. b. rhodesiense, is a highly acute and fatal disease if 
untreated. The major clinical features include rapid onset of high undulating 
fever following each peak of parasitaemia. This is accompanied by headache, 
general weakness, and exercise intolerance. Anaemia is a consistent finding in 
T. b. rhodesiense infection resulting in development of pale mucous membranes 
(Woodruff, Ziegler, Hathaway and Gwata, 1973). In the rhodesiense infection, 
the central nervous signs are not dramatic, but some individuals may show 
evidence of an acute myocarditis accompanied by electrocardiographic 
abnormalities, including, heart blocks and murmurs of varying degree 
(Ormerod, 1970; Jones et al, 1975). Affected individuals suffer from
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overwhelming parasitaemia, and death may occur within a few weeks or 
months (Apted, 1970a). On physical examination the lymph nodes, spleen and 
the liver are enlarged and easily palpable. Auscultation of the heart reveals 
cardiac abnormalities varying from tachycardia, murmurs and heart blocks. 
Oedema mainly of the lower limbs and occasionally affecting the face has been 
documented (Wellde, Chumo, Reardon, Mwangi, Asenti, Mbabi, Abinya, 
Wanyama and Smith, 1989), giving the moonface syndrome (Manson-Bahr and 
Charters, 1963).
Reproductive changes observed in human patients, include, abortion, 
amenorrhoea and impotence (Greenwood and Whittle, 1980), gynacomastia 
with feminine-like fat distribution in males (Molyneux et al, 1984; Boersma, 
Hublart, Boutignon, Noireau, Lemesre, O-Herbomez and Degand, 1989). 
Severe diarrhoea has also been observed (Basson, Page and Myburgh, 1977).
1.3.3. Pathology
Lymphoadenopathy and splenomegaly are common features in human 
and animal trypanosomiasis (Sadun, Johnson, Nagle and Duxbury, 1973). 
Lymph nodes are enlarged, flabby, oedematous, and sometimes haemorrhagic. 
This is accompanied by cellular proliferation in the lymphoid tissues consisting 
of large pyroninophilic lymphoid cell and plasma cells with occasional 
macrophages. In chronic cases, the lymph node plasma cells occupy the entire 
node except the lymphocytic follicles which sometimes contain active germinal 
centres while others are small and inactive. In the most advanced cases, 
capsular and trabecular fibrosis is evident (Ormerod, 1970). Similar changes 
occur in the spleen where the plasma cell response, expands and disrupts the 
white pulp including the thymic-dependent periarteriolar lymphocytic sheath 
and a large part of the red pulp. In the later stages of infection both the lymph 
nodes and spleen become depleted of immunological cell types exposing the
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underlying framework of reticulum cells and fibroblast or alternatively 
histiocyte-like cells and multinucleated giant cells become prominent with 
occasional Mott cell appearance (Low and Mott, 1904). At the same time the 
lymph node and spleen in chronic cases atrophy (Ormerod, 1970).
The heart involvement is a common occurrence especially in the acute 
stages of T. b. rhodesiense infection and most acute deaths result from cardiac 
failure (Hawking and Greenfield, 1941; Manuelidis et al, 1965). At post­
mortem examination, the heart is enlarged, soft and flabby, with effusions in the 
pericardium, pleura, and the peritoneal serous cavities (Manson-Bahr and 
Charter, 1963; Francis, 1972; Mbala, Blacket, Mbonifor, Leke and Etoundi, 
1988). The serous fluid varies in colour and content, but is rich in plasma 
proteins and often contains trypanosomes (Hawking and Greenfield, 1941). 
Histologically, cardiac involvement presents as a pancarditis affecting all the 
heart layers including valves, draining blood and lymphatic vessels, and the 
conducting system (Poltera, Cox and Owor, 1976). These changes are the basis 
for the clinically observed cardiac insufficiency and electrocardiographic 
changes reported in infected patients (Jones et al, 1975; Poltera and Cox, 1977; 
Mbala et al, 1988). Microscopically, there is focal or diffuse mononuclear cell 
infiltration of the interstitial tissue and the perivascular spaces, accompanied by 
myocytolysis and focal endocardial fibrosis of the conducting system (Hawking 
and Greenfield, 1941; Poltera et al, 1976). Occlusion of the local draining 
lymphatics due to cellular infiltration, and phlebitis are common occurrences.
The livers from infected patients are usually enlarged, congested, 
mottled and pale with varying degree of fatty changes (Jenkins and Robertson, 
1959; Apted, 1970a). Histologically there is an increased level of phagocytic 
cell activity and numbers, with enlargement of Kupffer cell and prominence of 
mitotic figures. Pneumonia is a common feature of trypanosomiasis 
accompanied by congestion and oedema of the lungs resulting from the
pancarditis, and/or secondary bacterial infection (Cohen, 1973; Poltera, Owor 
and Cox, 1977). This can be accompanied by pleuritis (Adams et al, 1986).
Ocular changes have been described in untreated human patients and 
include keratitis, iridocyclitis, retinitis, papilo-oedema, optic and atrophic 
neuritis (Greenwood and Whittle, 1980). In dogs varying degree of hypopyon, 
hyphema, and corneal opacity have been documented (Morrison, Murray, Sayer 
and Preston, 1981a).
Tne CNS involvement is the predominant sign of typical T. b. gambiense 
and chronic T. b. rhodesiense infection (Haller et al, 1986; Pentreath, 1989). 
The CNS shows minimal gross pathological changes during the acute phase of 
trypanosomiasis, but in the chronic cases there is thickening and congestion of 
the meninges (Greenwood, Whittle, Oduloju and Dourmaskin, 1976). 
Occasional purulent meningitis and brain oedema have been reported. On 
histological examination, brains of trypanosome-infected patients, present a non 
specific lymphocytic plasmacytic meningoencephalitis of varying intensity 
(Adams et al, 1986). The most striking feature is a perivascular infiltration of 
the Virchow-Robin spaces, i.e., perivascular cuffing by inflammatory cells 
mainly lymphocytes, plasma cells and in the advanced cases, macrophages. In 
these advanced cases, the inflammatory cells can be found extending into the 
neuropil with damage to the piaglial lining. These changes are most evident in 
the white matter of the cerebral hemispheres and cerebellum, the basal nuclei, 
and the brain stem, although similar lesions are seen in the deep layers of the 
cerebral cortex. Present also are Mott cells filled with immunoglobulins found 
at the perivascular space in association with other inflammatory cells or alone 
scattered in the neuropil. Diffuse microglial hyperplasia in the gray matter, and 
large reactive astrocytes throughout the white matter have been described in 
humans (Adams et al, 1986) and in experimental animals (Hunter, Jennings,
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Kennedy and Murray, 1992a). Inflammatory cells are also found in the 
ventricles and the choroid plexus alone or in association with trypanosomes.
Accompanying CNS pathology, are changes in the cerebrospinal fluid 
(CSF). Normal human CSF is usually clear, containing less than 5 white blood 
cells (WBC) per ml and a protein content of lower than 0.25 gm per litre 
(Abaru, Liwo, Isakina and Okori, 1984). Immunoglobulin levels are also low 
with undetectable IgM immunoglobulins. In patients with advanced 
trypanosomiasis, trypanosome invade the CSF causing cellular and 
immunological changes that are of pathological and diagnostic importance. 
There is cellular infiltration of the CSF giving it a tinge of cloudiness and 
viscosity. These cells are mainly of the lymphocytes and plasma cell series, but 
with progress of the infection, Mott cells and macrophages appear. Chronic 
infection, especially with T. b. gambiense, leads to a rapid CSF 
hypergammaglobulinaemia dominated by an increase in IgM immunoglobulins 
(Greenwood and Whittle, 1973). This results from an in situ production of the 
immunoglobulins by the infiltrating plasma cells. The raised CSF IgM is of 
diagnostic importance in chronic T. b. gambiense infections (Mattem, Klein, 
Radema and Van Furth, 1967). Accompanying the increase in immunoglobins 
is the appearance of immune complexes in the serum and cerebrospinal fluid 
(Lambert, Bemey and Kazyumba, 1981).
1.4. POSSIBLE PATHOGENIC MECHANISM OF TRYPANOSOMIASIS
The precise mechanism leading to the production of the many pathological 
alterations accompanying African trypanosomiasis is not yet clearly understood 
(Murray, 1974; Urquhart, 1980; Morrison, Murray, Sayer and Preston, 1981a; 
1981b; Pentreath, 1991). The major changes that occur, include, anaemia, 
lymphoid proliferation, immunosuppression, increased capillary permeability 
and circulatory disturbances, tissue inflammation accompanied by severe tissue
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damage, biochemical alterations and hormonal imbalances. Several hypothesis 
have been proposed to explain the mechanisms responsible for these 
pathological alterations, These include the possible presence of a trypanosome 
toxin, induction of pharmacological active products, release of enzyme from 
host tissues and disintegrating trypanosome and immune-mediated reaction 
with increased production of cytokines.
1.4.1. Toxin.
There has been speculation on the possible presence of a trypanosome toxin 
believed to be responsible for initiating the observed pathological changes 
during infection (Huan, Webb, Lambert and Meischer, 1975; Tizard et al, 
1978). Seed (1969) isolated a protein fraction from the homogenates o f T. b. 
gambiense which increased vascular permeability in rabbits while Murray, 
(1979) identified a haemolytic factor that may be operative in vivo during 
bovine trypanosomiasis (Murray, Huan, Lambert and Gerber, 1977). Indeed 
some of the pathological alteration of trypanosome infection can be produced 
by trypanosome lysate product, including, immunosuppression, mitogenic 
suppression (Clayton, Sacks, Ogilvie and Askonas, 1979), and increased 
vascular permeability. Recent work has demonstrated increased levels of 
endotoxin-like activity in serum of trypanosome infected mice and also in 
trypanosome lysates (Alafiatayo, Crawley, Oppenheim and Pentreath, 1993). 
Trypanosome product(s) have been shown to block cell growth, inhibit the 
complete development of T-lymphocytes through the cell cycle (Sztein and 
Kierszenbaum, 1991) and growth of human promyelocytic cell types 
(Temitope, Seed, Sechelski and Balber, 1993). The precise nature of this toxin 
has not been determined but it could be the trypanosome molecule(s) 
responsible for initiating the production of the polyclonal-B cell activation 
(Urquhart, Murray, Murray, Jennings and Bate, 1973; Greenwood, 1974),
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immunosuppression (Hudson, Byner, Freeman and Terry, 1976), and cytokine 
production (Reincke, Allolio, Petzke, Heppner, Mbulamberi, Vollmer, 
Winkelmann and Chrousos, 1993) during trypanosome infection. A 
trypanosome lymphocyte triggering factor (TLTF) has been purified from 
trypanosomes (Bakhiet, Olsson, Edlund, Hojeberg, Holmberg, Lorentzen and 
Kristensson, 1993). The TLTF was shown to be able to stimulate rat and human 
mononuclear cells to release interferon-y (IFN-y), an effect that was CD8+ T- 
lymphocyte dependent (Olsson, Bakhiet, Edlund, Hojeberg, van der Meide and 
Kristensson, 1991).
1.4.2. Induction of Harmful Metabolic Products
Trypanosomes have been shown to be able to metabolise aromatic amino 
acids to a series of potentially toxic products (Stibbs and Seed, 1973; 1975; 
1976). Tryptophan is catabolised to indole-pyruvate, indole-lactate, indole 
acetate, and indole-ethanol. Tyrosine is metabolised to p- 
hydroxyphenylpyruvate and /?-hydroxyphenyllactate while phenylalanine is 
catabolised to phenylpyruvate. Several of these compounds injected at 
pharmacological doses have been shown to have toxic properties. Indole- 
ethanol can induce a sleep-like state, alter body temperature (Seed and 
Sechelski, 1977), and be immunosuppressive (Sachez, Lockwood and Chavez, 
1981).
1.4.3. Immunopathogenesis
Trypanosome infection in humans and animals results in both 
quantitative and qualitative changes in the immune system of the affected host. 
There is a decreased response in antibody production and mitogenic response to 
both trypanosome and non-trypanosome antigens, and increased
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immunosuppression accompanied by elevated non-specific antibody 
production.
1.4.3.1. Changes in the lymphoid organs.
The lymphoid system in the trypanosome-infected host undergoes 
cellular and architectural changes that could undermine its effective function. 
There is normally enlargement of the spleen, and lymph nodes associated with 
marked cellular hyperplasia of the lymphocyte and mononuclear cells. This 
hyperplasia results in increased B-cell areas with increased large lymphoid cells 
and immature and mature plasma cells, while the periarteriolar lymphatic sheath 
(T-cell area) becomes depleted of small lymphocytes and is infiltrated with 
macrophages and plasmablasts (Murray Jennings, Murray and Urquhart, 
1974b).
1.4.3.2. Immune complexes
Immune complexes can increase to high levels in serum and CSF of 
infected humans. This has been found to correlate well with polyclonal B cell 
activation and with intracerebral immunoglobulin synthesis (Lambert et al, 
1981). The immune complexes are deposited in tissues and could lead to 
complement activation, disseminated intravascular coagulation, immune- 
mediated tissue damage, including vasculitis (Poltera, Hochmann, Rudin and 
Lambert, 1980a; Van Marck, Mulumba, Gigase and Wery, 1983), 
glomerulonephritis (Lambert and Houba, 1974; Sadun et al, 1973) and 
cardiomyopathy (Poltera, Hochmann and Lambert, 1980b), which are common 
alterations observed in trypanosomiasis. Similarly immune complex-deposition 
in tissues invaded by trypanosomes has been reported to occur in both rodents 
(Murray, 1974; Murray, Lambert and Morrison, 1975) and primates 
experimentally infected with African trypanosomes (Poltera, 1980).
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I.4.3.3. Autoimmunity
Auto-antibody production is a feature of sleeping sickness. Auto­
antibodies are produced against a wide range of antigens such as erythrocytes, 
smooth and striated muscles, and deoxyribonucleic acid (Kobayakawa, Louis, 
Izui and Lambert, 1979; Poltera et al, 1980a; Kazyumba, Bemey, Brighouse, 
Cruchaud and Lambert, 1986). Other studies have found in human sera, the 
presence of high titers of antibody against brain myelin proteins (Ansonganyi, 
Lando and Ngu, 1989), and against galactocerebrosides, a major component of 
myelin (Amevigbe, Jauberteau-Marchan, Bouteille, Doua, Breton, Nicolas and 
Dumas, 1992). Immunoreactivity against galactocerebrosides has been 
demonstrated in trypanosome-infected sheep (Jauberteau, Younes-Chennooufi, 
Amevigbe, Bouteille, Dumas, Breton and Baumann, 1991). In infected mice, a 
strong correlation exists between the levels of auto-antibodies to myelin basic 
protein, galactocerebrosides and gangliosides, and damage to the CNS caused 
by the progression of infection or by the enhanced reactive damage following 
drug treatment (Hunter, Jennings, Tierney, Murray and Kennedy, 1992b). This 
observations suggests the possible production of the tissue pathology through 
an autoimmune-mediated mechanism.
1.4.4. Pharmacological Active Products
1.4.4.1. Autacoids
These are pharmacologically active products derived from inflammatory 
cells and injured tissue and, if released in high amounts into the circulation, can 
result in a wide effect on the host homeostatic mechanism. They are known to 
cause several effects, including, hypotension, increased capillary permeability, 
and be chemotactic (Ackerman and Seed, 1976; Boreham, 1978). During 
human and animal trypanosome infections, several autacoids have been shown
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to increase significantly in the circulatory system, including, kinin, histamine, 
prostaglandin and 5-hydroxytryptamine (Richard, 1965; Boreman, 1970; 
Pentreath, Rees, Owolabi, Philip and Doua, 1990). These might be responsible 
for the observed cardiovascular disruption and changes in sleep patterns 
observed during trypanosomiasis (Pentreath et al, 1990). Increased
prostaglandin levels in CSF in humans are thought to be responsible for the 
alteration in the sleep pattern. Infected rabbits (Stibbs, 1984), and mice (Stibbs 
and Curtis, 1987; Amole, Sharpless, Wittner and Tanowitz, 1989), also show 
decreased levels of neurochemical molecules in brain tissue which could 
explain the observed behavioural symptoms in infected hosts.
1.4.5. Enzymes
1.4.5.1. Trypanosome enzymes
Several trypanosome species have been shown to contain phospholipase 
A \  and lysophosphalipase, with T. b. brucei having the highest levels (Mellor, 
1985). Accumulated high levels have been recorded in tissue fluid of T. b. 
brucei- infected rabbits (Hambrey, Tizard and Mellor, 1980). This 
phospholipase could lead to the generation of membrane-active products from 
phospholipids such as free fatty acids, which are known to be 
immunosuppressive (Mertin and Hughes, 1975).
Plasma of mice infected with T. b. brucei, contains increased levels of 
parasite derived peptidase enzyme (Knowles, Black and Whitelaw, 1987). The 
presence of this enzymes might contribute to the increased catabolism of serum 
proteins reported by Jennings, Murray, Murray and Urquhart (1973).
1.4.5.2. Lysosomal enzymes
Phagocytic cells, mainly of the mononuclear series, are known to 
accumulate in the vicinity of tissues and blood vessels during trypanosomiasis
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(Goodwin, 1971). These cells contain lysosomal enzymes which can be 
released with or without cell destruction, and which have the potential to 
destroy cell components and organelles. In trypanosomiasis, they could 
participate in the pathogenesis by increasing leakage from blood vessels by 
direct action on the vascular endothelium, by activating the kallikrein-kinin 
system, or by acting as chemotactic agents for granulocytes and destroying the 
connective tissue, features observed during trypanosome infection.
1.4.6. Other Reactive Molecules
Macrophages from trypanosome-infected hosts have been shown to 
produce high levels of nitric oxide and prostaglandin (PGE201) that are 
speculated to be responsible for the inhibition of T-cell lymphocyte 
proliferation and reduced response to mitogen and trypanosome antigen 
(Sternberg and McGuigan, 1992; Schleifer and Mansfield, 1993; Mabbot, 
Sutherland and Sternberg, 1995). This might lead to the immunosuppression 
observed during trypanosomiasis, eventually resulting in secondary infections 
which are responsible for many deaths in chronic infections.
1.5. CLINICAL PATHOLOGY
1.5.1. Role of Cytokines in Disease and Trypanosomiasis
Cytokines are regulatory peptides that are produced by virtually every 
nucleated cell type, including monocytes, lymphocytes, vascular endothelium 
and smooth muscle cells, fibroblasts and hepatocytes (Andus, Bauer and Gerok, 
1991).
Cytokines have pleiotropic regulatory effects on haemopoietic and non- 
haemopoetic cell types, which participate in the host defence and tissue repair 
processes. Monocytes and macrophages are the major source of most cytokines. 
Cytokines are extremely potent with autocrine and/or paracrine effects
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producing their action through binding to specific high affinity cell surface 
receptors on the target cell. A number of important physiological functions have 
been attributed to cytokines (Balkwill and Burk, 1989; Andus et al, 1991). For 
example, they form a complex communication network among cells of the 
haematopoetic system in which they control the differentiation and maturation 
of stem cells in the bone marrow (Thomas, Reasor and Wierda, 1989). 
Cytokines involved in haematopoiesis, include, interleukin-3 (IL-3), 
interleukin-4 (IL-4), interleukin-5 (IL-5), and interleukin-7 (IL-7) and colony- 
stimulating factors (CSFs).
Cytokines also contribute to both the specific and non-specific immune 
response by regulating lymphocyte proliferation, differentiation and activation, 
and by increasing resistance to viral infection and neoplasms (O'Garra, 1989a; 
1989b; Aiello, Longo, Overton, Takacs and Durum, 1990; Akira, Hirano, Taga 
and Kishimoto, 1990). Cytokines which regulate the immune system, include, 
interleukins, TNF-a, and interferons (Duff and Oppenheim, 1992; Akira et al, 
1990). Some cytokines, including, IL-1, IL-6 and TNF-a, decrease the synthesis 
of plasma proteins, such as albumin, and increase the synthesis of the acute 
phase proteins (Andus et al, 1991).
Although cytokines perform beneficial regulatory functions in the 
haematopoietic and immune system, and during inflammation, evidence from 
numerous studies suggests that they may be involved in the development of 
tissue injury under certain pathological disease conditions (Titus, Sherry and 
Cerami, 1991), including the induction of inflammatory changes (Grau, 
Fajardo, Piguet, Allet, Lambert and Vasalli, 1987; Waage, Halstensen, Shalaby, 
Brandtzaeg, Kierulf and Espevik 1989; Ramilo, Saez-Llorens, Jafari, Olsen, 
Hansen, Yoshinaga, Ohkawara, Nariuchi and McCracken, 1990; Saukkonen, 
Sande, Cioffe, Wolpe, Sherry, Cerami and Tuomanen, 1990), fever (Tewari, 
Buhles and Starnes, 1990; Kluger, 1991; Nakamori, Morimoto, Yamaguchi,
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Watanabe and Murakami, 1994), hypotension (Baldwin, Alpert, Caputo, 
Baskin, Parsonnet, Gillis, Thompson, Siber and Fleisher, 1991), and the 
production of hepatic acute phase proteins (Baumann and Gauldie, 1994). The 
extravasation of inflammatory cells to produce tissue inflammation is effected 
by cytokines through regulation of the production of adhesion molecules, 
including, intercellular adhesion molecule (ICAM) and endothelial adhesion 
molecule (ELAM) and also by the chemotactic effects of cytokines (Beutler and 
Cerami, 1988; Rees, 1991).
In the immune system, cytokines are potent regulators of both T and B 
cells growth and differentiation (Vilcek and Le, 1994). Cytokines are also 
known to activate macrophages by inducing macrophage differentiation ^nd 
enhancing major histocompatibility complex (MHC) expression (Mackenzie, 
Culpepper, de Waal Malefyt, Briere, Punnonen, Aversa, Sato, Dang, Cocks, 
Menon, de Vries, Banchereau and Zurawski, 1993). In addition, they cause 
changes in the endothelial cell by production of adhesion molecules and also 
increasing the vascular permeability, thus, causing transduction of 
inflammatory cell into the extravascular spaces and tissues (Sharief, Ciardi and 
Thompson, 1992).
During trypanosomiasis increased levels of cytokines have been reported 
(Bancroft, Sutton, Morris and Askonas, 1983; Askonas and Bancroft, 1984; Le 
and Vilcek, 1987; Hunter, Gow, Kennedy, Jennings and Murray, 1991; Hunter 
et al, 1992a; Reinke et al, 1993) and may be important factors in the production 
of most of the observed pathological changes. They are thought to be 
responsible for the initiation of inflammatory changes in the CNS (Hunter et al, 
1991; Hunter et al, 1992a), production of acute phase proteins (Ndungu, 
Eckersall and Jennings, 1991), and the cachexia and hypertriglyceridemia 
(Rouzer and Cerami, 1980; Beutler and Cerami, 1988; Ndungu, 1990). Indeed, 
cytokine production by the astrocytes is speculated to be involved in the
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initiation of CNS pathology of HAT (Hunter et al, 1992a). On the other hand, 
production of certain cytokines from lymphocytes, such as IL-2 and their 
receptors, are down regulated during infection (Alcina and Fresno, 1985; 
Sileghem and Flynn, 1992). This leads to the inhibition of T-cell proliferation 
and to a reduced response to antigens and mitogens both of which require the 
secretion of IL-2 and generation of surface IL-2 receptors (Smith, 1984). This is 
thought to be a contributory factor to the immunosuppression and reduction of 
cell mitogen response observed during trypanosomiasis (Sztein and 
Kierszenbaum, 1993). Similarly a TLTF released from trypanosomes has been 
shown to induce production of interferon-y, which subsequently stimulated 
parasite growth (Olsson et al, 1991). This cytokine is known to increase in vivo 
during trypanosome infection (Bancroft et al, 1983) and is immunosuppressive 
(Klimpel, Annable, Cleveland, Jerrels and Patterson, 1990). Interferon-y may 
therefore be responsible for the immunosuppression that occurs during 
trypanosome infection (Bancroft et al, 1983; Olsson, Bakhiet and Kristensson, 
1992; Bentivoglio, Grassi-Zucconi, Olsson and Kristensson, 1994).
Cytokines have also been shown to have an effect on the endocrine 
system. In this regard, in vivo and in vitro studies have indicated that, IL -lp and 
TNF-a can inhibit thyroid-stimulating hormone (TSH) secretion, as well as 
thyroid hormone release (Dubuis, Dayer, Siegrit-Kaiser and Burger. 1988; Van 
der Poll, Romijn, Wiersinga and Sauerwein, 1990; Ozawa, Sato, Han, 
Kawakami, Tsushima and Shizume, 1988). Similar hormonal changes have 
been observed during trypanosome infection (Boersma et al, 1989; Mutayoba, 
Gombe, Waindi and Kaaye, 1988a; Mutayoba, Oharar-Ireri and Gombe, 
1988b), possibly resulting from cytokine effects on the endocrine system 
(Mutayoba, 1993).
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1.5.2. Pathophysiological Effects of Endotoxin and the Possible Role in 
Pathogenesis of Trypanosomiasis
Endotoxins are components of the cell wall of gram negative bacteria 
that have profound effects on the immune and non immune system of many 
hosts (Hewett and Roth, 1993). Bacterial endotoxins are composed of complex 
lipopolysaccharides (LPS) with some diversity in the nature of polysaccharide 
but with a common lipid moiety, known as lipid-A (Fig. 1.1). Endotoxin-like 
molecules have also been described in a few protozoan pathogens, including, 
Plasmodia species (Jakobsen, Baek and Jepsen, 1988), Trypanosoma cruzi 
(Goldberge, Cordeiro Pereira and Mares-Guia, 1983) and Chlamydia species 
(Lewis, Thacker and Mitchell, 1979).
In most species, the liver is the main organ for the detoxification of LPS 
by an intracellular element of hepatic cells (Trapani, Waravdekar, Landy and 
Shear, 1962), although in some species, like sheep, the lung plays a major role 
(Warner, DeCamp, Molina and Brain, 1988; DeCamp, Warner, Molina and 
Brain, 1992), while the kidney can contribute to a lesser degree (Freudenberg, 
Kleine and Galanos, 1984).
The in vivo response to LPS is extremely complex, and dependent on a 
large number of variables, including, host species and age, dosage, timing and 
method of administration of LPS, and the immunological and health status of 
the animal (Durham, Brouwer, Barelds, Horan and Knook, 1990; Elliot, Welty 
and Kuo, 1991). LPS exerts profound effects on the preformed cellular elements 
and has potent effect on both the cellular and humoral limb of the immune 
system (Bayston and Cohen, 1990). They are potent immunostimulators, 
strongly activating B-lymphocytes, granulocytes and mononuclear cells. In 
addition, LPS strongly up regulates macrophage class II major 
histocompatibility complex expression (Ziegler, Staffileno and Wentworth, 
1984). Bacterial LPS has been demonstrated to have beneficial activities such
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as immunoadjuvanticity, anti-tumour activities, and enhancement of non­
specific host defence mechanisms against microbial infections (Chedid and 
LeGarrec, 1980; Nowotny, Abdelnoor, Behling, Butler, Johnson and Nowotny, 
1982;Parat, 1983; Nowotny, 1985).
However, when LPS is administered at a high concentration or released 
in large amounts as may happen during an infection, it can cause adverse effects 
by its direct action and through the production of pro-inflammatory molecules 
including cytokines and prostaglandin from the mononuclear cells (Morrison 
and Ryan, 1979).
Bacterial LPS is endowed with a broad spectrum of biological activity 
such as pyrogenicity and lethal toxicity. It is the dose of LPS and duration of 
exposure to it that determines the effects seen in the host. Different species 
differ in their response to the LPS. Man is the most susceptible to LPS 
(Morgan, 1965; Rubenstein, Mulholland, Jeffery and Wolff, 1965; Sauter and 
Wolfensberger, 1980), followed by the dog (Reddin, Starzecki and Spink, 
1966), while the lizard and the bird show the highest tolerance (Zuckerman and 
Yoeli, 1945; Goodwin and Stapleton, 1952). This could be dependent on the 
ability of their mononuclear cells to produce cytokines on stimulation by the 
LPS. Indeed, mice naturally resistant to endotoxin, are known to be unable to 
produce TNF (Beutler, Krochin, Milsark, Luedke and Cerami, 1986), and 
tolerance to endotoxin has been shown to be associated with reduced cytokine 
production (He, Fong, Marano, Gershenwald, Yurt, Moldawer and Lowry, 
1992: Roth, McClellan, Kluger and Zeisberger, 1994).
The clinical effects of LPS are wide ranging and include fever, 
hypotension, hypoglycaemia, coagulopathy, organ failure, shock, and death. 
Although endotoxin may cause direct damage to tissue, such as, endothelium, 
many of its effects are produced secondary to the triggering of an inflammatory 
reaction which includes activation of complement, neutrophil and platelets and
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release of arachidonic acid metabolites. Further secondary effects of LPS are 
caused by the production of cytokine in mononuclear cells (Rietschel, Brade, 
Schade, Seydel, Zahringer, Brandenburg, Helander, Holst, Kondo, Kuhn, 
Lindner, Rohrscheidt, Russa, Labischinski, Naumann and Brade, 1990; van 
Deventer, Buller, ten Cate, Aarden, Hack and Sturk, 1990). In this process LPS 
binds to a plasma protein referred to as lipopolysaccharide binding protein, 
forming a complex which activates mononuclear cells by attaching to CD 14 
surface receptor (Gaily, Carrel, Glauser, Barras, Ulevitch, Tobias, Baumgartner 
andHeumann, 1993).
One of the initial pathological events associated with endotoxin exposure 
is the direct breakdown of vascular endothelium (Harlan, Harber, Striker and 
Weaver, 1983) including in the CNS (Eckman, King and Brunson, 1958), 
resulting in impairment of the endothelial barrier, diffuse increased capillary 
permeability, and adherence of neutrophils to the endothelium with subsequent 
migration into the tissue (Kopaniak, Issekutz and Movat, 1980). It also acts as a 
pyrogen by a direct effect on the thermoregulatory centre in the brain or 
indirectly via the production of IL-1 (Roth et al, 1994).
On the non-haemopoetic system, circulating LPS produces prolonged 
neutropenia, fever, shock, thrombocytopenia, alteration in the concentration of 
plasma proteins (acute phase proteins), disseminated intravascular coagulopathy 
(DIC), activation of the classical complement pathway and hypotension 
(Hewett and Roth, 1993). As mentioned, many of these effects are mediated 
through mononuclear cell by their release of cytokines such as TNF-a, IL-1 and 
IL-6. In the adipose tissue, TNF-a causes suppression of the enzyme lipoprotein 
lipase, thereby preventing the uptake of exogenous triglycerides by fat cells and 
causing the paradoxical hyperlipidaemia associated with infection (Grunfeld 
and Feingold, 1991) or LPS administration (Kaufmann, Matson and Biesel, 
1976; Feingold, Staprans, Memon, Moser, Shigenaga, Doerrler, Dinarello and
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Grudfeld, 1992; Liao and Floren, 1993). The cytokines also influence the liver 
function by increasing the production of positive acute phase proteins such as 
haptoglobin, C-reactive protein (CRP) and serum amyloid P-component (SAP), 
while reducing the production of the negative acute phase proteins such as 
albumin (Heinrich, Castell and Andus, 1990; Steel and Whitehead, 1994).
Production of prostaglandins (Peters, Karck and Decker, 1990) and nitric 
oxide (Rees, Cellek, Palmer and Moncad, 1990) from mononuclear cells, are 
also stimulated by LPS. These are known to have immunosuppressive effect on 
the host, while chronic exposure to endotoxin results in polyclonal B-cell 
activation with hypergammaglobulinaemia, profound immunosuppression and 
decreased mitogenic response and cytokines production (Fraker, Stovroff, 
Merino and Norton, 1988; Friedman, Newton, Widen, Klein and Spitzer, 1992; 
Roth et al, 1994).
Lipopolysaccharide leads to impairment of glucose homeostasis 
(Knowles, Beevers and Pogson, 1986). Early or mild endotoxaemia generates 
hyperglycaemia, whereas prolonged endotoxaemia causes hypoglycaemia 
(Filkins, 1982; Knowles et al, 1986), an effect resulting from endotoxin 
stimulating the production of prostaglandin (PG2Ct) (Kuiper, Kamps and van 
Berkel, 1990).
Lipopolysaccharide exposure results in the development of circulatory 
shock due to decreased cardiac output accompanied by a marked decrease in 
mean arterial blood pressure (Hinshaw, 1979; D'Orio, Wahlen, Rodriguez, 
Fossion, Juchmes, Haleux and Marcelle, 1987; Wakabayashi, Hatake, Kakishita 
and Nagai, 1987). Similarly LPS directly activates the coagulation system 
resulting in DIC (Warr, Rao and Rapaport, 1990), and thus a reduction in 
circulating platelets, clotting factors and fibrinogen (Emerson, Foumel, Leach 
and Redeus, 1987; Sandset, War-Cramer, Maki and Rapaport, 1991). This leads
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to the formation of fibrin clots in the vasculature and ultimate deposition in 
tissues resulting in tissue damage due to a disruption in tissue perfusion.
Molecules with endotoxin-like activity, have been described in several 
parasites (see earlier) but only in a few of these has the endotoxin been 
compared to bacterial LPS and these include T. cruzi (Goldberge et al, 1983), 
and Coxiella burneti (Baca and Paretsky, 1974).
In trypanosomiasis increased endotoxin-like activity has been 
demonstrated in mouse serum infected with T. b. brucei and directly in parasite 
lysates (T. b. brucei) (Alafiatayo et al, 1993). The nature or/and chemical 
constituents of this endotoxin-like molecule(s), have not been characterised 
although it has been postulated to cause the production of pro-inflammatory 
molecules, including, cytokines, leading to the initiation of the pathological 
changes observed during trypanosomiasis (Pentreath, 1994). Bakhiet et al 
(1993) have managed to isolate and purify a TLTF molecule from T. b. brucei 
that was able to stimulate the production of interferon-y and parasite growth. 
Although not fully characterised the molecule has been speculated to be a 
glycoprotein (Bakhiet et al, 1993) but it is not known whether the TLTF also 
has the endotoxin-like activities identified with T. b. brucei.
1.5.3. Acute Phase Response
The acute phase reaction is a non-specific generalised reaction of an 
organism following inflammation, infection, and tissue damage (Fig. 1.2) 
(Dinarello, 1984; Dowton and Colten, 1988; Whicher and Westacott, 1992). It 
is accompanied by fever, leukocytosis, concentration changes in blood 
hormones, iron and zinc, and in blood plasma proteins, the acute phase proteins, 
such as haptoglobin, C-reactive protein, serum amyloid-A and serum amyloid-P 
(Dinarello, 1984). The acute phase response is evoked by pro-inflammatory 
molecules, including, cytokines released from leukocytes, primarily monocytes,
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and from damaged tissues cells, by prostaglandins and by other inflammatory 
mediators (Beutler, 1988; Baumann, Prowse, Marindo-Vic, Won and Jahreis, 
1989; Heinrich et al, 1990). Acute phase protein synthesis and liberation is as a 
result of cytokine-receptor regulated hepatocyte gene expression (Perlmuter, 
Dinarello, Punsal and Colten, 1986).
The magnitude and type of acute phase protein response is dependent on 
the host and the stimulating factor. Bacterial infection and infection where 
tissue invasion is involved are amongst the most potent stimulators (Whicher 
and Dieppe, 1985). The acute phase proteins are increasingly becoming of 
clinical significance in both human and animal disease conditions. They are 
being used for the diagnosis of subclinical disease (Gruys, van Ederen, 
Alsemgeest, Kalsbeek and Wensing, 1993), monitoring disease activity and 
tissue damage (Mozes, Friedman and Shainkin-Kestenbaum, 1989), and in 
assessing the response to therapy (Kaneti, Winikoff, Zimlichman and Shainkin- 
Kestenbaum, 1984). In this respect, serum amyloid-A (SAA) has been shown to 
be a sensitive marker for tissue damage and disease activity, and thus a good 
prognostic indicator following treatment (Kaneti et al, 1984; Biran, Friedman, 
Neumann, Pras and Shainkin-Kestenbaum, 1986; Mozes et al, 1989). C-reactive 
protein (CRP), on the other hand, has been documented to be a diagnostic 
indicator of secondary bacterial infection and response to antibiotic treatment 
(Mackie, Crockson and Stuart, 1979; Schofield, Voulgari, Gozzard, Leyland, 
Beching and Stuart, 1982), and as a guide to differentiating bacterial from non- 
bacterial infections (McCarthy, Frank, Ablow, Masters and Dolan, 1978; De 
Beer, Kirsten, Gie, Beyers and Strachan, 1984). Haptoglobin has been 
documented as a good indicator of infection and inflammation (Solter, 
Hoffmann, Hungerford, Siegel, Denis and Domer, 1991; Gruys et al, 1993; 
Skinner and Roberts, 1994), while serum amyloid-P (SAP) levels in mice with
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autoimmune arthritis, were shown to correlate significantly with the severity of 
polyarthritis (Rodorf-Adams, Serban Pataki and Gruninger, 1985).
The acute phase proteins could also play a part in the pathogenesis of 
diseases in which they are produced. Haptoglobin has been shown to affect the 
immune system, including, mediating non-specific immune suppression (Oh, 
Kim and Walker, 1990), while CRP and SAP can stimulate the production of 
pro-inflammatory molecules from monocytes (Sarlo and Mortensen, 1985; 
Ballou and Lozanski, 1992). ot2 -Macroglobulin can modulate the immune 
response and inhibit mitogen induced lymphocyte proliferation (Gravagna, 
Gianazza, Amaud, Neels and Ades, 1982; Miyanaga, Okubo, Kudo, Ikuta and 
Hirata, 1982), and also binds to cytokines thus modifying their properties 
(Matsudo, Hirano, Nagasawa and Kishimoto, 1989; Keith, 1990). Indeed, 
haptoglobin has been shown to be produced in higher amounts during 
trypanosome infection in resistant compared to susceptible mice (Shapiro and 
Black, 1992), while a-macroglobulin levels in T. cruzi infection were found to 
correlate well with resistance to acute infection (Araujo-Jorge, Lage, Rivera, 
Carlier and van Leuven, 1992). CRP injected into mice provided protection 
against Streptococcus pneumoniae (Mold, Nakayama, Hlzer, Gewurz and Du- 
Clos, 1981), while SAP enhanced macrophage listericidal activity (Singh, 
Gervais, Skamene and Mortensen, 1986).
An acute phase response detected by an increase in the serum 
concentration of acute phase proteins, has been documented following several 
parasitic infection in mice including T. cruzi (Scharfstein, Barcinski and Leon, 
1982; Araujo-Jorge et al, 1992; Luz and Araujo-Jorge, 1994), T. b. brucei 
(Pluschke, Jenni, van Alphen and Lefkovits, 1986; Shapiro and Black, 1992), 
Schistosoma mansoni (Pepys, Baltz, Gomer, Davies and Doenhoff, 1979), and 
Nippostrogylus brasiliensis (LaMontagne, Gauldie, Befus, McAdam, Baltz and 
Pepys, 1984).
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1.6. DISEASE IN THE CHRONIC MOUSE MODEL
1.6.1. Introduction
The trypanosome mouse model has been of extreme importance in the 
study on African trypanosomiasis (Jennings and Gray, 1983). It has been used 
for both pathogenesis and chemotherapy studies (Jennings, 1991; 1992a; 1992b; 
Hunter et al, 1992a).
Infected mice show pathological changes similar to those observed in 
infected humans. The mice become immunosuppressed to trypanosome 
antigens (Goodwin, 1970; Sacks and Askonas, 1974) and a variety of non 
trypanosomal antigens (Murray, Jennings, Murray and Urquhart 1974a; 1974b; 
Albright, Albright and Dusanic, 1977). Associated with this is a marked 
response of the lymphoid organs of the infected mice involving expansion of 
the mononuclear phagocytic system (Murray, Murray, Jennings, Fisher and 
Urquhart, 1974a; Morrison, Murray and Hinson, 1982) and increased levels of 
IgM immunoglobulins (Hudson et al, 1976). Changes in the production of pro- 
inflammatory molecules including prostaglandins (Fierer, Salmon and Askonas, 
1984), and cytokines have also been observed in this model (Bancroft et al, 
1983; Hunter et al, 1991).
1.6.2. Clinical Signs
Mice infected with trypanosomes show minimal observable clinical 
changes. They remain lively, but lose body condition and become anaemic, 
with abdominal distension associated with spleen and liver enlargement. A day 
or so before death, they become dull and lethargic ultimately dying of severe 
anaemia. Occasional posterior paresis (Jennings, Murray, Murray and Urquhart, 
1974) and oedema of the eye lids are observed. In experimental models utilising 
deer mice, (Peromyscus maniculatus), advanced infections show a clinical
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picture of neurological damage, lethargy, incordination, hyperkinesis, paralysis, 
convulsions and coma (Molton and Stevens, 1977; Murray and Jennings, 1983).
1.6.3. Pathology
The most common pathological changes observed in infected mice 
include lymphadenopathy, splenomegaly, hepatomegaly with mottling and fatty 
change. Chronic infections are accompanied by a decrease and gelatinisation of 
body fat and hyperaemic brain meninges.
The lymph nodes show an increase in proliferative activity in the 
follicular areas. These regions become expanded due to the presence of large 
active germinal centres containing large lymphocytes showing high mitotic 
activity and a narrow layer of small lymphocytes at the periphery of the follicle. 
The medullary cord also contain numerous plasma cells and large lymphocytes 
(Morrison, et al, 1982). The thymus shows similar changes to the lymph nodes 
except that later in the infection there is a reduction in the thymic cortex, 
although there is still marked mitotic activity in the thymic cortical thymocytes. 
The thymic vessels become distended and sometimes contain numerous 
macrophages (Morrison, Murray and Bovell, 1981c). On the other hand, the 
spleen shows an initial proliferative phase characterised by widespread 
hyperplasia of the white pulp with the production of large numbers o f plasma 
cells and an expansion of the erythropoietic component of the red pulp. 
Following the initial proliferative phase, a more protracted phase of further 
cellular proliferation leads to gradual disorganisation of the white pulp with 
eventual lymphoid depletion. This is also accompanied by a progressive 
expansion of the red pulp due to increased numbers of erythropoietic cells and 
to a lesser extent granulopoietic cells and macrophages (Morrison et al, 1981c).
Livers of infected mice show an increase in number and size of the 
Kupffer cells lining the hepatic sinusoids, many of which are found in mitosis
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(Murray et al, 1974a). There is also a marked increase in cellular infiltration 
particularly at the perivascular locations. In addition, small foci of hepatic 
cellular degeneration can be found in the substance of the liver and necrotic 
cells are sometimes observed within the sinusoid (Morrison et al, 1982).
Mice develop a pancarditis similar to the one observed in man. This is 
associated with severe cellular infiltration of the endocardium, myocardium and 
epicardium by mononuclear cell. Also encountered is destruction of muscles 
fibers (Poltera et al, 1980b). Parasites are predominantly observed on the 
endocardial and epicardial side but are also present in the valves, the conducting 
system and lymphatic system draining the heart and become particularly 
evident in late infection. Similarly during this late infection draining lymph 
nodes show marked histiocytic proliferation and the cardiac blood vessels 
become convoluted and distended (Poltera et al, 1980b).
In the early stages of infection the brain of infected mice present a non­
specific meningitis (Fig. 1.3, Fig. 1.4, Fig. 1.5). This later develops into a 
meningoencephalitis, with perivascular cuffing, and occasional damage to 
piaglial lining (Jennings and Gray, 1983). Dramatic astrocyte activation occurs 
(Hunter et al, 1992a). Treatment of infected mice with a number of trypanocidal 
drugs that do not cross the blood brain barrier and thus are unable to clear 
trypanosomes from the CNS, leads to the development of a severe post reactive 
encephalopathy (Jennings and Gray, 1983) similar to that observed in humans 
after treatment with melarsoprol (Adams et al, 1986). This reaction in mice has 
been utilised to study the pathogenesis of the disease and the associated 
encephalopathy. It has been shown that astrocyte activation occurs before any 
inflammatory changes can be observed, correlates well with cytokine 
production (Hunter et al, 1991; Hunter et al, 1992a) and therefore may be the 
core inductive event, i.e., trypanosome or trypanosome-derived factors may
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activate astrocytes with the consequent development of the inflammatory 
reaction.
1.7. JUSTIFICATION AND OBJECTIVES OF THE STUDY
Although the clinical and pathological changes following human and 
animal African trypanosomiasis are well described, the primary or pathogenic 
mechanisms involved, and the parasite interaction with the host still remains 
unclear (Pentreath, 1991). Most of the pathological changes are speculated to be 
produced as an result of the immune response to the parasite and increased 
cytokine production during infection (Rouzer and Cerami, 1980; Bancroft et al, 
1983; Hunter et al, 1992a). Trypanosome product(s) in vivo and in vitro, have 
been shown to produce some of the pathological effects observed in the infected 
host, including immunosuppression (Clayton et al, 1979) and stimulation of 
cytokines (Oka, Nagasawa, Ito and Himeno, 1989; Gichuki, 1994).
Thus, it has been hypothesised that a trypanosome product(s), possibly 
an endotoxin-like molecule(s), might be involved, but this has not been isolated 
or characterised (Greenwood, 1974; Tizard et al, 1978). Previous experimental 
work has demonstrated increased endotoxin-like activity in mice infected with 
T. b. brucei and in isolated trypanosomes (Alafiatayo et al, 1993). However, 
these studies did not clarify whether the endotoxin activity being measured was 
from the trypanosomes or from secondary bacterial infection (Alafiatayo et al, 
1993). Similarly, the pathogenic significance of secondary bacterial infection or 
of increased serum endotoxin-like activity in the disease process in the infected 
host was not examined.
A trypanosome lymphocyte triggering factor (TLTF), recently isolated 
from trypanosomes, has been shown to stimulate lymphocytes to produce 
interferon gamma (IFN-y) (Olsson et al, 1991). These findings seem to indicate 
the presence of active molecule(s) in trypanosomes which could be responsible
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for the pathogenesis of trypanosomiasis. This study addresses this possibility by 
measuring endotoxin-like activity and the associated acute phase response in 
plasma of trypanosome infected animals, determining the pathological 
significance of such endotoxin-like activity and identifying the origin, i.e., 
parasitic or bacterial.
1.7.1. Objectives of the Study
1). To develop and validate an assay for serum amyloid P-component (SAP), an 
acute phase reactant in mice.
2). To characterise the acute phase response during chronic trypanosome 
infections with tissue invasive and non-invasive trypanosome species, and 
establish whether acute phase proteins are indicators of parasite activity or 
reflect tissue damage during infection.
3). To exclude secondary bacterial infection as the source of the increased 
serum endotoxin levels activity during murine trypanosome infection by 
determination of endotoxin activity in infected animals compared to infected 
animals receiving antibiotic treatment.
4). To determine whether the endotoxin-like molecule(s) from trypanosomes is 
chemically related to bacterial LPS and in particular to lipid-A, the active 
moiety of LPS.
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Table 1.1. The classification of economically important trypanosomes.
ORDER Kinetoplastida. 
FAMILY Trypanomastida. 
SECTION Salivaria.
SUBGENERA SPECIES
Trypanozoon Trypanosoma brucei brucei 
Trypanosoma brucei rhodesiense 
Trypanosoma brucei gambiense 
Trypanosoma evansi 
Trypanosoma equiperdum
Dutonella Trypanosoma vivax
Nannomonas Trypanosoma congolense 
Trypanosoma simiae
Pycnomonas Trypanosoma suis
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Fig. 1.1. A schematic representation of the structure of  a gram negative 
l ipopolysaccharide (LPS) molecule.  GA; glucosamine.  N: nitrogen. N-FA; N-linked 
fatty acids, O-FA; O-linked fatty acids, O: oxygen, "-O4P; phosphate groups.
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Fig. 1.2. Diagrammatic representation of the acute phase response
Bacterial
Endotoxin
IschaemiaAraumaViruses
Necrosis
injured t is su e
leu k o cy te s
Monocytes/Macrophages
T N F a
IL-1
IL-1
T N F a
IL-6
m .
Keratmocytes Fibroblasts
Endothelial Cells
Pituitary Gland
T N F -a
IL-1
IL-6
ACTH Adrenal Cortex / IL-6
Hepatocytes
G lu cocortico id s
A cute
P h a se
P rotein s
Fig. 1.3. The cerebellum of a normal mouse. Haematoxylin and eosin. x50.
Fig 1.4. Brain of a Trypanosoma brucei brucei infected mouse in late stage 
infection showing large number of trypanosomes in the choroid plexus of the 
lateral ventricle (A) with slight cellular infiltration (C). Haematoxylin and eosin 
xlOO
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Fig. 1.3
Fig. 1.5. a and b. The cerebral section from a mouse killed in advanced stage of 
infection with Trypanosoma brucei brucei showing cellular infiltration of the 
meninges (C) and the perivascular spaces (D) by inflammatory cells and the 
presence of a Mott cell (M). Haematoxylin and eosin. x50 and xlOO.
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Fig. 1.5.
A
CHAPTER 2 
GENERAL MATERIALS AND METHODS
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2.1. EXPERIMENTAL ANIMALS
2.1.1. Mice
Adult female mice used in these studies were either CD-1 or inbred NIH 
mice obtained from Charles River Ltd., England. They weighed between 28-35 
gm body weight (bwt) and were housed in groups of six in standard mouse 
metallic cages. They were given food pellets and water ad libitum, and kept 
under standardised temperature, humidity and lighting condition unless 
otherwise stated. The animals were allowed to acclimatise to the animal house 
facilities for at least three weeks before being used for experimental purposes.
2.1.2. Rats
Rats used for the separation of trypanosomes, were adult white Sprague 
Dawley males of between 500-600 gm body weight. They were obtained from 
Harlan Olac Ltd., England.
2.2. TRYPANOSOME STABILATES
2.2.1. Trypanosoma brucei brucei-GVR 35
This was a cloned T. brucei brucei GVR 3 5/C 1.6 stabilate originally 
isolated from a wildebeest in the Serengeti in 1966 (Serengeti /66/SVRP/10). 
The stabilate produces a chronic infection in mice with a survival period of at 
least 30 days. The parasites are visible within the circulation 4-5 days after 
infection (DAI), progressing into the central nervous system (CNS) and by day 
21 post infection. There are considerable numbers o f trypanosomes in the CNS 
(Jennings and Gray, 1983).
2.2.2. Trypanosoma brucei brucei-TREV-226
This stabilate was obtained from the Centre for Tropical Veterinary 
Medicine, University of Edinburgh. It produces an acute infection in rats 
causing fatalities within 5-10 DAL
2.2.3. Trypanosoma congolense
The stabilate was obtained from the Department of Zoology, University 
o f Glasgow. This stabilate causes a chronic infection in mice with a survival 
period of 30-35 days post infection.
2.3. ANIMAL INOCULATION
The inoculum used for infections were prepared by diluting the frozen 
stabilate in phosphate buffered saline (PBS), (pH 8.0), containing 1.5% glucose 
to give the appropriate dose in a volume of 0.2 ml per mouse. All infections 
were performed by intraperitoneal injection (ip), using a 25 gauge needle and 1 
ml syringe.
2.4. PARASITOLOGICAL TECHNIQUES
2.4.1. Monitoring Parasitaemia
The parasitaemia in infected animals was monitored by wet smears from 
the tail bleeds. These were examined under the microscope at x 400 
magnification. At least 20 fields were examined before an animal was recorded 
as being negative.
2.5. SAMPLE COLLECTION
2.5.1. Blood
Blood was removed from the tail and used for parasite examination, 
measurement of packed red cell volume (PCV) and serial plasma collection. At 
the time o f sacrifice, the mice were terminally anaesthetised with carbon 
dioxide and bled by intracardial puncture using a 25 gauge needle and 2 ml 
syringe.
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2.6. TISSUE FOR HISTOPATHOLOGY
2.6.1. Tissue Fixation
Several organs including the brain, liver and spleen were carefully 
collected from experimental animals at different stages of infection. These 
tissues were fixed immediately in 1 0 % (v/v) buffered isotonic formol saline 
(100 ml-formalin, 4 g-acid sodium phosphate monohydrate-NaH2 P0 4 . H2 O, 
6.5 g-anhydrous disodium phosphate; Na2 HP0 4 ; made up to 1L). All tissue 
processing and staining were performed by the staff at the Department of 
Veterinary Pathology. After fixing for at least two weeks, the tissues were 
trimmed to the appropriate size and plane of section. The brain was cut into 
three sections through the fore, mid and hind brain. These were later processed 
for routine histopathology by the paraffin wax embedding procedure and 
staining with haematoxylin and eosin.
2.6.2. Tissue Processing and Staining
The fixed tissues were embedded in wax after dehydration with 
methylated spirit and absolute alcohol. All stages were performed in a 
programmable machine under vacuum and pressure. This involved putting the 
tissues through three, 1 hour (hr) cycles in methanol spirit, followed by three, 1 
hr cycles in absolute ethanol at 40° C. This was followed by 1 hour clearing in 
xylene/ethanol (1:1) and another 1 hr cycle in xylene at 40° C. The tissues were 
then put through four cycles of wax processing at 60° C, the first two of 1 hr 
each followed by two, 2  hr cycles.
Sections of 3-4 pm thickness were cut and stained by haematoxylin and 
eosin (H/E).
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2.7. HAEMATOLOGICAL TECHNIQUES
2.7.1. Estimation of Packed Red Cell Volume
The packed red cell volume (PCV) was estimated by the microcapillary 
method. Heparinised capillary tubes were filled to two thirds of their length 
with blood from the tail by capillary flow. One end was sealed with plasticine 
and the tubes spun in a Hawksley microhaematocrit centrifuge for 5 min. The 
tubes were read on a microhaematocrit reader, and recorded to the nearest 
percentage point.
After the estimation of the PCV, the microcapillary tubes were cut using 
a diamond pencil at a point 1 mm above the buffy coat. The plasma in the tube 
was then expelled into Eppendorff tubes by exerting pressure from one end of 
the tube.
2.8. BIOCHEMICAL ASSAYS
2.8.1. Endotoxin Assay
All the apparatus used for the endotoxin experiments were either new 
and endotoxin free, or was rendered endotoxin free by autoclaving at 180° C 
for 4 hr, followed by a further 2 hr in dry heat at 100° C.
All the buffers and other fluids used were endotoxin free or were 
rendered endotoxin free by autoclaving.
Endotoxin activity was measured using the end point-ELISA, 
quantitative chromogenic Limulus Amoebocyte Lysate test (LAL test) (Coatest 
endotoxin kit; Quadratech Ltd, Surrey, UK.) as specified by the manufactures. 
The test depends of the ability of endotoxin (lipid-A moiety) to catalyse the 
activation of proenzyme in the Limulus Amoebocyte Lysate (LAL). The 
enzyme then hydrolyses the para-nitroaniline (pNA) from the substrate, Ac-lle- 
Glu-Gly-Arg-pNA.HCL (S-2423). The pNA released is measured 
photometrically at 405 nm after stopping the reaction with acetic acid.
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The standards were prepared to encompass 0.015-0.12 endotoxin units 
per millilitre (EU/ml) for a low range or 0.15-1.2 EU/ml for a high range. A 
standard curve was included in every assay performed.
Samples and standards were diluted 1:10 with endotoxin free water and 
heated at 75° C for 5 min in a water bath to remove non-specific inhibition of 
the LAL/endotoxin reaction by serum proteases. The samples and standards 
were allowed to cool at room temperature and mixed vigorously for 30 sec with 
a vortex mixer before aliquoting. The working substrate solution S-2423 was 
reconstituted by mixing 1:1 (v/v) of S-2423 substrate solution and substrate 
buffer. The LAL was reconstituted by adding 1.4 ml of LAL reagent water per 
vial followed with a gentle swirl. Fifty pi of test samples and standards were 
pipetted, in duplicate, on to a microtiter plate, followed by incubation at 37° C 
for approximately 5 min. Into each well, 50 pi of reconstituted LAL reagent 
was added, mixed and the plates incubated for a further period as specified by 
the manufacturer. At the end of the incubation, 100 pi of substrate-buffer 
solution was added to each well, followed by a further incubation as specified 
by the manufacture for each batch type. The reaction was terminated by the 
addition of 100 pi of 20% acetic acid. Absorbance was read at 405 nm on a 
microtiter plate reader and the sample concentration extrapolated from a 
standard curve drawn by plotting the absorbance against the standard 
concentrations, using a personal computer running the immunosoft programme.
2.8.2. Acute Phase Protein Assay
2.8.2.1. Serum amyloid P-component assay
Plasma SAP levels were measured by a direct ELISA and quantified 
using commercially available murine SAP standards. The primary antibody was 
rabbit anti-mouse SAP IgG, while the secondary antibody was donkey anti­
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rabbit IgG conjugated to horseradish peroxidase (anti-rabbit HRP). This is 
described in more detailed in Chapter 3.
2.8.2.2. Haptoglobin assay
Haptoglobin (Hp) was measured using the method of Makimura and 
Suzuki (1982) with modifications by Conner, Eckersall, Wiseman and Douglas 
(1988). The assay uses purified bovine haptoglobin as standard. This test is 
based on the ability of haptoglobin to bind to haemoglobin and retain 
peroxidase activity at acidic pH whereas free haemoglobin loses its peroxidase 
activity.
Briefly haemoglobin (methaemoglobin) was prepared according to 
Makimura and Suzuki (1982), and stored as a stock solution at 3 g/100 ml in 
normal saline. Tetra methyl benzidine (TMB), in phosphate buffer, pH 3.8, was 
prepared according to Conner et al (1988). A stock sample of bovine 
haptoglobin of known concentration provided by Dr. P.D. Eckersall, 
Department of Veterinary Clinical Studies, University of Glasgow was used as 
the standard. This was serially diluted in normal saline to produce haptoglobin 
concentrations covering the range 0.066-2.14 g/1.
A 20 pi aliquot of the test samples and standards was pipetted into test- 
tubes. Into each tube was added 100 pi of the 30 mg/100 ml (1:100 dilution of 
stock solution) haemoglobin solution, which was mixed and allowed to react for 
10 min at room temperature. Five ml of normal saline was added to each test- 
tube and mixed. Twenty pi from each test-tube was then pipetted into the well 
o f a 96 well microtiter plates, each sample being prepared in duplicate. This 
was followed by adding 200 pi of TMB solution into each well, mixing and 
incubating at 37° C for 1 hr. At the end of the incubation period, 50 pi of 1% 
hydrogen peroxide (H2 O2 ) was added to each well, and left to react until a 
strong blue colour developed in the high standard. The reaction was terminated
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by adding 50 pi of 2 M sulphuric acid (H2 SO4 ) per well. The plates were read 
on a Titertek multiscan ELISA plate reader at 450 nm. The haptoglobin levels 
within the samples were extrapolated from the standard curve which was 
obtained from the standard optical readings, using a PC computer connected to 
the reader.
In each assay control samples containing a high and low concentration of 
haptoglobin were included.
2.8.3. Protein Assay
The protein content of the trypanosome lysates and protein rich 
membranes was estimated by the biuret method on an automated biochemical 
analyser (Cobas Mira, Roche Diagnostics, Welynn, UK.).
2.9. SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS AND WESTERN BLOT
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS 
PAGE) was carried out using the Laemmli buffer system (1970). This is 
explained in details in Chapter 6  where it was used extensively.
This employed a 15% (w/v) sodium dodecyl sulphate separating gel and 
4% (w/v) stacking gel at a constant current of 20 mili-amperes (mA) per gel. 
The transfer on to nitrocellulose membranes was carried out using the 
electrophoretic method of Towbin, Staehelin and Gordon, (1979) with slight 
modifications as described in individual chapters. This was done overnight with 
a constant current of 10 mA at 8 °C using a Biorad transfer apparatus (Bio-Rad 
Laboratories, Hercules).
Immunostaining of the membranes was carried out using the appropriate 
primary antibody and secondary antibodies as described in respective chapters 
(Chapter 3 and 6 ).
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2.10. STATISTICAL ANALYSIS
The data for the different parameters are presented as the mean ± 
standard error of the mean (mean ± SEM). The significance between group 
means over time and the effects of the various treatments was examined by 
analysis of variance. This was performed using a personal computer running the 
statistical analysis system package (SAS, SAS Institute, Cary, N. Carolina). 
Group differences were considered significant when P < 0.05.
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CHAPTER 3
DEVELOPMENT OF AN ENZYME-LINKED IMMUNOSORBENT 
ASSAY (ELISA) FOR THE QUANTIFICATION OF MURINE SERUM 
AMYLOID P-COMPONENT (SAP)
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3.1. INTRODUCTION
In mammals, the acute phase response constitutes an essential 
physiological process of the host's non-specific defence mechanism following 
tissue injury, inflammation or infection (Whicher and Westacott, 1992). During 
this response the liver, as described in Chapter 1, through the effect of pro- 
inflammatory mediators including cytokines and glucocorticoids, increases its 
synthesis of a number of plasma proteins referred to as acute phase proteins 
(APP) (Baumann and Gauldie, 1994). These APP are known to have important 
physiological functions in the inflammatory process including inhibition of 
proteases and mediator pathways, and scavenging of molecule debris following 
tissue damage (French, 1989).
The APP are becoming of increasing clinical importance in 
inflammatory and infectious conditions where they have been used as indicators 
of infection (Skinner and Roberts, 1994), in evaluation and monitoring the 
degree of tissue damage (Mozes et al, 1989; Solter et al, 1991), and following 
the effect of certain drug treatments including a number of immunomodulatory 
agents (McConkey, Crockson, Crockson and Wilkinson, 1973; Dixon, Bird, 
Sitton, Pickup and Wright, 1984). Studies on acute phase proteins in chronic 
inflammation such as rheumatoid arthritis in man (McConkey et al, 1973; 
Dixon et al, 1984), spontaneous and collagen-induced arthritis in mice (Glatt, 
Blattler, Schnebli and Feige, 1984; Rordorf-Adam et al, 1985), and during 
different infections (Gruys, Obwolo and Toussaint, 1994; Truyens, Angelo- 
barrios, Torrico, van Damme, Heremans and Carliers, 1994), have proven that 
they are useful markers for monitoring clinical infection and inflammation 
(Solter et al, 1991; Skinner and Roberts, 1994).
During trypanosomiasis, the concentration of acute phase proteins has 
been found to increase in the plasma of mice (Shapiro and Black, 1992), dogs 
(Ndungu, Eckersall and Jennings, 1991), rabbits (Cook, 1979; Thomasson,
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Mansfield, Doyle and Wallace, 1973), bovine (Esievo, Saror and Adegoke, 
1984), and humans (Basson et al, 1977).
The acute phase proteins in mice include SAP (Mortensen, Biesel, 
Zeleznik and Le, 1983), haptoglobin (Shapiro and Black, 1992), serum 
amyloid-A (SAA) (McAdam and Sipe, 1976) and a 2 -macroglobulin (Tunstall, 
Merriman, Milne and James, 1975).
Serum amyloid P-component, a normal serum protein, has been 
demonstrated to respond as an acute phase protein in the mouse during different 
pathological conditions (Pepys et al, 1979; Scharfstein et al, 1982; Luz and 
Araujo-Jorge, 1994). It is a glycoprotein known to be associated with virtually 
all kinds of systemic amyloid deposits (Skinner, Sipe, Yood, Shirahama and 
Cohen, 1982). The endogenous level of SAP in normal mice and during tissue 
injury, is dependent on the strain and age of the mice (Mortensen et al, 1983; 
Griswold, Hillegass, Antell, Shatzman and Hanna, 1986).
In the mouse, SAP is one of the major acute phase proteins. In contrast 
in man and many other species of animals (Pepys et al, 1979; Le, Muller and 
Mortensen, 1982), it remains relatively unchanged during disease. In the mouse, 
it occurs as a 23,000-dalton alpha-glycoprotein composed of 10 identical, 
noncovalently linked subunits arranged as two pentraxin binding face to face 
(Pepys, Dash, Fletcher, Richard, Munn and Finestein, 1978; Le et al, 1982). It 
is a molecular homologue of C-reactive protein (CRP), the prototype APP of 
humans (Osmand, Friedenson, Gewurz, Painter, Hofman and Shelton, 1977). 
The non stimulated endogenous concentration of SAP among inbred mice strain 
varies over a wide range, but in all the strains, SAP functions as a typical APP 
(Mortensen et al, 1983). The exact function of SAP is not known but it is 
thought to be a precursor of the glycoprotein amyloid P-component found in 
amyloid deposits (Skinner et al, 1982), and may therefore cause pathological 
lesions under certain conditions. Reported activities which may relate to its
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function include modulation of blood coagulation (Fiedel and Ku, 1986), 
regulation of platelet reactivity (Fiedel, Ku, Izzi and Gewurz, 1983), 
enhancement of bactericidal activity (Singh et al, 1986), enhancement of 
complement-mediated phagocytosis in monocyte/macrophage populations 
(Wright, Craigmyle and Silverstein, 1983), stimulation of IL-1 production by 
monocytes/macrophages (Sarlo and Mortensen, 1985), elastin inhibition and 
modulation of lymphocyte function (Li, Pereira, DeLellis and McAdams, 1984; 
Levo and Wollner, 1985).
The concomitant stimulation of SAP and IL-1 production by ultraviolet 
(UV) irradiation in vivo (Gahring, Blatz, Pepys and Daynes, 1984) and 
stimulation of SAP production in hepatocytes by IL -1 treatment in vitro (Le and 
Mortensen, 1984), or following infection (Luz and Araujo-Jorge, 1994) 
suggests that the measurement of SAP may have significant potential in 
assessing the severity of immune and non-immune mediated inflammatory 
tissue responses mediated by pro-inflammatory molecules such as cytokines 
during disease. Indeed, SAP levels in mice have been shown to correlate with 
the activity of macrophage-derived IL-1 containing supernatants and the 
activity of the SAP-inducing serum factor generated following an inflammatory 
stimulus (Mortensen et al, 1983). In vitro work has also demonstrated that SAP 
is capable of stimulating mononuclear cells to release cytokines (Sarlo and 
Mortensen, 1985), an effect also manifested by the human homolog CRP 
(Ballou and Lozanski, 1992).
These observations suggest that the measurement o f SAP during 
pathological changes might be useful in the study of the effect of anti­
inflammatory and trypanocidal drugs on the basic cellular and humoral 
interactions associated with inflammatory responses.
Currently, available techniques for the measurement of SAP include 
rocket immunoelectrophoresis (Le et al, 1982), rate nephelometry (Gertz, Sipe,
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Skinner, Cohen and Kyle, 1984), competitive enzyme-linked immunoassay 
(Truyen et al, 1994), enzyme-linked immunoassay (Luz and Araujo-Jorge, 
1994; Akiyama, Sugii and Hiroto, 1992; Serban and Rodorf-Adam, 1986), and 
Western blot assay (Griswold et al, 1986). These assays either require isolation 
and labelling of SAP, or utilise substantial quantities of standard SAP 
preparation and anti-SAP antibodies. Most require sophisticated equipment and 
expertise to perform, or express the SAP levels in arbitrary units. These 
observations and the high cost of commercial SAP, antibodies and equipment, 
makes it necessary for the development of a less expensive and easy to perform 
assay for SAP.
Despite the fact that SAP is recognised as being one of the principle 
acute phase proteins in mice, the plasma levels o f this protein have not been 
examined during experimental African trypanosome infection. Previous studies 
only examined C-reactive protein (CRP) and haptoglobin in this disease 
(Thomason et al, 1973; Basson et al, 1977; Cook, 1979; Esievo et al, 1984; 
Pluschke et al, 1986; Ndungu et al, 1991; Shapiro and Black, 1992).
There is great potential for utilisation of this acute phase protein in mice 
both in experimental trypanosomiasis and in other disease conditions (Jennings 
and Gray, 1983). As a first step it is necessary to determine the kinetics o f SAP 
during the course of a trypanosome infection. To permit such work, the 
development of a direct ELISA to determine SAP concentration in sera of mice 
was undertaken.
3.2. OBJECTIVES OF THE STUDY
1). To develop a direct ELISA assay for serum amyloid P-component, an acute 
phase reactant in mice.
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3.3. MATERIALS AND METHODS
3.3.1. Enzyme Linked Immunosorbent Assay 
Reagents and equipment
Reagents were obtained from the Sigma Chemicals Company (USA) 
unless otherwise stated. The microtiter plates were from Greiner (Labortechnik 
Ltd. Dursely Scotland), the electric shaker from Luckham (Luckham Recipro- 
shake, Luckham Limited, Sussex, UK) and the ELISA reader from Flow 
laboratories (Titertek Multiscan plus, Flow Laboratories, Helsinki, Finland). 
The ELISA reader was connected to a personal computer (IBM PC) running the 
ELISA reader programme Immunosoft (Flow Laboratories, Rickmansworth, 
UK.).
Primary antibody
Rabbit antiserum against murine serum amyloid P-component was 
purchased from Novobiochem (Calbiochem Novobiochem Corporation, 
Beeston Nottingham, UK).
Secondary antibody
Horseradish peroxidase-conjugated donkey anti-rabbit IgG was obtained 
from the Scottish Antibody Production Unit, Law Hospital (Lanarkshire, UK.).
Serum amyloid P-component standard
Commercial SAP in solution at a concentration of 80-100 jag/ml was 
obtained from Novobiochem (Calbiochem Novobiochem Corporation, Beeston 
Nottingham, UK).
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Coating buffer
The coating buffer consisted of 10 mM sodium bicarbonate (NaHC0 3 ) 
and 10 mM sodium carbonate (Na2 C0 4 ) buffered to pH 9.6 with sodium 
hydroxide (NaOH).
Assay buffer (Phosphate buffered saIine-Tween-20) (PBST)
Assay buffer consisted of 20 mM sodium dihydrogen phosphate 
(NaH2 PC>4 ), 20 mM di-sodium hydrogen phosphate (Na2 HP0 4 ), 154 mM 
sodium chloride (NaCl) and 0.05% (v/v) Tween-20 (Sigma) buffered to pH 7.4 
using sodium hydroxide (NaOH).
Blocking buffer (Phosphate buffered saline) (PBS)
The blocking buffer was 10% (w/v), instant dried skimmed milk powder 
(Marvel®) in assay buffer without Tween-20 (PBS, pH 7.4). The milk powder 
contained 1.5% (w/w) fat and 36.4% (w/w) protein.
Substrate buffer
Substrate buffer was 10 mM sodium acetate (CH3 COONa) in distilled 
water adjusted to pH 5.5 with citric acid.
Peroxidase substrate
The peroxidase substrate was prepared by adding into 25 ml o f the 
substrate buffer, 100 pi of 1% hydrogen peroxide (H2 O2 ) (v/v) and 400 pi of a 
stock solution of 0.6% (w/v) 3,3',5,5'-tetramethylbenzidine (TMB) in 
dimethylsulphoxide (DMSO).
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Bovine serum albumin (BSA)
The bovine serum albumin was a 1% (w/v) bovine serum albumin 
(Sigma Chemical Company USA.) in assay buffer without Tween-20 (PBS).
3.3.2. Preparation of SAP Standards and Samples
Commercial murine SAP was serially diluted in 1% (w/v) bovine serum 
albumin in assay buffer without Tween-20 to cover a concentration range of 
2.5-160 pg/ml. The samples were vortexed, aliquoted and stored at -20° C. 
Samples with low and high concentrations of SAP were always included in 
each assay as positive quality control samples while at the same time a 1 % 
(w/v) BSA solution without any SAP was used as a negative control.
3.3.3. Assay Procedure 
Coating
The standards and test samples were diluted 1:100 in coating buffer (pH 
9.6), mixed and allowed to stand for 5 min. The diluted samples and standards 
(100 pi) were pipetted in duplicate into a 96 well, flat bottom microtiter plate 
(Greiner) and incubated at room temperature overnight (18 hr) with continuous 
gentle shaking on a rotary shaker.
Blocking
At the end of the coating period, the excess samples were decanted and 
the non-specific binding sites blocked by adding into each well 300 pi of 
blocking buffer (10% (w/v) dried milk in PBS). Blocking was carried out at 
room temperature for 1 hr with constant gentle shaking.
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Washing
The excess blocking buffer was decanted and the ELISA plates rinsed 
three times with 300 pi per well of PBST.
Primary antibody
Washing of the plates was followed by the addition of 100 pi per well, of 
a 1:4,000 dilution of primary antibody (rabbit anti-mouse SAP IgG) in assay 
buffer. The plates were then incubated for 90 min at room temperature. At the 
end of the incubation, the plates were rinsed three times with 300 pi washing 
buffer as above.
Secondary antibody
After decanting the washing buffer, 100 pi of a 1:2,500 dilution of 
secondary antibody (Horseradish peroxidase conjugated donkey anti-rabbit 
IgG) in assay buffer was added into each well, and the plates further incubated 
for 90 min at room temperature. Following the incubation the excess secondary 
antibody was decanted and the plates rinsed four times as above.
Substrate
The peroxidase absorbed to the wells was detected by adding 150 pi of 
freshly prepared peroxidase substrate to each well. The plates were covered 
with aluminium foil and incubated in the dark for about 30 min to allow the 
enzyme reaction to take place.
Assay termination
The peroxidase enzyme reaction was terminated after the development of a 
reasonable colour in the high standard which took up to 30 min, by the addition 
of 50 pi of 2 M sulphuric acid (H2 SO4 ) per well.
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Absorbance
The absorbance was read at 450 nm wavelength using an ELISA plate 
reader connected to a computer. The results were analysed using the 
Immunosoft programme employing a linear logarithmic transformation (lin-log) 
in the calculation of the SAP concentration from the absorbance readings by 
comparing with the readings from the standards.
3.3.4. Assay Optimisation
The assay optimisation was carried out in steps as described for serum 
amyloid A (SAA) ELISA (Sipe, Gonnerman, Loose, Knapschaefer, Xie and 
Franzblau, 1989). Each step was performed at least three times.
3.3.4.1. Titration of the antibodies (primary and secondary antibody)
Initially the approximate optimal dilution of the primary and secondary 
antibodies were determined by coating ELISA plates with serially diluted 
commercial SAP that was diluted 1:100 in coating buffer. The primary antibody 
ranged from 1:500 to 1:20,000 while the second antibody covered the range 
1:500 to 1:10,000.
3.3.4.2. Optimisation of standards and sample dilution
Standards for the ELISA were prepared as described above. The 
standards were diluted either 1:50, 1:100, or 1:200 in coating buffer. 100 pi 
aliquots from each dilution set were applied to the ELISA plates in duplicate 
and the assay carried out as before.
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3.3.4.3. Incubation temperatures
The effect of the incubation temperature on the SAP plate binding ability 
was determined by coating four plates with the standard SAP preparations. 
Three of the plates were left overnight at 4° C and the other three at room 
temperature under constant gentle agitation. The remaining steps were carried 
out as described before.
3.3.4.4. Optimisation of incubation time for primary antibody
The influence of the incubation time for the primary antibody on the 
ELISA was determined. Six plates were coated overnight at room temperature 
(23° C) as described above. After blocking with blocking buffer, and washing, 
the primary antibody was added at 1:4,000 and the plates incubated for different 
time periods. Duplicate plates were incubated at 30 min, 90 min and 120 min. 
All the remaining steps were carried out as before.
3.3.5. Assay Validation
3.3.5.1. Specificity of assay
The specificity of the rabbit antibody against murine SAP was 
determined using the double immunodiffusion and the Western blot following 
separation of protein by sodium dodecyl-sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE).
3.3.5.1.1. Double immunodiffusion-Ouchterlony technique
An agarose gel of 10 mm thickness was prepared by layering boiled 1% 
(w/v) gel powder in Tris-buffer saline, pH 7.4 on a horizontal glass plate. This 
was then allowed to cool and solidify at room temperature for 15 min, followed 
by a further step in a humid chamber at 4° C for 15-30 min.
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After solidifying, six wells were cut out around a central well. Into the 
central well, 5 pi antiserum was added while in the surrounding wells 5 pi of 
antigen was placed (acute phase serum and purified SAP). The antigen and 
antibody were allowed to diffuse producing a visible precipitate at points of 
optimal antigen-antibody concentration.
The gels were stained by the Coomassie blue stain technique. The gels 
were stained in Coomassie blue stain (0.5% (w/v) Coomassie blue in 9:9:2 
ethanol:distilled water:acetic acid mixture) for 30 min after which they were 
washed with destaining solution consisting of 9:9:2 ethanohdistilled 
water:acetic acid mixture. The gels were allowed to destain to give minimal 
background colour of the gels while retaining an intense protein stain.
3.3.5.1.2. Sodium dodecyl sulphate polyacrylamide gel electrophoresis and  
Western blot
SDS PAGE was carried out using the Laemmli buffer system (1970). 
This is explained in details in Chapter 6  where it was used extensively.
For the analysis of SAP, this method employed a 15% sodium dodecyl 
sulphate (w/v) separating gel and 4% stacking gel at a constant current of 20 
mili-amperes (mA) per gel. The transfer of the protein was carried out using the 
method of Towbin et al, (1979).
Serum (diluted 1:20) from normal mice and trypanosome-infected mice 
containing high levels of SAP and haptoglobin, and Commercial SAP in 1:1 
dilution with treatment buffer (4% SDS (w/v), 20% glycerol (w/v), 10% 2,3- 
dihydroxybutane-1-4-dithiol (dithiothrietol) (w/v) and 0.001% bromophenol 
blue (w/v)) were heated in a water bath at 100°C for 5 min. After the treatment 
procedure, 10 pi of protein was taken and loaded into each well. The gels were 
run in duplicate and after electrophoresis, one was stained with Coomassie blue 
while the other was immunostained using rabbit anti-mouse SAP antibody after
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an overnight transfer of the protein onto nitrocellulose membranes at 10 mA 
using a Biorad transfer apparatus.
Immunostaining of the membranes was carried out using primary 
antibody solution at a 1:500 dilution and secondary antibody (horseradish 
peroxidase-conjugated donkey anti-rabbit IgG) (Scottish Antibody Production 
Unit, Law Hospital, Lanarkshire, UK), at 1:1,000 dilution.
3.3.6. Assay Precision
Assay precision was determined as described by Fraser (1986). Thus, the 
intra assay variation was tested by preparing 2 0  wells in duplicate using the 
same sample and running in the same assay. For the inter assay variation, two 
quality control samples with low and high SAP levels were included in the 18 
different assays performed during the study period in Chapter 4.
3.3.7. The Limit of Detection
The limit of detection was calculated as the least amount of SAP that 
could be distinguished from the negative control. It was calculated as the SAP 
concentration at 2 standard deviations (SD) away from the mean of the zero 
standard (Fuentes-Arderiu, 1992).
3.3.8. Clinical Validation of Assay
As a final validation of the assay, plasma samples from trypanosome- 
infected mice at different stages of infection were assayed for the levels of SAP. 
These findings are reported in Chapters 4 and 5.
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3.4. RESULTS
3.4.1. Assay Optimisation
3.4.1.1. Titration of primary and secondary antibody
Results from the initial titration of the antibodies, covered a dilution 
range of 1:500 to 1:20,000 for the primary antibody and 1:500 to 1:10,000 for 
the secondary antibody. The results showed that a combination of 1:4,000 for 
the primary antibody (Fig. 3.1) and 1:2,500 of the secondary antibody (Fig. 3.2) 
showed the best results combining high signal with low background, with the 
highest standards giving a maximum optical density of 0.64.
3.4.1.2. Optimisation of coating temperature
Coating the plates overnight at 4° C and room temperature (23° C) 
resulted in similar binding in the assay, but at room temperature, the 
background in the negative control resulted in a slightly lower optical density 
thus subsequent coating was performed at room temperature (Fig. 3.3).
3.4.1.3. Optimisation of standards and sample dilution
The dilution of 1:50 gave a high optical density but high background and 
1 : 1 0 0  and 1 : 2 0 0  did not differ much although the 1 : 1 0 0  gave a slightly lower 
background and a high optical density for the high standard, and it was chosen 
for all subsequent tests (Fig. 3.4).
3.4.1.4. Optimisation of primary antibody incubation time
Incubating the primary antibody for 60 min resulted in low optical 
density (OD) values while for 120 min the OD was high but with high 
background. Thus after addition of the primary antibody, the plate were 
subsequently incubated for 90 min in all subsequent tests (Fig. 3.5).
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3.4.2. Assay Validation
3.4.2.1. Specificity of antibody to mouse SAP
The mouse acute phase serum, i.e., from trypanosome-infected animals, 
and commercial SAP tested with the rabbit SAP monoclonal antibody by 
double immunodiffusion gave a single band of complete identity (Fig. 3.6).
Similarly, testing the rabbit antibody to mouse SAP gave a single band 
(23,000 radius) in Western blots in serum from mice in acute phase and 
commercial SAP (Fig 3.7). Staining the blots without including first antibody 
did not give any bands.
An SDS-PAGE gel stained with Coomassie blue of the same sample 
(Fig. 3.8) confirms that SAP had a molecular radius of 23,000 and was present 
in the serum from trypanosome-infected mice.
3.4.2.2. Repeatability of standard curve
The absorbance and the coefficient of variance (CV) for the standard 
curves at 450 nm of 18 assays performed over several months are presented in 
Figure 3.9 and Table 3.1. The CVs of standard curve varied from 6.5 to 10.3%.
These standard curves from the different assays during studies in 
Chapters 4 and 5 resulted consistently in essentially equivalent standard curves.
3.4.2.3. Assay precision
The intra-assay coefficient of variation for the 20 duplicate sample wells 
was 4.6% at 40 pg/ml SAP concentration. The inter-assay coefficient of 
variation of plasma sample used as controls and analysed independently in 18 
different assay runs was 12.4% at 30 pg/ml and 10.6% at 80 pg/ml SAP 
concentrations.
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3.4.2.4. The limit of detection
The limit of detection was 5 |ig/ml. This was determined as the amount 
of SAP that could be distinguished from the zero standard (Fuentes-Arderiu, 
1992), and was calculated as the zero standard mean ± 2 SD.
3.4.2.5. Clinical validation
The assay was able to measure different SAP levels in plasma samples 
from mice infected with trypanosomes. This showed a rapid rise to reach peak 
levels of 120 fig/ml 14-16 day after infection (DAI) and then a dramatic 
decrease to the baseline level towards the terminal stages of infection as fully 
described in Chapters 4 and 5.
3.5. DISCUSSION
The results in this study demonstrate that serum amyloid P-component 
can be measured using a direct ELISA. The method described here 
demonstrates the use of a simple procedure for measuring SAP, utilising readily 
available SAP standard, antibodies, and equipment available in most 
laboratories thus allowing the assay to be easily transferable. The method is 
relatively inexpensive and utilises small amounts of SAP and anti-SAP 
antibody, unlike the alternative methods such as antibody-coated ELISA 
(Akiyama et al, 1992) and electroimmmunoassay (Laurell, 1972) which require 
substantial amounts of the antigen and antibodies. The small amount o f sample 
used for the assay makes it possible to measure SAP concentration in serial 
samples collected from small animals such as the mouse. To further reduce the 
requirement for commercial SAP, serum from mice during the acute phase 
response can be pooled, calibrated using commercial SAP and used as 
standards. Indeed pooled serum as standard eliminates any possible matrix
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effect which can be a problem when standard in buffer is used to quantify 
analyte in serum.
The assay uses a standard curve to calculate the levels of SAP which 
enables the analysis of many samples at the same time. Additional benefits are 
the quantification of serial samples, follow-up cases undergoing pathological 
changes, or monitoring responses following different treatments, a task not 
possible with other assays such as Western blot (Griwold et al, 1986) and 
electroimmunoassay (Laurell, 1972).
The inclusion of a standard curve for each assay allows comparison 
between assays and inclusion of a high and low standard of known 
concentration of SAP as quality control samples in each assay, confirmed the 
repeatability of the assay with a CV of < 15% which is acceptable for 
immunoassays.
Although the physiological importance of most of the acute phase 
proteins is not well known, there is growing recognition of the clinical 
importance of APP including SAP during different pathological conditions 
(Kent, 1992; Sheldrick, Kent and Blackmore, 1982; Eckersall and Conner, 
1988; Scott, Murray and Penny, 1992; Gruys et al, 1994), and the possible 
significant effect of APP in the pathogenesis of disease conditions (Shapiro and 
Black, 1992; Mold et al, 1981). Indeed the physiological function of SAP is not 
well known but the protein has been demonstrated to enhance macrophage 
listericidal activity (Singh et al, 1986), to agglutinate complement coated 
erythrocytes (Hutchcraft, Gewurz, Hansen Dyck and Pepys, 1981), and to 
stimulate cytokine production by mononuclear cells (Sarlo and Mortensen, 
1985). Clinically, SAP levels have been shown to have a significant correlation 
with the severity of inflammation during polyathritis in mice (Rordof-Adam et 
al, 1985). In T. b. brucei-infected dogs, an increase in the plasma concentration 
of C-reactive protein (CRP) and haptoglobin has been demonstrated. In this
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experiment, increases in the levels of CRP, the human equivalent to SAP, were 
shown to correlate well with the parasitaemia, and to be a good indicator of an 
active infection and the efficiency of chemotherapy (Ndungu et al, 1991).
The SAP assay described here allows investigation of the kinetics of 
SAP synthesis during the acute phase response following trypanosome and is 
likely to aid studies of other disease processes.
The detection of elevated SAP levels in the serum of mice following a 
trypanosome infection as described in detail in Chapters 4 and 5, supports the 
current method's experimental potential value to monitor SAP during disease 
conditions, and in following the effect of immunomodulators and therapeutic 
drugs on the acute phase response (McConkey et al, 1973; Kusher, 1982; 
Kaneti et al, 1984; Eckersall and Conner, 1988). This assay will allow the study 
of kinetic changes and possible pathogenic significance of the acute phase 
response during trypanosomiasis.
3.6. CONCLUSION
The SAP assay offers distinct advantages over the existing methods in 
that it is simple, accurate, reproducible and sparing of antigen and antibody. 
The direct ELISA minimises the amount of commercial SAP and antibodies 
used, and at the same time enables the analysis of a larger number o f samples 
than the existing assays, making it useful in the sequential study of disease 
processes. The assay will facilitate the study of SAP as a pathological disease 
marker and as an indicator of the response of animals following treatment with 
trypanocidal and other therapeutic management regimes.
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Fig. 3.1. Optimisation of the ELISA for murine serum amyloid P-component: 
The effect of the primary antibody (rabbit anti-mouse SAP) dilution at 1:2,500, 
1:4,000 and 1:20,000 with secondary antibody at 1:4,000 dilution on the 
standard curve.
Fig. 3.2. Optimisation of the ELISA for SAP: the effect of the secondary 
antibody (Donkey horseradish peroxidase conjugated donkey anti-rabbit IgG) 
dilution at 1:1,250, 1:2,500 and 1:10,000 and primary antibody at 1:4,000 
dilution on the standard curve.
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Fig. 3.3. Optimisation of the ELISA for murine serum amyloid P-component: 
the effect of the coating incubation temperature at 4°C and 23°C (room 
temperature) with primary antibody at 1:4,000 and secondary antibody a 
1:2,500 dilution on the standard curve.
Fig. 3.4. Optimisation of the ELISA for murine serum amyloid P-component: 
the effect of sample dilution at 1:50, 1:100 and 1:200 with primary antibody at 
1:4,000 and secondary antibody a 1:2,500 dilution on the standard curve.
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Fig. 3.5. Optimisation of the ELISA for murine serum amyloid P-component: 
the effect of the primary antibody incubation time at 30, 90 and 120 min with 
primary antibody at 1:4,000 and secondary antibody a 1:2,500 dilution on the 
SAP standard curve.
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Fig. 3.6. Specificity of primary antibody on murine SAP by the double 
immunodiffusion-Ouchterlony technique. Wells loaded with 5 pi of rabbit anti­
mouse SAP antibody (well-1), acute phase serum (well-2), commercial SAP 
(well-3) and saline (well-4). The bands between the acute serum and 
commercial SAP gave a band of complete identity (Arrow).
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Fig. 3.6
Fig. 3.7. Specificity of primary antibody of the murine SAP by the Western 
blot. Wells were loaded with 10 pi of APR serum (lane 1), commercial SAP 
(lane 2), saline (lane 3) and molecular weight markers (lane 4). The primary 
antibody (rabbit anti mouse SAP) was used at 1:5,000 and secondary antibody 
(Horseradish peroxidase donkey anti-rabbit IgG) at 1:1,000 dilution. Note the 
single band in lane 1 and lane 2 with molecular weight of about 23,000 daltons.
Fig. 3. 8 . SDS polyacrylamide gel (15% separating gel and 4% stacking gel) 
electrophoresis stained with Coomassie blue. Wells were loaded with 10 pi of 
commercial serum amyloid P-component (lane 1), acute phase serum from 
trypanosome-infected mice (lane 2) and normal mouse serum (lane 3). Note the 
SAP band with molecular weight of approximately 23,000 daltons in the lanes 1 
and 2 .
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Fig. 3.9. Standard curve for the quantification of mouse-SAP ELISA (mean ± 
SEM).
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Table 3.1. The repeatability o f the SAP standard curve assessed by the 
coefficient o f variance of the absorbency at 450 nm of standards in 18 SAP 
ELISA assays.
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Murine SAP 
(fig/ml)
Absorbance 
(Mean ± SD)
CV (9c)
0 0.188 ±0.155 10.3
5 0.227 ± 0 . 0 2 1 9.7
1 0 0.265 ± 0.028 9.4
2 0 0.307 ±0.031 8.5
40 0.380 ±0.034 7.6
80 0.471 ±0.051 8 . 6
160 0.615 ±0.061 6.5
Table 3.1. The repeatability of the SAP standard curve assessed by the coellicient 
of variance of the absorbency at 450 nm of standards in 18 SAP ELISA assays.
CHAPTER 4
ACUTE PHASE REACTION IN TRYPANOSOMA B RU C EIB RU C EI 
(INVASIVE) AND TRYPANOSOMA CONGOLENSE  (NON-INVASIVE)
INFECTION OF MICE
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4.1. INTRODUCTION
Human and animal infection with African trypanosomiasis leads to the 
development of parasitaemia, anaemia, acute inflammatory reactions, 
immunological derangements, tissue damage and ultimately death if untreated 
(de Raadt and Seed, 1977; Soltys and Woo, 1977). Accompanying these 
pathological alterations are biochemical changes in the levels of numerous 
plasma components among which are the acute phase proteins (APP). Many 
workers have demonstrated that monitoring the plasma concentration of APP is 
an effective means of quantifying the immediate host response to infection 
(Whicher and Dieppe, 1985; Kusher and Mackiewics, 1987; Horadagoda and 
Eckersall, 1994).
In trypanosomiasis, the APP observed to be affected include increased 
plasma levels of haptoglobin (Esievo et al, 1984; Pluschke et al, 1986; Ndungu 
et al, 1991; Shapiro and Black, 1992), C-reactive protein (Thomason et al, 
1973; Basson et al, 1977; Cook, 1979; Ndungu et al, 1991), and a decrease in 
albumin levels (Jenkins and Robertson, 1959).
In mammals the concentration of these acute phase proteins can increase 
by between 2  and 1 0 0  fold in response to many different types of tissue injury, 
including immune and non-immune mediated inflammation, parasitic infections 
and neoplasms (Stadnyk and Gauldie, 1991; Whicher and Westacott, 1992; 
Baumann and Gauldie, 1994). The proteins involved in the acute phase 
response (APR), depend on both the stimulating factors and the host species. 
Bacterial endotoxin is one of the most active stimulators of hepatic synthesis of 
APP (Whicher and Dieppe, 1985). The concentration of APP in blood is a 
balance between the rate of production and catabolism.
The APR is initiated by a large number of diverse inflammatory 
mediators, including cytokines, anaphylatoxins and glucocorticoids (Baumann 
and Schendel, 1991; Baumann and Gauldie, 1994). The mediators are released
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initially at the site of inflammation by activated mononuclear phagocytes, 
lymphocytes and other differentiated cell types, and have potent local and 
systemic effects. Among the factors released in response to inflammation, are 
several cytokines which specifically regulate the transcription of APP, in 
particular interleukin-1 (IL-1), interleukin- 6  (IL-6 ), and tumour necrosis factor- 
a  (TNF-a) (Baumann and Schendel, 1991). Of these IL-1 and TNF-a can, 
indirectly via the CNS and by action on the pituitary gland, stimulate the 
synthesis of glucocorticoids by the adrenal gland, resulting in a co-operative 
enhancement of IL-1 and TNF-a activity. Similarly these two cytokines cause 
the production of IL-6 , the cytokine directly responsible for the hepatic 
stimulation of the APP synthesis (Heinrich et al, 1990).
Although the pathophysiological significance of the APR is not clearly 
known, the measurement of APP is becoming of increasing clinical importance 
in the diagnosis and assessment of disease activity (Kent, 1992; Gruys et al, 
1994), and as an indicator of tissue damage (Kushner and Mackiewicz, 1987; 
Mozes et al, 1989). The known functions of APP include, mediation of local 
inflammatory changes, inflammatory protease inhibition, scavenger-transport 
molecules, and modification of phagocytic cell function (Pepys and Baltz, 
1983; French, 1989).
In experimental studies in mice increased plasma levels o f SAP have 
been reported in a variety of pathological states including infections with 
Trypanosoma cruzi (Scharfstein et al, 1982; Luz and Araujo-Jorge, 1994), 
Nippostrongylus brasiliensis (LaMontagne et al, 1984) and Schistosoma 
mansoni (Pepys et al, 1979).
Haptoglobin (HP) is another APP secreted by hepatocytes as part of the 
acute phase response in most species studied (Kushner and Mackiewicz, 1987) 
and has also been demonstrated in response to many types of injury (Makimura 
and Suzuki, 1982; Solter et al, 1991; Skinner and Roberts, 1994), including
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infection with trypanosomes (Esievo et al, 1984; Ndungu et al, 1991; Shapiro 
and Black, 1992). Haptoglobin is involved in scavenging of haemoglobin to aid 
in the recycling of endogenous haem following haemolysis (French, 1989) and 
has also been shown to mediate non-specific immune suppression (Oh et al, 
1990).
Due to the growing clinical usefulness of APP levels as a quantitative 
measure of the in vivo response to infection and the emerging evidence that 
APP could be playing an active role in the pathogenesis of diseases, it was 
decided to extend knowledge of the usefulness of APP in African 
trypanosomiasis, using the trypanosome mouse model system. This knowledge 
might lead to the use of the APP in assessment of the disease condition and the 
response to different treatments. Indeed SAA (Mozes et al, 1989) and SAP 
(Rordorf-Adam et al, 1985) have been demonstrated to be good markers of 
tissue damage in humans and mice, respectively, while CRP has been used as a 
guide to the efficacy of antibiotic treatment in bacterial infection (Schofield et 
al, 1982).
Although APP have been found in response to African trypanosomes 
infections (Thomason et al, 1973; Basson et al, 1977; Cook, 1979; Esievo et al, 
1984; Pluschke et al, 1986; Ndungu et al, 1991; Shapiro and Black, 1992), the 
mechanism of their stimulation is not known. It might be due either to parasite 
factors directly stimulating the cytokine network or be the result of the tissue 
damage caused by parasite. Indeed it is known that bio-molecules, including 
endotoxins, stimulate APP mediators (Knyszynski and Burger, 1971), while 
tissue damage due to infectious and non-infectious conditions, can result in the 
hepatic stimulation of APP (Whicher and Westacott, 1992). Tissue-invading 
parasites such as T. b. burcei could cause APP production via the latter 
mechanism.
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An important aspect of infection with tissue invasive parasites of the 
brucei sub-group is that treatment with trypanocidal drugs that do not cross the 
blood brain barrier, do not eliminate the parasite from the CNS. This leads to 
major inflammatory reactions in the brain associated with parasite persistence 
and with increased cytokine transcripts (Jennings and Gray, 1983; Hunter et al, 
1991 ; Hunter et al, 1992a). It is not known whether this produces a systemic 
acute phase reaction.
Interestingly, trypanosomes have been demonstrated to contain cytokine- 
inducing molecules (Oka et al, 1989; Alafiatayo, Cookson and Pentreath, 
1994), while plasma from infected mice and purified parasites contain 
endotoxin-like activity (Alafiatayo et al, 1993). These reports would suggest 
that trypanosomes stimulate APP production via an endotoxin-like molecule(s). 
However, there have been no studies to eliminate the invasion of tissue by the 
parasite as the causative factor for cytokine and hence APP production.
Therefore to differentiate these mechanisms of acute phase response 
activation and possible pathological significance in trypanosomiasis, APP (SAP 
and Hp) were measured in response to tissue invasive (Jennings, Whitelaw, 
Holmes Chizyuka and Urquhart, 1979; Morrison et al, 1981a; Jennings and 
Gray, 1983) and non-invasive (Abede, Shaw and Eley, 1993) trypanosome 
species. In addition, it is not known whether the inflammatory reaction in the 
CNS, caused in HAT by trypanocidal treatment and in T. b. brucei infected 
mice by subcurative treatment with the trypanocidal drug (Chapter 1) 
diminazine aceturate, is associated with a systemic APR. Therefore APP were 
also monitored in T. b. brucei and T. congolense infections after diminazine 
aceturate treatment.
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4.2. OBJECTIVES
1). To characterise the APR in T. b. brucei infected mice by measuring the 
plasma concentration of the acute phase proteins, SAP and Hp.
2). To establish whether the acute phase response occurs with an infection with 
non-invasive T. congolense.
3). To establish whether the inflammation in the CNS after trypanocidal drug 
treatment of T. b. brucei infected mice causes a systemic acute phase reaction.
4.3. EXPERIMENTAL DESIGN
4.3.1. Study One
In this experiment, the APR was monitored in inbred NIH mice infected 
with a tissue invasive trypanosome, T. b. brucei as described in Chapter 2. The 
animals were tail bled at 2-3 day intervals and were treated on 30 DAI with 
diminazine aceturate (ip) (40 mg/kg bwt). Treatment with diminazine aceturate 
clears the parasites from the circulation and tissues other than the CNS. This 
produces increased pathology in the brains of treated mice (Jennings and Gray, 
1983; Chapter 1).
4.3.2. Study Two
This experiment involved monitoring the acute phase response in 
outbred CD-I mice infected with a non invasive trypanosome, T. congolense. 
The animals were tail bled at 2-3 day intervals and were treated on 31 DAI with 
diminazine aceturate (ip). Treatment with diminazine aceturate clears all 
parasites from mice infected with T. congolense.
Different strains of mice were used in study one and two due to 
unavailability of the NIH mice for the second experiment.
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4.4. MATERIALS AND METHODS
4.4.1. Animals
Twelve female inbred NIH and 12 female outbred CD-I mice, of 28-35 
gm body weight were used in study one and two, respectively. They were 
maintained in metallic cages in two groups of six in each study, fed ad lib on 
commercial mice pellets and allowed continual access to drinking water.
4.4.2 Trypanosomes Stabilates 
4.4.2.1. Trypanosoma brucei brucei
This is a cloned stabilate GVR 35. The stabilate has been shown to 
produce a chronic infection with the mice surviving for at least 30 days 
(Jennings and Gray, 1983; Chapter 2).
4.4.2.2. Trypanosoma congolense
The stabilate was obtained from the Department of Zoology at the 
University of Glasgow. This stabilate causes a chronic infection in mice with a 
survival period of 30-35 days post infection (Chapter 2).
4.4.3. Infection
Six mice in each study were infected with approximately 10^ 
trypanosomes ip in a volume of 0.2 ml phosphate buffered saline (PBS), pH 8.0 
containing 1.5% glucose. The remaining six uninfected mice were used as 
controls.
4.4.4. Drugs
The infected mice were treated at a dose of 40 mg/kg bwt ip, with 
diminazine aceturate on 31 and 30 DAI, and sacrificed on 38 and 35 DAI in the 
T. congolense and T. b. brucei infected mice respectively.
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4.4.5. Parasitological and Haematological Techniques
The parasitaemia was monitored by wet smear and the PCV estimated by 
the microhaematocrit centrifugation techniques as described in detail in Chapter 
2. The plasma collected from the capillary tubes was stored at -20 °C until 
assayed for the APP, SAP and Hp.
4.4.6. Biochemical Assays
4.4.6.1. Acute phase protein assays
4.4.6.1.1. Serum amyloid P-component
The plasma concentration of SAP was estimated by the use of the direct 
enzyme-linked immunosorbent assay (ELISA) described in Chapter 3.
In this assay, commercial mouse SAP (Calbiochem) was used as 
standard and was serially diluted to cover a SAP concentration range of 2.5-160 
pg/ml . The primary antibody was rabbit anti-mouse SAP IgG (Calbiochem 
Novobiochem) while the secondary antibody was donkey anti-rabbit IgG 
horseradish peroxidase conjugate (Scottish Antibody Production Unit, Law 
hospital, Lamark UK.).
4.4.6.1.2. Haptoglobin assay
Haptoglobin concentrations were estimated using the method by 
Makimura and Suzuki (1982) with modifications by Conner et al, (1988) as 
described in Chapter 2.
4.4.7. Histopathology
At the end of study one and two, the mice were sacrificed, the brains 
removed and immediately fixed in 10% buffered formalin. These were later
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processed after paraffin embedding and stained with haematoxylin and eosin 
stain for microscopic examination as described in Chapter 2.
4.5. STATISTICAL ANALYSIS
The results are presented as the mean (± SEM). Differences between the 
means in the infected and uninfected controls within each study were compared 
by the two way analysis of variance with repeated measures (ANOVA). 
Differences were considered significant at P < 0.05.
4.6. RESULTS
4.6.1. Study One: Trypanosoma brucei brucei: Invasive
4.6.1.1. Parasitaemia
After infection, parasites appeared in the blood of mice 4-5 DAI. A high 
parasitaemia was maintained during the course of infection although 
fluctuations related to parasitaemic waves were apparent (Fig. 4.1). On 
treatment with diminazine aceturate on 30 DAI, the parasites disappeared from 
the circulation by 2-3 days after treatment (DAT) and were still absent at the 
end of the experiment on 35 DAI.
4.6.1.2. Acute phase proteins
4.6.1 2.1. Serum amyloid P-component
The mean (± SEM) SAP concentration changes in NIH mice during the 
T. b. brucei infection are presented in figure 4.2. The mean SAP concentrations 
in the uninfected animals did not change significantly during the experimental 
period from the values on 0 DAI (30-35 ug/ml). In the infected mice, the mean 
SAP concentrations started to increase by 2 DAI, and reached peak 
concentration of 129.3 ± 13.2 pg/ml on 13 DAL By 17 DAI, the mean 
concentration had decreased but was significantly higher than the uninfected
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controls. After 17 DAI the concentrations of SAP in the infected mice kept 
fluctuating between 41-49 p,g/ml until termination of the experiment 35 DAI. 
The SAP concentration in the infected mice were not affected significantly after 
treatment with diminazine aceturate. The mean SAP concentrations in the 
infected animals were significantly higher than the uninfected controls (P < 
0.05) throughout the infection.
4.6.1.2.2. Haptoglobin
The mean (± SEM) haptoglobin concentrations in Trypanosoma brucei 
brucei infected and control mice are presented in figure 4.3. Haptoglobin was 
not detectable in plasma samples collected on 0 DAI. Following infection, 
serum haptoglobin was detectable by 2 DAI, and the mean concentration rose to 
reach a peak level of 2.02 ± 0.19 g/1 on 10 DAI (P < 0.001). This was followed 
by a slight decline to about 1.42 g/1 on 13 DAI, around which the levels 
fluctuated until termination of the experiment. Treatment o f the infected mice 
with diminazine aceturate on 30 DAI did not affect the haptoglobin 
concentrations although the mean concentrations had started to increase slightly 
before the drug treatment.
In the uninfected control mice, haptoglobin was not detectable in the pre­
infection serum samples or at any later stage of the experimental period.
4.6.I.3. Packed red cell volume
The mean PCV values of T. b. brucei infected and control mice are 
shown in figure 4.4. The uninfected groups of animals maintained a relatively 
constant mean PCV of 55-58% throughout the experimental period (P > 0.05).
The infected animals maintained preinfection PCV levels until 10 DAI. 
This was followed by a significant decrease in the mean PCV values on 13
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DAI, a decline that continued to reach the lowest value of 38.8 ± 0.9% on 35 
DAI in spite of treatment with diminazine aceturate on 31 DAI.
On statistical analysis, the infected and uninfected control mean values 
demonstrated a significant difference in PCV during the infection (P < 0.05).
4.6.1.4. Histopathology
The brains from uninfected mice sacrificed showed no significant 
changes (Fig. 4.5). The brains from infected mice treated with diminazine 
aceturate, 30 DAI and sacrificed 5 DAT showed marked meningitis and 
perivascular cuffing. The cuffs included lymphocytes, plasma cells, 
macrophages, and occasionally Mott cells (Fig. 4.6). A similar cellular 
infiltration infiltrated the meninges, with the cells also being found along the 
fissure and the Virchow-Robin spaces around the blood vessels forming the 
perivascular cuffs.
4.6.2. Study Two: Trypanosoma congolense: Non-invasive
4.6.2.1. Parasitaemia
After infection with T. congolense, trypanosomes were detected by 3-4 
DAI. The parasites were demonstrated in all infected animals at the sampling 
times (Fig. 4.8). Following treatment with diminazine aceturate on 31 DAI, the 
parasites could not be detected in any animals by 2-3 DAT and remained 
negative until the end of the experimental period 38 DAI.
All the infected mice maintained a relatively high parasitaemia with 
fluctuations common in trypanosome infection.
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4.6.2.2. Acute phase protein
4.6.2.2.1. Serum amyloid P-componenl
The changes of mean plasma concentrations of SAP in the T. congolense 
infected and uninfected controls are depicted in figure 4.9. The uninfected mice 
had a mean SAP level of 65-75 fig/ml which did not vary significantly during 
the experimental period (P > 0.05). Following infection, the mean plasma SAP 
concentrations started to increase within 2 DAI reaching a mean peak 
concentration of 144.6 ± 8.5 |ig/ml at 12 DAI. This was followed by a decrease 
to a mean of 86.8 ± 8.2 (ig/ml on 21 DAI and then an increase which was more 
pronounced and significant, following diminazine aceturate treatment, 31 DAI, 
to reach a second peak of 152.6 ± 5.6 pg/ml on 34 DAI. Thereafter, the mean 
plasma SAP concentration started to decrease until termination of the 
experiment but was still significantly higher than the control concentrations.
Statistical analysis revealed that the infected animals showed a 
significant increase in the mean plasma SAP concentrations compared to the 
uninfected control animals (P < 0.05).
4.6.2.2.2. Haptoglobin
The mean haptoglobin concentrations in the infected and uninfected CD- 
1 mice are depicted in figure 4.10. The uninfected controls had a mean 
haptoglobin plasma concentration of 0.12-0.22 g/1, which did not vary 
significantly throughout the experimental period.
On infection, the mean plasma concentration increased significantly 
from 0.15 ± 0.02 g/1 on 0 DAI, to reach a peak concentration of 2.86 ± 0.33 g/1 
7 DAI (P < 0.001). This was followed by a decrease at 14 DAI, to about 1.3-2 
g/1 at which level it fluctuated until the animals were treated with diminazine 
aceturate, on 31 DAI. Following treatment, the haptoglobin concentration in the
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infected animals decreased rapidly from 34 DAI to just above uninfected values 
by 36 DAI, where it remained until termination of the experiment on 38 DAI.
The mean plasma haptoglobin concentrations in mice following infection 
were significantly higher when compared to uninfected controls (P < 0.05).
4.6.2.3. Packed red cell volume
The mean PCV values in the uninfected controls and infected mice are 
depicted in figure 4.11. The uninfected controls did not show any significant 
changes in the PCV values which ranged from 52 to 55% throughout the 
experimental period.
After infection, the mean PCV values in the infected mice started 
decreasing around 7 DAI, reaching a low mean value of 36.8 ± 1.6% on 21 
DAI. This was followed by a slight recovery thereafter, which was more 
marked after the diminazine aceturate treatment on 31 DAI and reached the pre­
infection values of 55.7 ± 0.5% by 4 DAT where it was maintained until 
termination of the experiment 38 DAI.
4.6.2.4. Histopathology
There were no noticeable changes in the histopathology of brains from 
the infected CD-I mice treated on 31 DAI and sacrificed 7 DAT (Fig. 4.12). 
Similarly the uninfected CD-I mice did not show any detectable changes (Fig. 
4.13).
4.7. DISCUSSION
Infection with T. b. brucei and T. congolense in study one and two 
respectively, resulted in the development of anaemia, and an acute phase 
response reflected by an increase in the plasma concentrations of SAP and Hp.
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However, pathological changes in the brain, after diminazine aceturate 
treatment only occurred with T. b. brucei infection.
Anaemia was manifested by a decrease in the PCV values which started 
to decline around 8 DAI in the T. congolense and 10 DAI in the T. b. brucei 
infections respectively. Treatment with diminazine aceturate on 31 and 30 DAI 
in the T. congolense and T. b. brucei respectively, resulted in disappearance of 
parasites from the circulation 2-3 DAT in both infections. There followed a 
rapid recovery of the PCV values to pre-infection levels in T. congolense, 
whereas treatment had little effect in the PCV values in T. b. brucei infected 
animals which remained low up to the end of the experiment. This difference 
was considered significant and it was concluded that the experimental design 
with a 2 DAT longer recovery period in T. congolense mice had no effect on the 
results.
In both infections, the acute phase proteins, SAP and Hp, rose rapidly 
from pre-infection concentrations in CD-I and undetectable levels for 
haptoglobin in NIH mice to reach peak concentrations 12 and 13 DAI for T. 
congolense and T. b. brucei infections, respectively. The SAP levels in both 
infections dropped to relatively low concentrations by about 17-20 DAI, 
although they were still above the uninfected control concentrations. In T. b. 
brucei infections the SAP concentrations did not change much thereafter, 
except for a slight increase on 25 DAI, and were not significantly affected by 
diminazine aceturate treatment. In contrast in T. congolense-infections, the SAP 
concentrations increased giving a second peak 34 DAI which was not 
significantly affected by drug treatment although the concentrations had started 
decreasing in the samples taken on 36 and 38 DAI.
Haptoglobin increased significantly from pre-infection and undetectable 
concentrations in T. congolense and T. b. brucei infected mice, respectively. 
The concentration of this protein reached peak concentrations on 7 and 10 DAI
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in T. congolense and T. b. brucei infections, respectively. Thereafter, in both 
infections, the concentrations remained elevated but in T. congolense, the 
concentrations of Hp decreased dramatically following diminazine aceturate 
treatment to just above control concentrations at the end of the study, whereas 
in T. b. brucei-infected animals, the Hp concentrations remained elevated by the 
end of the study and were not significantly affected by treatment.
The two strains of mice had different pre-infection endogenous 
concentrations of both SAP and Hp. SAP was demonstrable in both strains but 
was found to be higher in the CD-I mice. This strain difference in SAP has also 
been observed to occur in other strains of mice (Pepys et al, 1979; Mortensen et 
al, 1983). Similarly the two strains of mice showed differences in the 
endogenous non-stimulated haptoglobin concentrations. Haptoglobin was 
demonstrable in CD-1 mice and was absent or below the level of detection in 
the NIH mice. Haptoglobin concentrations in different strains of mice have 
previously been shown to vary in amount and in some strains, found at low or 
undetectable concentrations in normal animals (Peacock, Gelderman, Ragland 
and Hoffman, 1967). Haptoglobin has also been found to vary with age of the 
mice (Palmer, 1976). It was unfortunate but unavoidable that two different 
strains of mice were used in these studies. Nevertheless, this did not affect the 
main finding that SAP and haptoglobin are acute phase reactants during murine 
trypanosome infections and that this occurs with both tissue-invasive and non- 
invasive trypanosome species.
Although haptoglobin concentrations in plasma have previously been 
documented to increase in response to trypanosome infections in different 
species including dogs (Ndungu et al, 1991), mice (Shapiro and Black, 1992), 
and cattle (Esievo et al, 1984), this is the first time that SAP has been shown to 
react as an acute phase protein in African trypanosomiasis. At the same time, 
this is the first study to quantify haptoglobin in a murine model of African
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trypanosomiasis as previous studies had only demonstrated haptoglobin by 
qualitative and semi-quantitative methods (Shapiro and Black, 1992). 
Furthermore it was shown that there is acute phase proteins increase in response 
to both invasive and non-invasive trypanosome infections.
The haptoglobin and SAP reactions were similar in that large initial 
responses to infection were observed, but were dissimilar in that the 
haptoglobin concentration remained at an elevated concentrations while the 
SAP value decreased to a similar concentration as the uninfected controls. This 
difference in the response of the two proteins could be because haptoglobin is 
more responsive to long term stimulation or due to it having a longer plasma 
half life of 3 days (Koj, 1974), compared to 7-8.25 hrs for SAP (Baltz, Dyck 
and Pepys, 1985). A combination of these effects would thus make haptoglobin 
a better indicator of chronic infections. Indeed in cattle with different 
inflammatory conditions, levels of haptoglobin and serum amyloid-A (SAA) 
expressed as a haptoglobin/SAA ratio have been used to indicate the chronicity 
of the underlying condition (Alsemgeest, Kalsbek, Wensing, Koeman, van 
Enderen and Gruys, 1994).
Similar differences in the response of acute phase proteins have also 
been observed in the response of SAP and a 2 -macroglobulin in mice infected 
with T. cruzi (Luz and Araujo-Jorge, 1994). Similar results in the SAP response 
showing an initial increase to peak levels followed by a decrease, in spite of 
continued stimulation, has also been observed in Schistosoma mansoni 
infections in mice (Pepys et al, 1979), and in amyloidosis tolerant and 
susceptible mice injected daily with casein. In the latter experiment, SAP 
concentrations in the susceptible mice strains increased and remained elevated 
while in the tolerant strains the concentrations rose and later dropped in spite of 
continued stimulation (Baltz, Gomer, Davies, Evans, Klaus and Pepys, 1980).
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Haptoglobin plasma concentrations have been shown to decrease or be 
depleted by intravascular haemolysis which has been reported in trypanosome 
infection in cattle infected with T. vivax (Esievo et al, 1984). In both the T. b. 
brucei and T. congolense infections, haptoglobin levels remained elevated in 
spite of the development of severe anaemia. This suggests that the anaemia was 
not caused by intravascular haemolysis which would increase the plasma 
clearance of haptoglobin (Koj, 1974 ). Similar findings were observed in dogs 
infected with trypanosomes (Ndungu et al, 1991).
Following infection, CD-I mice gave higher haptoglobin responses to T. 
congolense than NIH mice gave to T. b. brucei. This difference in response 
could be due to differences in the trypanosome species, T. b. brucei and T. 
congolense, or the strain of mice used. However, as T. b. brucei is tissue 
invasive, this species would have been expected to result in higher values due to 
the tissue damage resulting from direct effect of the parasite and/or 
inflammatory responses to the parasite in tissue. This is in contrast to T. 
congolense which is generally restricted to the vascular system (Abede et al, 
1993), although also accompanied with tissue damage (Sekoni, Njoku, Kumi- 
Diaku and Saror, 1990; Katunguka-Rwakishaya, 1992). In contrast to infection 
with T. b. brucei which results in severe cellular infiltration and tissue damage 
in most tissues, with T. congolense infection these changes are much less severe 
(Murray, 1974).
The difference due to the strains of mice used could also affect the 
haptoglobin response. A difference in haptoglobin response following 
trypanosome infection has been demonstrated in mice with known differences 
in their resistance to trypanosomiasis (Shapiro and Black, 1992). In their study, 
the more resistant strain resulted in higher haptoglobin production; a similar 
effect was observed in this study where CD-1 mice produced higher levels than 
NIH mice which are less resistant to infection (Jennings, unpublished
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observation). Similarly, the difference in mouse strains might be due to the 
ability of the CD-1 mice to produce higher levels of cytokines as demonstrated 
with TNF-a production (Haranaka, Satomi and Sakurai, 1984). Indeed in 
trypanosome infections in mice, the more resistant strains have been 
demonstrated to produce higher levels of interferon (DeGee, Sonnnefeld and 
Mansfield, 1985).
The observation that the CD-I mice infected with T. congolense gave 
two peaks of SAP while the NIH mice had a small second peak might also be 
related to the patterns of cytokine production in the two strains of mice. 
Differences in cytokine concentrations and pattern of response have been 
observed in trypanosome infected mice. The more trypanosome resistant strains 
of mice such as B10.BR, gave higher second peaks of interferon, whereas, this 
second peak was either of small magnitude or absent in the less resistant strains 
(CBA) (DeGee et al, 1985). Therefore, this difference could be related to the 
different strain of mice or the parasite used. Different strains of mice have been 
shown to respond to the same stimulus giving different levels of SAP (Baltz et 
al, 1980; Le et al, 1982; Mortensen et al, 1983). Indeed the response of SAP in 
some of these mice was found to be dependent on the ability o f macrophages to 
produce interleukin-1 (Mortensen et al, 1983).
Whether this differences in response of SAP and haptoglobin is due to 
differences in the trypanosome species or the strain in the mice used can not be 
clearly elucidated by this study. Further work needs to be done using the same 
trypanosome species on the different strains of mice.
The observation that the haptoglobin concentrations decreased rapidly 
following diminazine aceturate treatment in the T. congolense and not T. b. 
brucei infection, is likely to be due to the treatment being curative for T. 
congolense (Abede et al, 1993), as opposed to T. b. brucei infection where it is 
known that this treatment does not clear the parasite from the CNS. This effect
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might be further aggravated in the T. b. brucei infection, as it has been shown 
that increased CNS pathology occurs after administration of diminazine 
aceturate in mice with established CNS trypanosome infection, a phenomenon 
associated with increased cytokine transcripts and thus possibly cytokine 
proteins in the CNS (Hunter, Gow, Kennedy Jennings and Murray, 1991; 
Hunter et al, 1992a). Intracerebroventricular injection of IL-1 and leukocytic 
pyrogens, have been shown to result in increased response in the hepatic 
synthesis of haptoglobin and CRP (Turchik and Bomstein, 1980; Dao, Bell, 
Feng, Jameson and Lipton, 1988) and a similar process might be in operation 
here. The possible effect of the CNS on the hepatic acute phase response was 
not studied in this experiment and further experiments are needed to identify the 
effect o f the CNS infection on the hepatic acute phase response.
The occurrence of SAP and Hp increases during trypanosomiasis might 
have a useful role in this trypanosome mouse model as sensitive markers for 
inflammation or trypanosome activity. However, it will be important to identify 
the mechanisms responsible for the development of the APR. This study has 
shown that, in mice, an APR occurred in infections of both invasive and non- 
invasive species of trypanosome. It was notable that increased SAP and Hp 
were detected in both infections before trypanosome could be demonstrated in 
circulation.
Acute phase proteins might have pathophysiological functions during 
disease conditions such as trypanosomiasis. Haptoglobin can influence the 
pathogenesis of disease in several ways. In the circulation, it binds iron, an 
effect that in the long run could improve iron conservation which would 
mitigate the chronic anaemia which is a major pathologic consequence of 
trypanosomiasis. Also, the peroxidase activity of the haemoglobin-haptoglobin 
complexes, might locally inactivate inflammatory cell products which cause 
tissue damage in chronic disease (Koj, 1974.). Haptoglobin, at acute phase
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response concentrations, has been shown to be able to significantly depress T- 
cell stimulation (Oh et al, 1990), a common phenomenon during
trypanosomiasis (Alcina and Fresno, 1985; Sileghem and Flynn, 1992). In 
addition, SAP has been shown to agglutinate complement-coated antibody 
sensitised erythrocytes (Hutchraft et al, 1981), enhance interleukin-1 production 
mediated by monocyte/macrophage cells (Sarlo and Mortensen, 1985), and also 
enhance macrophage listericidal activity (Singh et al, 1986). Thus in 
trypanosomiasis high levels of SAP in circulation might augment cytokine 
production of the monocyte/macrophage cells, and by agglutinating red blood 
cells, SAP might contribute to the destruction of the erythrocytes by the 
reticuloendothelial system leading to the development of anaemia.
The measurement of haptoglobin has proven to be a useful pointer to the 
severity of infection in cattle (Skinner, Brown and Roberts, 1991) and a useful 
marker for bacterial infection in sheep (Skinner and Roberts, 1994), cattle 
(Blackshaw, 1979; Makimura and Suzuki, 1982; Conner, Eckersall, Doherty 
and Douglas, 1986; Eckersall, Parton, Conner, Nash, Watson and Douglas, 
1988; Skinner et al, 1991) and dogs (Solter et al, 1991). In these cases, it was 
found to be more sensitive, specific, efficient and less likely to give false 
positive and negative results in comparison to other indicators such as 
haematology (Skinner and Roberts, 1994).
Serum amyloid-P component has been found to correlate well with the 
severity of polyathritis (Rordorf-Adam et al, 1985), and CRP the human SAP 
homologue, has been shown to correlate well with the level of trypanosome 
parasitaemia (Ndungu et al, 1991). In mice, a good correlation between the 
ability to produce IL-1 and the response of SAP has been demonstrated 
(Mortensen et al, 1983). Similarly haptoglobin levels in infected mice was 
found to increase at higher levels in trypanosome resistant mice, compared to 
the susceptible strains (Shapiro and Black, 1992), and also stimulation of Hp
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has been shown to be related to the ability of the inflammatory cells such as 
macrophages to produce the stimulating factors (Palmer, 1976). Therefore the 
circulating levels of APP have the potential to be used as markers for the 
overall activity of inflammatory mediators.
Indeed APP have advantages over other clinical indicators of 
inflammation and infection, such as the measurement of the levels of pro- 
inflammatory cytokines, haematology and enzyme activity. Assays for 
cytokines in biological fluids, are difficult and expensive to perform. The very 
transient nature of the cytokines in the circulation due to their short plasma half- 
life, makes it difficult to detect any peak levels (Hoi, Snel, Draaijer and Gruys, 
1987), and in certain diseases localisation of the cytokines occurs and they 
remain in the area of production thus not detectable in most biological fluids 
(Waage et al, 1989).
Although the measurement of the levels of individual cytokine might not 
give a true picture of their effect in vivo, it would be of interest to establish the 
levels of the peptides during a trypanosome infection. The cytokine interaction 
in vivo is complex and their effect can be influenced by the presence of other 
biologically active agents including hormones, growth factors and 
prostaglandins. Indeed, cytokines have been known to be synergistic (Elias and 
Lentz, 1990; Neta, Sayers and Oppenheim, 1992; Lee, Klampfer, Shows and 
Vilcek, 1993), antagonistic (Kamijo, Shapiro, Le, Huang, Anguet and Vilcek, 
1993), and even in some situations produce a complete different effect than 
individual cytokines (Feinman, Henriksen-DeSteano, Tsujimoto and Vilcek, 
1987; Gauldie, Richard, Northemann, Fey and Bauman, 1989). This is a major 
drawback in the interpretation of the results from the measurement of cytokines 
in biological fluids during disease, such as in investigations of trypanosomes 
infection. The levels of the APP on the other hand, remain elevated for at least 
24 hours and sometimes for 2-3 days in circulation and also represent the
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outcome of the interaction of the different molecules in the host and between 
different cytokines produced during disease.
The current approach to monitoring inflammation in infectious disease 
includes haematological screening. This requires a whole blood sample that is 
freshly drawn for analysis. In contrast, APP are not only more stable than 
cellular components of blood, but also the assays can be performed on 
previously frozen serum samples. Indeed haematological analyses in 
trypanosomiasis might not be useful as inflammatory indicators because of the 
inconsistency of the results which depend on the type of trypanosome and the 
host involved (Paling, Moloo, Scott, Mcodimba, Logan-Henfrey, Murray and 
Williams, 1991; Katunguka-Rwakishaya, 1992). Nevertheless, it must be 
emphasised that haematological screening is an important component of 
trypanosome infections which can be accompanied by anaemia and leucopenia 
associated with neutropenia, lymphopenia, eosinopenia and monocytosis, 
effects attributed to haemopoetic depression and sequestration of the cellular 
components in the tissue and the mononuclear phagocytic system (Anosa, 
1983).
Acute phase protein assays are also less affected by transient 
physiological stimuli, such as excitement, although exogenous glucocorticoids 
can affect some assay results (Harvey and West, 1987). Acute phase protein 
assays can also aid in determining the existence of inflammation in animals 
with bone marrow suppression or depletion (Jain, 1989) as occurs in 
trypanosomiasis (Andrianarivo, Muiya, Oppollo and Logan-Henfrey, 1995). 
This situation, the bone marrow being a major haematopoetic centre and thus 
source of inflammatory cells, can result in a reduced blood cells and 
inflammatory response which can significantly affect haematological cell 
counts results.
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The measurement of APP as indicators of activity of pro-inflammatory 
molecules and pathological changes during infection is likely to be important in 
the study of the pathogenesis of African trypanosomiasis giving an overall view 
of the integrated outcome of the cytokine network. During infection with 
trypanosomiasis, there are many changes accompanied by activation of the 
mononuclear system/polymorphonuclear system (Murray et al, 1974a), and an 
increase in the production of cytokines including TNF, IL-6, IL-1 and 
interferon-y among others (Bancroft et al, 1983; Reincke et al, 1993). These 
pro-inflammatory molecules are postulated to be responsible for generating the 
inflammatory changes observed in the CNS (Pentreath et al, 1990; Hunter et al. 
1991) and general circulation during trypanosomiasis (Rouzer and Cerami, 
1980).
4.8. CONCLUSION
This study has demonstrated that SAP and haptoglobin are acute phase 
reactants during chronic murine trypanosomiasis. SAP and haptoglobin, 
responded immediately but SAP concentrations dropped more rapidly than 
haptoglobin which remained elevated throughout the infection in both T. b. 
brucei and T. congolense infections. The results suggest the mediation of 
pathological changes during murine trypanosomiasis, such as cytokine 
production and thus APP, starts early before the demonstration of parasites in 
the circulation, and is not dependent on the invasiveness of the parasite but 
possibly occurs through the release of active molecule(s) by the parasites. In 
addition, the measurement of APP during infection confirms their potential use 
as indicators of infection, monitoring efficacy of treatments, and in the study of 
the pathogenesis of trypanosomiasis.
101
LO
G 
10 
T
R
Y
PA
N
O
SO
M
E
S/
M
L
PARASITAEMIA
D A I
Fig. 4.1. Changes in the parasitaemia in mice infected with Trypanosoma 
brucei brucei and treated with diminazine aceturate (B) 30 DAI.
Fig. 4.2. Mean (± SEM) plasma serum amyloid P-component concentration 
changes in Trypanosoma brucei brucei-infected and control NIH mice, and 
following subcurative treatment with 40 mg/kg diminazine aceturate (B) on 30 
DAI.
Fig. 4.3. Mean (± SEM) plasma haptoglobin concentration changes in 
Trypanosoma brucei brucei-infected and control NIH mice and following 
subcurative treatment with 40 mg/kg diminazine aceturate (B) on 30 DAI.
Fig. 4.4. Mean (± SEM) packed red cell volume changes in Trypanosoma 
brucei brucei-infected and control NIH mice and following subcurative 
treatment with 40 mg/kg diminazine aceturate (B) on 30 DAI.
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Fig. 4.5. The cerebellum of a normal NIH mouse. Haematoxylin and eosin. 
xlOO.
105
Fig. 4.5
Fig. 4.6. Brain from a NIH mouse with advanced infection with Trypanosoma 
brucei brucei. Note the dilatation and massive trypanosomal infiltration of the 
lateral ventricle choroid plexus (T) and occasional lymphocyte and plasma cell 
(C). Haematoxylin and eosin. xlOO.
Fig 4.7. Cerebellum from Trypanosoma brucei brucei infected NIH mouse with 
a subcurative treatment at dose of 40 mg/kg (ip) with diminazine aceturate 30 
DAI and sacrificed on 35 DAI, showing severe meningitis and perivascular 
cuffing. x50.
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Fig. 4.6
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Fig. 4.8. Changes in the parasitaemia in mice infected with Trypanosoma 
congolense and treated with diminazine aceturate (B) 31 DAL
Fig. 4.9. Mean (± SEM) plasma serum amyloid P-component concentration 
changes in Trypanosoma congolense-mfQcteti. and control CD-I mice and 
following curative treatment with diminazine aceturate (B) on 31 DAI.
Fig. 4.10. Mean (± SEM) plasma haptoglobin concentration changes in 
Trypanosoma congolense-infected and control CD-I mice and following 
curative treatment with diminazine aceturate (B) on 31 DAI.
Fig. 4.11. Mean (± SEM) packed red cell volume changes in Trypanosoma 
congolense-infected and control CD-I mice and following curative treatment 
with diminazine aceturate (B) on 31 DAI.
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F ig  4 .1 2 . Cerebral cortex from Trypanosoma congolense-infected mouse and 
with a curative treatment with diminazine aceturate 31 DAI and sacrificed on 
38 DAI. There were no detectable histological changes. Haematoxylin and 
eosin. X100.
F ig . 4 .1 3 . The cerebral cortex of a normal CD-I mouse. Haematoxylin and 
eosin. x50.
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Fig. 4.12
Fig. 4.13
CHAPTER 5
THE EFFECT OF ANTIBIOTIC TREATMENT ON THE PLASMA 
LEVELS OF ENDOTOXIN ACTIVITY, ACUTE PHASE PROTEINS 
AND THE PATHOLOGICAL CHANGES IN MICE INFECTED WITH 
TRYPANOSOMA BRU C EIBRU C EI
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5.1. INTRODUCTION
The African trypanosome causes a myriad of changes of a physical, 
neurological, immunological, and biochemical nature in infected human and 
animal hosts, eventually leading to death (Murray, Morrisson and Whitelaw, 
1982; Molyneux et al, 1984). The specific mechanisms leading to these 
pathological alterations are not yet fully characterised and so there has been a 
continuous search for the primary event(s) and factor(s) involved in initiating 
these changes. Various hypothesis have been proposed to explain the 
pathological events, including the possible production by the parasite of toxin­
like molecule(s) (Tizard et al, 1978) and various forms of immune-mediated 
pathology in the host (Mansfield, 1990).
The existence and involvement of parasite-derived molecule(s) similar in 
action to bacterial endotoxin has been suggested and it may be responsible for 
the hypergammaglobulinaemia and polyclonal cell activation observed in 
trypanosomiasis (Greenwood, 1974). Recent experimental work has 
demonstrated an increase in the levels of such endotoxin-like activity in the 
plasma of trypanosome-infected mice, and purified trypanosomes demonstrated 
high endotoxin activity as measured by the in vitro limulus amoebocyte lysate 
test (LAL); the recognised method for determination of endotoxin activity 
(Alafiatayo et al, 1993).
The possible involvement of a trypanosome endotoxin has been further 
supported by the observation that trypanosome product(s), when administered 
to animals, have pronounced biological activity similar to endotoxin 
preparations. Thus trypanosome products are mito genic and cause 
immunosuppression (Assoku and Tizard, 1978; Clayton et al, 1979; Albright 
and Albright, 1981). In addition, trypanosomes are known to produce molecules 
that inhibit cell growth (Sztein and Kierszenbaum, 1991; Temitope et al, 1993), 
and whole viable trypanosomes or non viable trypanosome lysate have been
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shown in vitro to stimulate the production of cytokines in astrocytes (Gichuki, 
1994), and macrophages (Hotez, le Trang and Cerami, 1984). Furthermore, 
prostaglandin production has been stimulated in astrocytes and fibroblasts 
(Alafiatayo et al, 1994) by similar trypanosome preparations. In vivo injection 
of crude trypanosome membranes into mice results in increased granulocyte- 
macrophage colony stimulating activity in their serum (Oka et al, 1989), an 
effect known to be due to the cytokine, granulocyte-macrophage stimulating 
factor (GM-CSF). Meanwhile, in vitro investigation has shown that 
macrophages harvested from trypanosome-infected animals, show alteration 
from normal in their ability to produce cytokines and express cytokine receptors 
upon stimulation with several immunostimulants, including, LPS and 
Concanavalin-A (Sileghem, Darji, Hamers and De Baetselier, 1989).
Interactions between trypanosome and lipopolysaccharide (LPS) have 
been reported in vivo. The administration of bacteria or LPS, at different stages 
during a trypanosome infection, influences the course of the infection (Singer, 
Kimble and Ritts, 1964; Murray and Morrison, 1979). LPS injection before, 
during or shortly after infection increases resistance while if administered after 
an established infection, results in reduced resistance as measured by the 
survival rate, possibly indicating a common mechanism of action between the 
trypanosomes and LPS.
The presence of an endotoxin-like substance has been demonstrated in 
other parasites, notably Plasmodium species (Jakobsen et al, 1988), Sarcocystis 
cruzi (Fayer, 1988), Chlamydia (Lewis et al, 1979), and Trypanosoma cruzi the 
latter being closely related to the African trypanosome (Goldberg et al, 1983).
Among the pathological changes in the host which are common to 
trypanosome infection and to administration of LPS are immunosuppression, 
hypergammaglobulinaemia, polyclonal cell activation (Greenwood, 1974; 
Murray et al, 1974a; 1974b; Roelants, Pearson, Morrison, Mayor-Whithey and
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Lundin, 1979), and the production of pro-inflammatory molecules such as 
cytokines (Hewett and Roth, 1993; Reincke et al, 1993). These pro- 
inflammatory molecules are increasingly being recognised as important 
mediators of the different pathological alterations observed in trypanosomiasis 
(Rouzer and Cerami, 1980; Pentreath et al, 1990; Hunter et al, 1991).
Bacterial LPS, and disease conditions where tissue is damaged, are 
among the most potent inducers of acute phase protein synthesis (Whicher and 
Dieppe, 1985). Indeed, SAP which is an APP in mice, has been shown to be 
very sensitive to endotoxin (Poole, Gordon, Baltz and Steinning, 1984), and 
haptoglobin has been documented to respond to bacterial infections making it a 
useful and sensitive indicator of bacterial infection in cattle (Blackshaw, 1979; 
Makimura and Suzuki, 1982; Conner et al, 1986; Eckersall et al, 1988; Skinner 
et al, 1991). This phenomenon has made it possible to utilise the assay of APP 
as markers of inflammation (Mozes et al, 1989; Kent, 1992; Kusher and 
Mackiewicz, 1987) and in the diagnosis of complications resulting from 
secondary bacterial infection occurring in other disease conditions (Mackie et 
al, 1979; Becker, Waldburger, Hughes and Pepys, 1980). When serial serum 
samples are taken during secondary bacterial infections, the measurement of the 
acute phase proteins is valuable in assessing the response to antibiotic therapy 
(Philip, 1982; Schofield et al, 1982; Walker, Rogers, Riches, White and Hobbs, 
1984; Whicher and Dieppe, 1985).
Chapter 4 demonstrated that an APR occurs in mice infected with T. b. 
brucei (a tissue invasive parasite). As the response also occurs with T. 
congolense (a non tissue invasive parasite), it is possible that the APR is a direct 
parasite stimulated response rather than a response to tissue damage. Therefore, 
the APP can be used to study the likelihood that stimulation may be caused by 
production of trypanosome endotoxin-like activity as demonstrated in Chapter 
4. O f the APP, SAP and Hp are suitable for study of infection in mice.
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Previous studies have searched for the origin of the increase in plasma 
endotoxin-like activity, and the possible presence of such a molecule in 
trypanosomes. However, difficulties have been encountered in confirming the 
source of the activity as being from trypanosome parasites rather than from 
other pathogens in the host such as secondary bacterial infection or 
gastrointestinal tract (GIT) bacteria (Alafiatayo et al, 1993). Although there are 
no data available showing a significant contribution by secondary bacterial 
sources m the pathogenesis of HAT, in T. cruzi infection, bacterial LPS from 
the GIT has been postulated to affect the pathology of the infection (Bambirra, 
Cruz, Campos and Lima, 1984) and increased absorption of LPS from the GIT 
following intestine damage has been documented (Caty, Guice, Oldham, 
Remick and Kunkel, 1990).
Antibiotic treatment provides a means to investigate these areas. 
Previous observations (Dr. FW. Jennings, unpublished observations) have 
indicated that T. b. brucei infected mice treated with antibiotics norfloxacin and 
ciprofloxacin, survive longer than the untreated counterparts, possibly 
supporting the hypothesis that bacterial endotoxin is responsible for 
pathological changes. Furthermore the post-treatment reactive encephalopathy 
which follows treatment of T. b. brucei infected mice with trypanocidal drugs 
such as diminazine aceturate and which is a common feature of HAT, has been 
modified in mice treated with antibiotic norfloxacin (Dr. FW. Jennings, 
unpublished observations), suggesting that the antibiotic could be modulating a 
bacterial endotoxin mediated response.
The present study was designed to identify the presence in plasma of 
endotoxin activity during T. b. brucei infected mice; to establish whether it is 
derived from the parasite or from secondary bacterial sources; to utilise the APP 
for monitoring endotoxin-like activity; to demonstrate the presence of cytokines
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during trypanosome infection, and to characterise the differential effects of 
antibiotics on CNS pathology following trypanocidal treatment.
The experiments were conducted in the chronic mouse model of 
trypanosomiasis as described in Chapter 1.
5.2. OBJECTIVES OF STUDY
1). To test the hypothesis that a trypanosome-derived endotoxin-like 
molecule(s) acting via cytokines is responsible for the pathological effects seen 
in the host and that secondary bacterial infection does not contribute to these 
effects. This was to be achieved by monitoring the acute phase proteins, SAP 
and Hp concentrations, packed red cell volume, endotoxin activity levels, and 
the presence of cytokines in plasma of trypanosome-infected mice under an 
antibiotic umbrella.
2). To test the hypothesis that antibiotic treatment will affect the early stage of 
infection by monitoring the acute phase response in frequent sampling early in 
infection.
3). To test the hypothesis that an antibiotic umbrella will reduce the pathology 
produced in T. b. brucei infected mice and, in particular, will reduce the 
neuropathology following diminazine aceturate induction of a post treatment 
reactive encephalopathy.
5.3. EXPERIMENTAL PROGRAMME
5.3.1. Study One
5.3.1.1. Part one
In study one, infected mice were treated orally with two different 
antibiotics. One set of mice were treated orally with polymyxin-B, an antibiotic 
which is not absorbed from the gastrointestinal tract, and which also binds to
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lipid-A, the active moiety of LPS, thus neutralising the pathologic effects of 
endotoxins (Palmer and Rifkind, 1974). This treatment was designed to 
eliminate the GIT as the source of endotoxin in the circulation.
A second set of mice were treated with norfloxacin, a broad spectrum 
antibiotic, that is readily absorbed from the GIT. This acts both locally in the 
GIT and in the general circulation against any secondary bacterial infection 
which could then be eliminated as a source of endotoxin.
For each antibiotic experiment, 10 groups with 6 mice per group were 
used. The animals were infected with 10^ T. b. brucei parasites. The infected 
animals were divided randomly into two sets of 5 groups each. One set was put 
under oral antibiotic treatment Vvith the drug in the drinking water from day 0 of 
infection. The remaining set were used as the infected, untreated control, and 
were given water without the antibiotic. Corresponding groups of uninfected 
treated and uninfected untreated groups were included as controls, and each 
control group was treated similarly to the infected counterparts.
In this study, 6 mice per group were sacrificed at 7 day intervals until 35 
DAI, to provide plasma for the analysis of acute phase proteins (SAP and Hp), 
cytokines, and endotoxin-like activity, and tissues for histopathology.
5.3.1.2. Part two
Previous experiments in the infected mouse model under antibiotic cover 
with norfloxacin, and treated with the trypanocidal drug diminazine aceturate to 
induce a post treatment reactive encephalopathy, had demonstrated differences 
in the brain histopathology between antibiotic treated and untreated infected 
mice (Dr. FW. Jennings, unpublished observation).
In order to examine the effect of antibiotic treatment on the CNS 
pathology in infected mice treated with diminazine aceturate, a further two 
groups of mice in each antibiotic experiment were infected with trypanosomes
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as above. One of the groups was treated and one was not treated with antibiotic. 
Control groups consisting of uninfected untreated and uninfected treated mice 
were included. The infected antibiotic treated and the infected antibiotic 
untreated groups, were then given diminazine aceturate on day 31 DAI and 
sacrificed 38 DAI. Control groups were treated similarly. Brain tissues were 
taken, fixed in formalin, and processed for histopathology.
5.3.2. Study Two
Animals were treated with both antibiotics as in study one. This study 
involved a more frequent blood sampling from tail bleeds (2-3 day interval) to 
measure APP as markers of endotoxin-like action. This would highlight any 
differences in the APR between the 7 day sampling regime used in study one. 
However, the samples were of insufficient quantities for the estimation of 
cytokines and endotoxin-like activity.
In these experiments, for each antibiotic, twenty four mice were divided 
into 4 groups of 6 mice each. Two groups were infected while the other two 
groups acted as uninfected controls. One group from the infected and another 
from the uninfected group of mice were kept under the relevant antibiotic 
treatment from one day before infection until the termination of the experiment, 
35 DAI. The remaining two groups were given water without antibiotic.
5.4. MATERIALS AND METHODS
5.4.1. Experimental Animals
Experiments were conducted on adult female inbred NIH mice weighing 
between 25-30 g bwt. The mice were maintained in groups of 6 per cage and 
fed on commercial pellets and allowed liberal access to water with or without 
antibiotic.
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5.4.2. Trypanosomes
A strain of T. b. brucei GVR 35/C. 1, which causes a chronic infection in 
mice with a survival period of about 35 days was used (Jennings and Gray, 
1983; Chapter 2).
5.4.3. Drugs
The antibiotics used were polymyxin-B sulphate (Sigma chemicals 
company), and norfloxacin (Sigma chemicals company), a broad spectrum 
antibiotic. The drugs were administered in the drinking water at a dose rate of 3 
mg/ml for each drug which is an equivalent dose of 0.6 mg (20 mg/kg bwt) in 
0.2 ml per mouse per day, for each antibiotic.
The animals in both study one and two were kept under an alternate 4 
hour light-2 hour dark regime, to facilitate maximal uptake of drug-containing 
water. The daily water consumption was determined each morning by 
measuring the amount of water in the bottles before and after topping up with 
fresh drug.
Diminazine aceturate was prepared in distilled water and administered ip 
at a dose rate of 40 mg/kg in 0.2 ml of solution.
5.4.4. Infection
Animals were infected by ip inoculation with approximately 10^ 
parasites prepared in 0.2 ml phosphate-buffered saline, pH 8.3. Control animals 
were injected with 0.2 ml of phosphate buffered saline.
5.4.5. Parasitaemia
Parasitaemia was monitored in the infected animals by examination of 
wet blood smears from tail snip at 2 day intervals in study one and at the time of 
blood sampling in study two.
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5.4.6. Blood Sampling and Tissue Preparation
5.4.6.1. Study one
Animals were serially sacrificed at 7 day intervals starting at the seventh 
day after infection until 35 DAL Five mice from each group under study, were 
anaesthetised and aseptically bled, intracardially. An aliquot (0.5 ml) of blood 
from each mouse was transferred into endotoxin free, sterile heparinised tubes 
containing 3.5 ml of sterile endotoxin free water, and placed in a bucket 
containing ice. The remaining blood from each mouse was mixed with heparin 
(1,000 units/ml) for the preparation of plasma. A corresponding number of 
uninfected controls were bled and the blood treated in a similar manner to the 
infected groups. The blood was then centrifuged at 2000 xg for 15 min at 4 °C 
to obtain plasma which was stored at -20 °C until assay for cytokines and APP. 
At the same time, tissue from the liver, spleen and the whole brain were taken 
and fixed in 10% buffered formalin for histological examination.
In the diminazine aceturate-treated animals, the brain tissues were 
harvested and treated in a similar manner as above at the time of sacrifice.
5.4.6.2. Study two
Each mouse was bled from the tail every 2-3 days until 35 DAI, for 
examination of parasitaemia, and at the same time a heparinised microcapillary 
tube for each mouse was filled with blood up to two third of the length. One end 
was sealed with plasticine and spun in a microhaematocrit centrifuge for 8 min 
to separate plasma. The PCV was read. The capillary tubes were then cut using 
a diamond marker pen, about 1 mm above the buffy coat and the plasma content 
expelled into an Eppendorf tube by exerting pressure on one end of the capillary 
tube. This plasma was stored at -20 °C until used for the estimation of SAP and 
Hp.
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5.4.7. Biochemical Assays
5.4.7.1. Limulus amoebocyte lysate test
Endotoxin activity was measured using a quantitative chromogen LAL 
test (ELISA plate-end point method) (Coatest endotoxin kit; Quadratech Ltd., 
Epsom, Surrey UK.) as described in Chapter 2.
5.4.7.2. Acute phase protein assays
5.4.7.2.1. Serum amyloid P-component assay
Serum amyloid-P was measured using a direct ELISA utilising 
commercial mouse SAP as standard (Calbiochem) (Chapter 3). The primary 
antibody was rabbit anti-murine SAP antibody, while donkey anti-rabbit 
conjugated horseradish peroxidase IgG was used as the secondary antibody.
5.4.7.2.2. Haptoglobin assay
Haptoglobin was measured using the method by Suzuki and Makimura 
(1982) with modification by Conner et al, (1988) as described in Chapter 2.
5.4.7.3. Cytokines
Cytokine assays for IL-1, TNF-a, and IL-6 were performed at the 
Division of Infectious Disease Lausanne, Switzerland by Dr. D. Heumann 
using the bioassay methods described by Baumgartner, Heumann, Gerain, 
Weinbreck, Grau and Glauser (1990).
5.4.8. Histopathology
Brain, liver and spleen were taken from each mouse at the time of 
sacrifice, in both study one and two. These were immediately fixed in 10% 
buffered formalin and later processed by the routine histological procedure.
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After paraffin embedding, sections of 3-4 pm thickness were cut and stained 
with haematoxylin and eosin (H&E) stain. The brain tissues were sectioned into 
three parts to reveal the fore, mid and hind brain.
5.5. STATISTICAL ANALYSIS
The data from study two and study one, were analysed using three way 
analysis and two way analysis of variance, respectfully. Comparisons were 
considered significantly different at P < 0.05.
5.6. RESULTS
5.6.1. Study One: Polymyxin-B
5.6.1.1. Parasitaemia
T. b. brucei parasites were demonstrated in the circulation of all infected 
animals by 4-5 DAI and the animals remained parasitaemic thereafter.
5.6.1.2. Endotoxin assay
The mean (±SEM) weekly plasma endotoxin levels in the trypanosome- 
infected and uninfected mice, with or without treatment with the antibiotic 
polymyxin-B are shown in figure 5.1.
In all the infected mice, with or without antibiotic treatment, plasma 
levels of endotoxin-like activity increased significantly (P < 0.05) by between 
2-2.5 times by 7 DAL This increased activity was demonstrated in the plasma 
of all infected animals at all the stages of infection. In uninfected animals, the 
endotoxin-like activity did not change significantly in plasma of either the 
antibiotic treated or untreated mice at any stage of the experiment (P > 0.05).
The mean plasma endotoxin-like activity in the infected animals ranged 
from 33.1 to 53.4 pg/ml compared to 10.9 to 14.8 pg/ml in the uninfected 
controls.
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Statistical comparison of the treated and untreated animals for the effect 
o f treatment with antibiotic polymyxin-B, indicated the antibiotic had no 
statisticaly significant effect on the levels of endotoxin activity in infected 
animals (P > 0.05). Similarly there was no significant difference between the 
endotoxin-like activity between the uninfected treated and uninfected untreated 
mice (P > 0.05).
5.6.1.3. Acute phase protein assay
5.6.1.3.1. Serum amyloid P-component
The mean (SEM) SAP concentrations in mice plasma of T. b. brucei 
infected, with or without polymyxin-B treatment are presented in figure 5.2. 
The uninfected animals showed comparable mean SAP levels and did not 
change significantly throughout the experimental period (P > 0.05). The mean 
concentrations ranged from 21.3 ± 6.7 to 33.2 ± 3.9 pg/ml and 21.1 ± 3.3 to 
36.3 ± 3.0 pg/ml in the uninfected treated and uninfected untreated groups, 
respectively.
The infected mice showed a significant increase in the mean SAP plasma 
concentrations throughout the experimental period compared to the mean of the 
respective control samples. The mean concentrations ranged from 46.6 ± 3.5 to 
122.6 ± 18.4 pg/ml and 44.2 ± 3.6 to 125.2 ± 9.7 pg/ml in the treated and 
untreated infected animals, respectively.
The SAP concentrations were markedly elevated on 7 and 14 DAI, but 
had decreased by 21 DAI and thereafter showed a gradual rise.
On statistical examination, the infected animals with or without 
antibiotic treatment, showed elevated mean SAP concentrations throughout the 
experimental period (P < 0.05). There was no significant differences due to the 
effect of treatment with antibiotic polymyxin-B in the infected treated when 
compared to the infected untreated groups (P > 0.05). Similarly in the
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uninfected groups, antibiotic treatment had no significant effect on the baseline 
SAP concentrations (P > 0.05).
5.6.1.3.1. Haptoglobin
Haptoglobin was not detectable in the plasma of any uninfected control 
animals throughout the polymyxin-B experimental period. In the infected 
animals there was a significant increase in the concentration of haptoglobin in 
all samples taken throughout the experimental period. The mean concentrations 
are presented in figure 5.3. The mean concentrations ranged from 0.78 ± 0.07 to 
1.99 ± 0.05 g/1 and 0.87 ± 0.08 to 2.20 ± 0.06 g/1 in the treated and untreated 
animals respectively (P < 0.05). The haptoglobin levels reached about 2 g/1 by 7 
DAI, but had decreased by about 50% by 14 DAI and remained at this level 
thereafter.
Comparison of the infected, treated and infected, untreated groups of 
animals for the effect of antibiotic treatment, indicated that Polymyxin-B had 
no statistically significant effect on the concentrations of haptoglobin (P > 
0.05). Similarly comparison of the uninfected, treated and uninfected, untreated 
animals also indicated no significant differences (P > 0.05).
5.6.1.4. Cytokine assay
The cytokine levels are presented in figure 5.4. The cytokine IL-6 was 
detected in a few samples from the infected animals while TNF-a and IL-1 was 
not detectable in any of the infected animal samples. The detected IL-6 levels 
varied from 20-120 pg/ml, were distributed throughout the infection period and 
were not affected by the treatment with the antibiotic polymyxin-B. In only one 
sample in the uninfected, control animals was 20 pg/ml of IL-6 measured.
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5.6.1.5. Histopathology
5.6.1.5.1. Liver
The livers of uninfected animals did not show any significant 
pathological alterations at any stage during the polymyxin-B experiment. Those 
from infected animals were all grossly enlarged and showed a mottled to pale 
appearance with occasional fatty changes. On histological examination these 
livers showed enlarged hepatocytes with prominent Kupffer cells. There were 
significant localised areas of cellular infiltration, mainly around the central 
vein, involving plasma cells, lymphocytes and occasionally macrophages, and 
in most cases this was accompanied by centrolobular necrosis (Fig. 5.5). The 
infiltrating cells were of the mononuclear cell type series and were more 
prominent at the late stages of infection. Treatment with antibiotic polymyxin-B 
had no significant effect on the gross pathology or histopathology of the liver 
tissues taken at any stage of the experiment from infected or uninfected 
animals.
5.6.1.5.2. Spleen
Spleens of infected mice demonstrated an increased number of active 
germinal centres with hyperplasia of cellular components during the early 
stages of infection. This was accompanied by an increase of large lymphoblasts 
and a predominance of plasma cells. In later stages of infection after 21 DAI, 
there was a reduction in the numbers of active germinal centres accompanied by 
a depletion of the cellular components and a relative increase in number of 
plasma cells and macrophages. There was no significant histological difference 
between spleens of polymyxin-B antibiotic treated and the untreated, infected 
mice.
The uninfected control mice did not show any observable histological 
changes irrespective of antibiotic treatment.
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5.6.1.5.3. Brain
There were no gross or histological changes in the CNS of the uninfected 
mice irrespective of polymyxin-B treatment.
Brains from infected mice from 21 DAI in both the antibiotic treated and 
untreated mice, contained numerous trypanosomes in the choroid plexus and in 
a few mice this was accompanied by a slight cellular infiltrate of lymphocytes 
and plasma cells in the choroid plexus (Fig. 5.6). There was no significant 
difference between the infected animals with or without treatment with the 
antibiotic polymyxin-B.
In the brains of infected mice treated with diminazine aceturate 31 DAI 
and killed 7 DAT, there was marked cellular infiltration of the meninges and 
prominent perivascular cuffing (Fig. 5.7). This was mainly composed of the 
mononuclear cell series including lymphocytes and plasma cells. There was no 
significant histological differences between the brains from the antibiotic 
treated and untreated mice.
5.6.2. Study One: Norfloxacin
5.6.2.1. Parasitaemia
Trypanosomes were demonstrated in wet blood smears taken from the 
tails of infected mice by 4-5 DAI. Thereafter the parasites were detectable in 
the circulation of all mice unless treated with diminazine aceturate.
5.6.2.2. Endotoxin assay
The mean (±SEM) weekly plasma endotoxin levels in the trypanosome- 
infected and uninfected mice, with or without treatment with the antibiotic 
norfloxacin, are shown in figure 5.8.
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In all the infected mice with or without antibiotic treatment, plasma 
levels of endotoxin-like activity increased significantly (P < 0.05) by between 
2-2.5 times by 7 DAI. This increased activity was demonstrated in the plasma 
of infected animals throughout the experimental period. In the uninfected 
animals, the endotoxin-like activity did not change significantly in either 
uninfected treated or untreated mice at any stage of the experiment (P > 0.05).
The mean plasma endotoxin-like activity in the infected animals ranged 
from 32.1 to 44.4 pg/ml compared to 11.4 to 15.0 pg/ml in the uninfected 
controls. Statistical comparison indicated that there were no significant 
differences in the levels of endotoxin-like activity between the infected, treated 
and infected, untreated groups (P > 0.05). Similarly, there was no significant 
difference in the endotoxin-like levels between uninfected, treated and 
uninfected, untreated mice (P > 0.05).
5.6.2.3. Acute phase protein assay
5.6.2.3.I. Serum amyloid P-componenl
The mean plasma SAP concentrations are presented in figure. 5.9. The 
uninfected animals showed similar mean SAP concentrations that did not 
change significantly throughout the experimental period (P > 0.05). The mean 
concentrations ranged from 21.4 ± 3.2 to 33.0 ± 3.9 pg/ml and 23.7 ± 3.1 to
30.2 ± 2.3 pg/ml in the treated and untreated groups respectively.
The infected mice showed significant increases in the mean SAP 
concentrations throughout the experimental period compared to their respective 
controls. The mean SAP concentrations were significantly elevated ranging 
from 50.9 ± 5.2 to 106.3 ± 14.3 pg/ml and 45.5 ± 2.9 to 121.1 ± 6.8 pg/ml in 
the treated and untreated groups, respectively (P < 0.05).
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The higher concentrations were found in the samples taken in the early 
stages of infection, i.e., from 7 and 14 DAI, followed by a decrease by 21 DAI 
and a slight increase on 35 DAI.
Statistical analysis of the infected animals, with or without antibiotic 
treatment, showed significantly elevated mean SAP concentrations throughout 
the experimental period (P < 0.05). There were no statistically significant 
differences for the effect of the antibiotic norfloxacin, i.e., in the infected, 
treated compared to the infected, untreated group (P > 0.05). Similarly, in the 
uninfected groups treatment had no effect on the baseline SAP concentrations 
(P > 0.05).
5.6.2.3.2. Haptoglobin
The mean haptoglobin concentrations are presented in figure 5.10. 
Haptoglobin was not detectable in the plasma of uninfected control animals 
throughout the experimental period (35 DAI).
In the infected animals, haptoglobin was detectable by 7 DAI, and 
thereafter there were significant increases in the concentration of haptoglobin in 
all samples taken throughout the experimental period compared to the 
uninfected controls.
The mean concentrations ranged from 0.84 ± 0.14 to 1.95 ± 0.17 g/1 and 
1.04 ± 0.02 to 1.99 ± 0.32 g/1 in the treated and untreated, infected animals, 
respectively. These differences were significant (P < 0.05). The haptoglobin 
increased to 2 g/1 on 7 DAI and then fell by 50 % on 14 DAI where it remained 
elevated for the rest of the experimental period. From 28 DAI onwards, the 
infected, untreated mice plasma, had consistently higher concentrations of 
haptoglobin compared to the infected, treated mice.
Statistical analysis of the effect of antibiotic treatment, indicated that 
norfloxacin treated animals had significantly lower levels of haptoglobin
131
compared to the untreated groups (P < 0.05). This decrease in the levels of 
haptoglobin due to treatment with norfloxacin, was more pronounced during the 
terminal stages of infection after 21 DAI.
5.6.2.4. Cytokines assay
The cytokine levels are shown in figure 5.11. The cytokine IL-6 was 
only detected in some plasma samples while TNF-a and IL-1 were not detected 
in any samples. Infected mice IL-6 concentration varied from 20-40 pg/ml. 
Positive values were distributed throughout the infection period and were not 
affected by the treatment with the antibiotic norfloxacin. In two samples from 
the uninfected, control animals IL-6 was detected at the 25 pg/ml level.
5.6.2.5. Histopathology
5.6.2.5.I. Liver
The livers of uninfected animals with or without antibiotic treatment, did 
not show any significant pathological changes during the experiment. In 
contrast, those from all infected animals were grossly enlarged and showed a 
mottled to pale appearance with occasional fatty changes. On histological 
examination, these livers showed enlarged hepatocytes with prominent Kupffer 
cells lining the sinusoids. There were significant localised areas of cellular 
infiltration, mainly around the central vein involving the plasma cells, 
lymphocytes and occasionally macrophages, and in most cases this was 
accompanied by centrilobular necrosis. These changes were more pronounced 
during the late stages of infection.
In contrast, the livers from norfloxacin-treated mice, showed a 
significant reduction in the severity of cellular infiltration in the early stages of 
infection, before 21 DAI (Fig. 5.12), but in the later stages of infection, all mice 
livers were equally affected regardless of antibiotic treatment.
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5.6.2.5.2. Spleen
Spleens of all infected mice with or without norfloxacin treatment 
demonstrated an increased number of active germinal centres with marked 
cellular hyperplasia, during the early stages of infection. This was accompanied 
by an increase in the number of large lymphoblasts and a predominance of 
plasma cells. In the later stages of infection, after 21 DAI, there was a reduction 
in the numbers of active germinal centres accompanied by a depletion of the 
cellular components with a relative increase in number of plasma cells and 
macrophages. There was no obvious histological difference due to treatment 
with the antibiotic norfloxacin.
The uninfected control mice did not show any observable histological 
changes irrespective of antibiotic treatment, but in term of gross pathology, 
spleens from norfloxacin-treated mice were visually relatively smaller in size 
compared to those from the corresponding uninfected, untreated groups.
5.6.2.5.3. Brain
There were no significant gross or histological changes in the CNS of the 
uninfected mice irrespective of antibiotic treatment.
The brains from infected mice sacrificed from 21 DAI, contained 
numerous trypanosomes in the choroid plexus especially in the lateral ventricles 
of the mid-brain, and in a few mice this was accompanied by a mild cellular 
infiltrate of lymphocytes and plasma cells. There was no significant difference 
in the brain histopathology between infected animals with or without antibiotic 
treatment.
In the brains of infected mice treated with diminazine aceturate 31 DAI 
and killed 7 DAT, there was marked cellular infiltration of the meninges and 
prominent perivascular cuffing. This was mainly composed of mononuclear
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cells including lymphocytes and plasma cells. The pathology was similar in 
brains from antibiotic treated and untreated mice.
5.6.3. Study Two: Polymyxin-B Experiment
This study was done in order to highlight any differences that occured, between 
the 7 day intervals, in the parameters monitored in study one.
5.6.3.1. Parasitaemia
Trypanosomes were demonstrated in the circulation by 4-5 DAI. All 
mice had high parasitaemias throughout the experimental period with 
fluctuating parasitaemic waves.
5.6.3.2. Packed red blood cell volume
The mean PCV values are presented in figure 5.13. The uninfected mice 
did not show any significant change in the mean PCV levels throughout the 
experimental period (P > 0.05). Treatment with the antibiotic polymyxin-B in 
the uninfected animals did not have any significant effect on PCV (P > 0.05).
On the other hand, the mean PCV levels in the infected animals showed 
a significant gradual and continuous drop from 15 DAI (P < 0.05). This reached 
a lowest level of 40.6 ± 1 .0  and 41.1 ± 0.8% in the treated and untreated mice, 
respectively, 30 DAI (P < 0.001).
Comparison of the infected polymyxin-B treated and infected untreated 
mice showed no significant difference in the mean PCV values (P > 0.05).
5.6.3.3. Acute phase proteins assay
5.6.3.3.I. Serum amyloid P-component
The changes in the SAP concentrations are presented in figure 5.14. The 
plasma samples from the pre-infection and uninfected control mice had a mean
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base line SAP concentrations ranging from 20.5 ± 4.8 to 37.3 ± 2.7 pg/ml 
throughout the experiment.
The mean plasma SAP concentrations in the infected mice started 
increasing shortly after infection and were significantly different from the SAP 
in controls by 2 DAI (P < 0.05). This rise continued, reaching peak mean 
concentrations of 141.4 ± 21.8 and 127.8 ± 24.5 pg/ml in the treated and 
untreated mice 14 and 11 DAI, respectively (P < 0.001). This was then followed 
by a sharp decline to levels above baseline values of between 40-50 pg/ml, at 
which it was maintained until termination of the experiment.
Statistical comparison of the mean SAP levels of the untreated and 
polymyxin-B treated infected or uninfected mice during the experiment, did not 
show any significant difference due to antibiotic treatment (P > 0.05).
5.6.3.3.2. Haptoglobin
The mean haptoglobin concentrations are presented in figure 5.15. 
Haptoglobin was undetectable in all samples from pre-infection and from 
uninfected animals. Following infection, haptoglobin was found in plasma 3 
DAI. This rose to peak mean concentrations of 1.84 ± 0.25 g/1 and 2.16 ± 0.14 
g/1 in the treated and untreated animals 6 DAI. Thereafter, the concentrations 
decreased to about 1 g/1 where they remained for the rest of the experiment.
On statistical analysis the haptoglobin concentrations were significantly 
elevated throughout the experimental period in all infected mice. The antibiotic 
polymyxin-B had no significant effect on the mean haptoglobin concentrations 
in the treated groups compared to the untreated groups (P > 0.05).
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5.6.4. Study Two: Norfloxacin Experiment
5.6.4.1. Parasitaemia
Parasites were demonstrated in the circulation of all infected animals by 
4-5 DAI and the animals maintained a relatively high parasitaemia throughout 
the infection period.
5.6.4.2. Packed red blood cell volume changes
The mean PCV values during the infection are presented in figure 5.16. 
The mean PCV in the control mice did not show any significant changes 
throughout the experiment and there was no significant effect of treatment (P > 
0.05). In the infected animals, there was a gradual and significant decrease in 
the mean PCV from 11 DAI which reached a low value of 36.2 ± 0.5 and 38.8 ± 
0.9% in the treated and untreated groups, respectively, 35 DAI (P < 0.001).
There was no significant difference on the effect o f treatment with 
norfloxacin on the mean PCV levels in the infected animals between the treated 
and untreated groups (P > 0.05). Similarly the antibiotic treatment had no effect 
on the mean PCV values of the uninfected animals.
5.6.4.3. Acute phase protein assays
5.6.4.3.I. Serum amyloid P-component
The mean SAP concentrations are presented in figure 5.17. SAP 
concentrations in the infected mice rose significantly by 2 DAI from baseline 
concentrations to reach peak mean concentrations of 122.6 ± 18.4 and 129.3 ±
13.2 |ug/ml in treated and untreated mice, respectively, 14 DAI (P < 0.001). 
This was later followed by a decline to near pre-infection concentrations, but 
remaining higher than the mean of the controls, where it was maintained till 
termination of the experiment. Treatment of the infected mice with norfloxacin
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did not have a significant effect on the SAP concentrations compared to the 
infected untreated groups (P > 0.05).
The uninfected animals did not show any significant change in the base 
line mean concentrations of SAP with or without treatment with norfloxacin (P 
>0.05).
5.6.4.3.2. Haptoglobin
The mean haptoglobin concentrations are presented in figure 5.18. The 
preinfection and plasma samples from the uninfected animals did not have any 
detectable haptoglobin. On infection, haptoglobin was detected 3 DAI and a 
gradual increase reached peak mean concentrations of 1.95 ± 0.17 and 2.02 ± 
0.19 g/1 on 10 DAI in the treated and untreated groups, respectively. This was 
followed by a drop to about 1 g/1 15 DAI where it remained in both infected 
groups of animals for the rest of the experiment. Statistical analysis on the 
possible effect of antibiotic treatment on the mean haptoglobin concentrations 
showed significant decreases in haptoglobin concentrations toward the terminal 
stages of infection, i.e. 28 DAI (P < 0.05), but there was no significant effect of 
antibiotic treatment (P > 0.05).
5.7. DISCUSSION
The results in this chapter demonstrate that infection of mice with T. b. 
brucei is associated with a significant increase in the levels of plasma 
endotoxin-like activity, anaemia, tissue pathology, and confirms the findings of 
Chapter 4 showing the development of an acute phase response demonstrated 
by increases in the plasma concentrations of the acute phase proteins, SAP and 
haptoglobin. The endotoxin-like activity increased significantly (200%) by 7 
DAI in all infected mice in study one, and remained elevated throughout the 
experiment. The endotoxin-like activity was not affected by treatment with the
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antibiotics polymyxin-B and norfloxacin. This suggests that the endotoxin-like 
activity is of parasite origin and not from bacteria or absorption from the GIT.
The APP in plasma of infected mice in studies one and two, increased to 
peak levels by 10-15 and 7-10 DAI, for SAP and Hp, respectively. Thereafter in 
both studies, SAP decreased to just above baseline control levels and remained 
low for the remaining part of the experiment. Haptoglobin, on the other hand, 
decreased to around 50% of the peak concentration, and remained elevated for 
the rest of the experimental period.
The plasma concentration of the APP in the mice treated with 
polymyxin-B in studies one and two were not affected by the treatment with the 
antibiotic. Polymyxin-B which not only kills gastrointestinal tract bacteria but 
also binds to bacterial LPS preventing absorption, virtually eliminating the 
gastrointestinal tract as a source of endotoxin, had no significant effect on the 
development of the APP. Treatment with norfloxacin in both studies, did not 
affect the concentrations of SAP in plasma of infected mice, but plasma from 
infected treated mice had slightly lower Hp concentrations compared to the 
infected untreated groups in study one, an effect that was more pronounced 
during the later stage of infection, i.e., 28 DAI. This finding was not repeated in 
study two where there was no significant differences in haptoglobin 
concentrations between infected, untreated and infected norfloxacin treated 
mice. It is probable that the slight fall in study one was artificial, although a 
contribution from secondary bacterial infection can not be totally dismissed. 
Indeed serial measurements of CRP in leukaemia (Mackie et al, 1979; 
Schofield et al, 1982; Walker et al, 1984) and systemic lupus erythematosus 
(Becker et al, 1980) were found to be higher in cases with secondary bacterial 
infections compared to the uncomplicated cases. Also the CRP concentrations 
in these cases of intercurrent bacterial infections were found to decrease
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following effective antibacterial treatment but remained elevated in the 
unresponsive cases (Philip, 1982; Schofield et al, 1982).
The only effect of antibiotic treatment shown by histological 
examination of the tissues, was in the norfloxacin treated mice where a decrease 
in the cellular infiltration of the liver was observed during the early stages of 
infection, before 21 DAI. However after this all tissues were equally affected 
with or without antibiotic treatment, further evidence that bacterial products are 
unlikely to be responsible for the trypanosome pathology.
The presence of a toxin-like molecule in trypanosomes has been 
postulated for a long time (Tizard et al, 1978) and may be responsible for 
initiating the pathogenesis of African trypanosomiasis (Pentreath, 1994). 
Indeed, endotoxin-like activity has been demonstrated by the LAL method in 
trypanosome lysate and elevated levels have been reported in the serum of mice 
infected with trypanosomes (Alafiatayo et al, 1993).
In previous experiments, the origin of this toxin in different parasitic 
infections including trypanosomiasis, and its pathological significance has not 
been elucidated. Notably, the occurrence of secondary bacterial infection and 
the absorption of endotoxin from the gastrointestinal tract of infected host 
following damage to the intestinal wall during infection, an observation 
documented in T. cruzi infection (Bambirra et al, 1984) have been possible 
sources of the activity demonstrated in trypanosomiasis (Alafiatayo et al, 1993).
In T. cruzi, a close relative of the parasite causing African 
trypanosomiasis, an endotoxin-like lipopolysaccharide molecule has been 
demonstrated (Goldberg et al, 1983). Although endotoxins have been 
extensively studied in bacteria, molecules with endotoxin-like activity have also 
been demonstrated in other micro-organisms including Plasmodium falciparum  
(Jakobsen et al, 1988), Sarcocystis cruzi (Fayer, 1988), and Chlamydia (Lewis
139
et al, 1979). Presumably, all these endotoxin-like activities operate in vivo by 
activation of the cytokine network which is discussed below.
These results suggest that the endotoxin-like activity measured in plasma 
of infected mice is of trypanosome origin. This is based on the observation that 
when animals were treated with antibiotic throughout the infection, the 
endotoxin-like activity in plasma was not diminished in comparison to infected 
untreated animals. Although tissue damage is known to be an inducer of 
cytokines and thus the APR (Whicher and Dieppe, 1985; Mozes et al, 1989), 
the possibility that the observed APR was due to the tissue damage resulting 
from the infection and the invasiveness of T. b. brucei is unlikely. This is not 
only from the result of Chapter 4 where a tissue invasive and non-invasive 
trypanosome species caused an APR, but also because the protein 
concentrations of Hp and SAP, started rising before parasites were 
demonstrable in circulation and most significantly when little or no tissue 
pathology was observed. The highest response of both proteins in the infected 
animals was observed during early infection, i.e., 7-10 DAI, whereas, during 
late infection when maximum tissue pathology was observed, the levels of the 
acute phase proteins had decreased by 50% for Hp and to near baseline levels 
for SAP. It is of interest that macrophages, which are known to be a main 
source of cytokines, from trypanosome-infected animals during early infection, 
show increased cytokine production (Sileghem, Flynn, Saya and Williams, 
1993), while in late infections they show a decreased ability to produce 
cytokines (Mitchel, Pearson and Gouldie, 1986) and prostaglandins (Fierer et 
al, 1984), although species differences have been reported (Sileghem et al, 
1989).
In addition, non-invasive trypanosomes such as T. congolense that 
produce minimal tissue damage cause the production of pro-inflammatory 
molecules including cytokines (Mitchel et al, 1986; Sileghem et al, 1993),
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prostaglandins (Mutayoba, Meyer, Osaso, and Gombe, 1989), and also APP 
(Thomson et al, 1973). Trypanosoma congolense infection has also been shown 
to induce an increase in TNF-a receptor expression on peripheral blood 
leukocytes in sheep (Winstanley, Holmes, Katunguka-Rwakishaya, Perkins, 
Fishwick and Murray, 1993).
Furthermore whole viable trypanosome and non viable trypanosome 
lysates have been documented to be able to stimulate the production of 
cytokines in vitro (Hotez et al, 1984; Gichuki, 1994; Pentreath, 1994) and in 
vivo (Oka et al, 1989). This suggests that cytokine production is not dependent 
on an active infection but is possibly due to a host response to parasite derived 
product(s) such as the endotoxin-like activity identified here.
The decrease in the concentrations of the APP, in spite of the elevated 
endotoxin-like activity which is maintained from 7 to 35 DAI, might be 
explained by reduction in endogenous production of the pro-inflammatory 
mediators during trypanosomiasis (Fierer et al, 1984; Mitchel et al, 1986), an 
observation also noted during continuous exposure to sub-lethal doses of gram 
negative bacterial endotoxin (Flohe, Heinrich, Schneider, Wendel and Flohe, 
1991; Roth et al, 1994). Indeed, mice made tolerant to lethal doses of endotoxin 
by continuous injection with sublethal doses of Escherichia coli LPS before 
infection, showed increased survival time and were able to withstand high 
parasitaemia, following infection with T. b. brucei, T. congolense, T. duttoni 
and T. rhodesiense (Singer et al, 1964) suggesting a possible similarity in the 
mechanism of action between trypanosomes and LPS.
The fact that only minor changes in APP and liver pathology were 
observed in norfloxacin-treated mice, suggests that secondary bacterial 
infection, is not a major factor in the pathogenesis of trypanosomiasis. 
However, the pathological changes during the later stages of trypanosome 
infection such as meningoencephalitis, could be exacerbated by secondary
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bacterial infection (Mott, 1907). Secondary bacterial infection is a common 
cause of death in chronic infections (Goodwin, 1970). The results also suggest 
that endotoxin from the gastrointestinal tract, is not important to the endotoxin­
like activity during trypanosomiasis as treatment with polymyxin-B, an 
antibiotic known to have antibacterial effect and the ability to bind to and 
inactivate endotoxin (Palmer and Rifkind, 1974; Corrigan and Bell, 1971), did 
not have any effect on the levels of APP, endotoxin-like activity, or the tissue 
pathology.
The nature of the molecule(s) responsible for the increased endotoxin­
like activity is not clear. Although the LAL assay for endotoxin is assumed to 
be lipid-A specific, it has also been shown to react with other non 
lipopolysaccharide molecules, including, polynucleotides and proteins (Elin and 
Wolff, 1973), Mycoplasma lipoglycans (Weinberg, Smith and Kahane, 1980) 
and antigens from gram positive bacteria (Brunson and Watson, 1976; Baek, 
Hoiby, Hertz and Espersen, 1985). The chemical nature of the trypanosome 
molecule(s) responsible for the LAL reaction and/or induction of the APR 
needs to be determined in order to understand the mechanism behind the 
production of the pathological changes and the APR during trypanosome 
infection.
Only low amounts of IL-6 were detected in occasional samples in study 
one. This is probably due to the length of time between sampling which was 7 
days and is also likely to have resulted in missing raised levels of IL -1 and 
TNF-a as cytokines have short plasma half-lives resulting from enzymatic 
degradation, tissue binding (Beutler, Milsark and Cerami, 1985), or as a result 
of local compartmentalisation (Nelson, Bagby, Bainton, Wilson, Thomson and 
Summer, 1989; Waage et al, 1989). The absence of cytokines in the circulation, 
though the biological activity can be demonstrated, has been documented in 
mice (Hinshaw, Tekamp-Olson, Chang, Lee, Taylor, Murray, Peer, Emerson,
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Passey and Kuo, 1990). The investigation of circulating cytokines in T. b. 
brucei was limited here to the assay of the weekly samples taken in study one. 
To provide more conclusive results, samples should be taken more frequently. 
A problem might arise because of the small volume of plasma which could be 
taken. Alternatively a large number of animals could be sacrificed. Such 
investigations might provide useful information.
APP can act as markers of combined cytokine activity. They remain in 
the circulation for at least 24 hours and also represent the systemic outcome of 
the complex interaction of the cytokine network within the host. IL-6, a 
multifuctional cytokine known to activate T and B-cells (Kishimoto and Hirano, 
1988), is the major regulating cytokine for the hepatic APP synthesis (Heinrich 
et al, 1990). It is likely that IL-6 was responsible for the stimulation of the 
observed APR but its production has been shown to be initiated by other 
cytokines including TNF-a and IL-1 (Heinrich et al, 1990) but these were at an 
undetectable level. Similarly in horses treated with endotoxin, TNF-a elevation 
has been shown to precede that of IL-6 (Mackey and Lister, 1992) and in rats, 
repeated doses of endotoxin resulted in repeated IL-6 formation but reduced 
TNF-a formation (Flohe et al, 1991).
In the infected animals treated with diminazine aceturate, severe 
pathological changes were observed which were confined to the CNS. However 
the severity of the lesions was not affected by the antibiotic treatments.
This is the first study to link trypanosome endotoxin-like activity, 
cytokine IL-6, the APP response, and the pathological changes observed during 
African trypanosomiasis. It suggests that trypanosomes may cause pathological 
alterations in infected hosts by releasing active molecule(s) with endotoxin-like 
activity, which lead to the production of cytokines and the development o f the 
APR observed during trypanosomiasis.
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5.8. CONCLUSION
These results demonstrate that infection of mice with trypanosomes 
causes a significant increase in the plasma levels of endotoxin-like activity as 
well as the acute phase proteins, SAP and haptoglobin. This is also 
accompanied by increased levels of cytokine IL-6. Treatment of infected mice 
with the antibiotics norfloxacin or polymyxin-B, to eliminate any other 
secondary source of endotoxin including secondary bacterial infection and 
absorption from the gastrointestinal tract, did not have any significant effect on 
these parameters except a slight modification of liver pathology and minor 
reduction in haptoglobin concentrations in the terminal stage of infection. This 
suggests that the trypanosomes and not bacteria were responsible for the 
pathological changes, possibly by producing during the infection, a molecule(s) 
with endotoxin-like activity.
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Fig. 5.1. Weekly mean (± SEM) changes in the plasma endotoxin levels in 
Trypanosoma brucei brucei-infected and control mice with or without 
polymyxin-B antibiotic treatment.
Fig. 5.2. Weekly mean (± SEM) changes in the plasma concentrations of serum 
amyloid P-component in Trypanosoma brucei brucei-infected and control mice 
with or without polymyxin-B antibiotic treatment.
Fig. 5.3. Weekly mean (± SEM) changes in the plasma concentrations of 
haptoglobin in Trypanosoma brucei brucei-infected and control mice with or 
without polymyxin-B antibiotic treatment.
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Fig. 5.4. Weekly levels of cytokine IL-6 in Trypanosoma brucei brucei-infected 
mice with (A) or without (B) polymyxin-B treatment. Six samples were 
analysed at each time point for IL-6 concentration, only samples containing a 
detectable concentration of IL-6 are shown on the figure.
Fig. 5.5 a and b. Liver of Trypanosoma brucei brucei-infected mouse killed on 
day 35 DAI showing severe cellular infiltration in the portal area (C) and the 
parenchyma (D) with hepatocyte necrosis (N). Haematoxylin and eosin. xlOO 
and x80.
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Fig. 5.5
< »
F ig . 5 .6 . Brain of Trypanosoma brucei brucei-infected mouse killed on day 35 
DAI. Note the large number of trypanosomes in the choroid plexus (T). 
Haematoxylin and eosin. xlOO.
F ig . 5 .7 . Cerebrum of Trypanosoma brucei brucei-infected mouse treated with 
diminazine aceturate 31 DAI and killed 7 DAT. Note the severe meningitis (M) 
and perivascular cuffing (C). Haematoxylin and eosin. x80.
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Fig. 5.6
Fig. 5.7
F ig . 5 .8 . Weekly mean (± SEM) changes in the plasma endotoxin levels in 
Trypanosoma brucei brucei-infected and control mice with or without 
norfloxacin antibiotic treatment.
F ig . 5 .9 . Weekly mean (± SEM) changes in the plasma concentrations of serum 
amyloid P-component in Trypanosoma brucei brucei-infected and control mice 
with or without norfloxacin antibiotic treatment.
F ig . 5 .1 0 . Weekly mean (± SEM) changes in the plasma concentrations of 
haptoglobin in Trypanosoma brucei brucei-infected and control mice with or 
without norfloxacin antibiotic treatment.
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Fig. 5.11. Weekly levels of cytokine IL-6 in Trypanosoma brucei brucei- 
infected mice with (A) or without (B) norfloxacin treatment. Six samples were 
analysed at each time point for IL-6 concentration, only samples containing a 
detectable concentration of IL-6 are shown on the figure.
Fig. 5.12. Liver sections of Trypanosoma brucei brucei-infected mouse killed 
on day 21 post infection. Infected norfloxacin treated (Fig. 5.12a) and infected 
untreated (Fig. 5.12b). Note the reduced centrilobular cellular infiltration in the 
antibiotic-treated and compared to the untreated mice. Haematoxylin and eosin. 
x50.
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Fig. 5.12
Fig. 5.13. Mean (± SEM) changes in the packed red cell volume (PCV) in 
Trypanosoma brucei brucei-infected and control mice with or without 
polymyxin-B antibiotic treatment.
Fig. 5.14. Mean (± SEM) changes in the plasma concentrations of serum 
amyloid P-component in Trypanosoma brucei brucei-infected and control mice 
with or without polymyxin-B antibiotic treatment.
Fig. 5.15. Mean (± SEM) changes in the plasma concentrations of haptoglobin 
in Trypanosoma brucei brucei-infected and control mice with or without 
polymyxin-B antibiotic treatment
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Fig. 5.16. Mean (± SEM) changes in the packed red cell volume (PCV) in 
Trypanosoma brucei 6rwce/-infected and control mice with or without 
norfloxacin antibiotic treatment.
Fig. 5.17. Mean (± SEM) changes in the plasma concentrations of serum 
amyloid P-component in Trypanosoma brucei brucei-infected and control mice 
with or without norfloxacin antibiotic treatment.
Fig. 5.18. Mean (± SEM) changes in the plasma concentrations of haptoglobin 
in Trypanosoma brucei brucei-infected and control mice with or without 
norfloxacin antibiotic treatment.
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CHAPTER 6
LIPOPOLYSACCHARIDE AND LIPID-A IN TRYPANOSOME 
LYSATES AND MEMBRANE-ENRICHED TRYPANOSOME
FRACTIONS
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6.1. INTRODUCTION
In African trypanosomiasis attempts to develop a vaccine as a means of 
controlling the disease have been hampered by the ability of the parasite to 
evade the immune system of the host through antigenic variation of the surface 
coat (Vickerman, 1978; Nantulya, 1986).
Once established in the host, the parasite causes a variety of 
immunological and non-immunological changes eventually leading to death 
(Murray et al, 1982; Molyneux et al, 1984). Although the pathological changes 
following trypanosome infection have been well described in infected hosts, the 
underlying pathogenic mechanisms are not clearly understood (Pentreath, 
1991). This has led to several hypotheses being put forward to explain the 
observed pathological alterations, which include the immune-mediated 
responses (Mansfield, 1990) and trypanosome-derived toxins (Tizard et al, 
1978). Observations described in the previous chapters of this thesis support the 
hypothesis that trypanosomes can produce an endotoxin-like molecule(s) 
capable of stimulating the host defence system.
The pro-inflammatory molecules such as cytokines and interferons have 
been shown to produce, at least in part, the pathological changes observed 
during trypanosomiasis and other parasitic diseases (Titus et al, 1991; Jakobsen, 
Bate, Tavern and Playfair, 1995). During trypanosomiasis increased production 
and release of cytokines have been documented (Hunter et al, 1992a; Reincke et 
al, 1993) and trypanosomes or their products have been shown to have the 
ability to induce the production of cytokines from different cell types in vitro 
(Hotez et al, 1984; Olsson et al, 1991; Gichuki, 1994; Alafiatayo et al, 1994).
In trypanosomiasis, these pro-inflammatory molecules are thought to be 
responsible for initiating the inflammatory and non-inflammatory changes in 
the infected hosts (Rouzer and Cerami, 1980; Bancroft et al, 1983; Hunter et al, 
1991; Hunter et al 1992a), but the precise mechanisms or trypanosome
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molecule(s) involved in their production are not well understood (Pentreath, 
1991). Trypanosomes are known to produce factor(s) that cause peritoneal cells 
to produce mediators with lipoprotein lipase enzyme suppressive activity 
(Hotez et al, 1984), an effect known to be mediated by TNF-a. Trypanosomes 
are also documented to release molecule(s) that inhibit human promyelocytic 
HL-60 cell growth (Keku, Seed, Sechelski and Balber, 1994), and prevent the 
progression of activated human T-lymphocytes through the cell cycle (Sztein 
and Kierszenbaum, 1991). A trypanosome product, trypanosome lymphocyte 
triggering factor (TLTF) has been purified from T. b. brucei and has been 
demonstrated to activate CD8+ T cells to release interferon-y (Olsson et al, 
1991). The chemical nature of this molecule(s) is not known although the 
possible presence of a trypanosome toxin has been speculated (Tizard et al, 
1978). Membrane fractions of trypanosomes injected into mice have been 
shown to mimic the immunosuppressive and mitogenic effects of the living 
parasite (Clayton et al, 1979). Indeed the possible production of a trypanosome 
mitogen and its involvement in immunosuppression through non-specific 
stimulation and multiplication of B-lymphocytes, preventing their participation 
in immune responses has been suggested (Urquhart et al, 1973; Murray et al, 
1974b). This mitogen is also postulated to be involved in the production of the 
marked increase in serum immunoglobulins, particularly IgM, and the 
production of heterophile antibodies and auto-antibodies characteristically 
found in trypanosomiasis (Greenwood, 1974). Recent work by several workers 
(Alafiatayo et al, 1993) and the observations in this thesis, have demonstrated 
increased endotoxin-like activity in plasma from trypanosome-infected mice. In 
addition, trypanosome lysates showed high activity in the LAL assay for 
endotoxin activity, although the molecule(s) responsible for this activity has not 
yet been characterised (Alafiatayo et al, 1993).
163
As discussed earlier, the involvement of toxin-like molecules in parasitic 
infections has been suggested in the pathogenesis of other parasitic diseases 
including malaria (Jakobsen et al, 1988), Chlamydia (Lewis et al, 1979), 
Sarcocytis (Fayer, 1988) and Chagas' disease (Goldberg et al, 1983). In 
Trypanosoma cruzi (Chagas' disease) infections, the toxin has been 
characterised and shown to be a lipopolysaccharide molecule (Goldberg et al, 
1983; de Simone, Pinho, Vanni and de Carvalho, 1991).
The most characterised toxin with similar activity is the LPS molecule of 
gram negative bacteria. This is known to consist of two distinct parts, the outer 
core containing polysaccharide and an inner core containing the lipid-A moiety 
(Luderitz, Freudenburg, Galanos, Lehmann, Rietschel and Shaw, 1982). The 
lipid-A moiety is a highly conserved part of the LPS molecule in the different 
species of the genera (Mutharia, Crockford, Bogard and Hancock, 1984: 
Bogard, Dunn, Abemethy, Kilgarriff and Kung, 1987). Most o f the 
immunogenic and pathogenic activity of such bacterial LPS is known to be the 
property of this lipid-A moiety (Rietschel, Brade, Brandenburg, Flad, de Jong- 
Leuveninck, Kawahara, Lindner, Loppnow, Luderitz, Schade, Seydel, 
Sidorczyk, Tacken, Zahringer and Brade, 1987; Miller and Hjelle, 1990). Gram 
negative bacteria LPS is one of the most potent inducers of cytokines and other 
pro-inflammatory molecules. Indeed during bacterial infections, the release of 
cytokines has been associated with the harmful effects of endotoxin (Saukkonen 
et al, 1990; Sharief et al, 1992). The use of LPS inhibitors such as antibodies 
and chemicals that bind LPS has been documented to counteract the 
pathological effects of endotoxin and reduce cytokine release (Baldwin et al, 
1991).
The study described in the previous chapter demonstrated in plasma of T. 
b. brucei-infected mice the presence of endotoxin-like activity which was not
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eliminated by antibiotic treatment and was therefore likely to be derived from 
the parasite.
In order to further our understanding of the pathogenesis of 
trypanosomiasis it is necessary to characterise the molecule(s) producing the 
endotoxin-like activity. Greater understanding of the nature of molecule(s) in 
trypanosomes that are directly involved in the production of the pathological 
effect of the parasite would be of value in development of therapy and could be 
useful candidate antigens for vaccine production.
6.2. OBJECTIVES OF THE STUDY
1). To identify and quantify endotoxin-like activity in trypanosome lysates and 
protein rich trypanosome membranes using the LAL assay.
2). To establish whether the endotoxin-like activity of trypanosomes is derived 
from compounds similar to those in the lipopolysaccharide of gram negative 
bacteria. This was attempted with a highly sensitive silver stain for LPS and by 
Western blotting with a monoclonal antibody to Lipid-A.
6.3. EXPERIMENTAL PROGRAMME
This study involved the measurement of endotoxin levels and 
electrophoretic characterisation of trypanosome lysates and protein rich 
membranes for the presence of LPS and/or a lipid-A moiety. The sodium 
dodecyl sulphate polyacrylamide gel electrophoresis method (SDS PAGE) used 
to study different proteins in complex mixtures, has been adapted for the study 
of bacterial LPS (Davies, Ali, Parton, Coote, Gibbs and Freer, 1991; Davies, 
Parton, Coote, Gibbs and Freer, 1994). The method separates different 
molecules according to their molecular radius. The molecules can be visualised 
by appropriate staining techniques or can be transferred on to nitrocellulose 
membranes for Western blotting and identified with appropriate antibodies
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(Towbin et al, 1979; Mutharia et al, 1984). For the study of LPS, a very 
sensitive silver stain method has been widely used to demonstrate low levels of 
LPS (Tsai and Frasch, 1982). Modifications of the conditions such as 
temperature and concentrations of reagents, ensures that LPS is stained and not 
proteins (Hitchcock and Brown, 1983). This can further be improved by the use 
o f proteinase K to digest proteins in LPS samples (Davies et al, 1991).
In this study endotoxin activity was assessed by use of the LAL assay 
which is believed to react with lipid-A of LPS while Western blotdng was 
carried out using an anti lipid-A monoclonal antibody (Mutharia et al, 1984; 
Dunn, Warren, Bogard and Cerra, 1985). The SDS-PAGE gels were stained by 
the silver stain method as described by Tsai and Frasch, (1982).
6.4. MATERIAL AND METHODS
6.4.1. Animals
6.4.1.1. Rats
The rats used to expand trypanosome populations were Sprague Dawley 
white males (500-600 g). These yield 10-15 ml of blood by intracardial 
bleeding.
6.4.2. Trypanosome
Trypanosoma brucei brucei stabilate TREU-226 raised in rats was used 
as the source of trypanosome products. This causes an acute infection in rats 
leading to death 5-7 days after infection.
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6.4.3. Endotoxin Controls
6.4.3.1. Lipopolysaccharide
LPS from Escherichia coli 0111 :B4 prepared by water phenol extraction 
procedure was obtained from Sigma Chemicals, Dorset UK. and was used as 
the LPS positive control.
6.4.3.2. Lipid-A
Lipid-A was purchased from Calbiochem-Behring Corporation La Jolla, 
California. This lipid-A was derived from Salmonella minnesota bacteria by 
extraction using the water phenol procedure and was used as the lipid-A 
positive control. Endotoxin-free distilled water was used as the negative 
control.
6.4.4. Proteinase K
Proteinase K was purchased from Sigma Chemical Company St. Louis 
USA. and was from Tritirachium album (EC 3.4.21.14), containing 18 mg/ml 
protein, 330 units/ml in 40 % (v/v) glyceral, 10 mM Tris-HCl, pH 7.5, and 1 
mM calcium acetate.
6.4.5. Monoclonal Antibody
Monoclonal antibody 8A1, was a generous gift from Centorcor 
(Malvern, Pennsylvania. USA.) and was raised from mice spleen cells harvested 
from animals immunised intraperitonealy with heat-killed E. coli J5 LPS and 
then boosted intravenously with a mixture of E. coli J5 LPS and S. minnesota 
Re LPS. Three days after the immunisation spleen cells were harvested and 
fused with the NS-1 murine myeloma cell line (Bogard et al, 1987). The 8A1 
monoclonal antibody has been demonstrated to have a wide range of cross­
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reactivity with many species of gram negative bacteria and shows strong and 
specific binding to lipid-A (Mutharia et al, 1984; Dunn et al, 1985).
6.5. PARASITOLOGICAL TECHNIQUES
6.5.1. Infection
Rats were infected by intraperitoneal inoculation with approximately 10^ 
trypanosomes in 0.2 ml of phosphate saline buffer containing 15% glucose 
(PBSG), pH 8.0.
6.5.2. Monitoring Parasitaemia
The parasitaemia was monitored by tail bleeds and examined under the 
microscope. The blood was collected from the rats at peak parasitaemia.
6.6. BLOOD SAMPLING AND TRYPANOSOME SEPARATION
6.6.1. Blood Sampling
Heparinised blood was collected aseptically by intracardiac puncture 
from infected rats at the peak parasitaemia. The rats were terminally 
anaesthetised using carbon dioxide and bled by intracardiac puncture using a 27 
gauge needle and 10 ml syringe.
6.6.2. Trypanosome Separation
All buffers, other fluids and apparatus used were either endotoxin free or 
were rendered endotoxin free by autoclaving for 4 hr at 180° C and for the 
apparatus this was followed by 2 hr in dry heat at 100° C.
Trypanosomes were separated from blood with diethylaminoethyl 
(DEAE-52) cellulose anion exchange columns (Whatman Paper Ltd, Spring 
Mill, Kent, England) by the method of Lanham (Lanham, 1968; Lanham, 
Williams and Godfrey, 1972). The separating column consisted of a slit-sieve
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funnel, rubber tubing, retort stand and clamp, tubing tip and pasteur pipette. The 
apparatus was assembled by clamping the funnel on the stand, and at the end of 
the funnel, rubber tubing with an attached pasteur pipette was connected.
The separating buffer (PBS) consisted of di-sodium hydrogen phosphate 
(Na2HP04~13.48 gm), sodium di-hydrogen phosphate (NaH2P04. 2H2O-0.78 
gm), and sodium chloride (NaCl-4.25 gm), made up to 1 litre with distilled 
water (H2 O), and the pH adjusted to pH 8.0. The PBS was mixed with distilled 
water at a ratio of 6:4, and into each litre of buffer water mixture, was added 15 
gm of glucose just prior to use (PBSG).
The DEAE-52 cellulose was prepared by suspending the pre-swollen 
DEAE-52 in PBS while gently stirring to avoid the formation of fine particles. 
The pH was adjusted to pH 8.0 using dilute orthophosphoric acid. The cellulose 
was then allowed to settle, after which the supernatant was poured off and more 
buffer added. This washing procedure was repeated at least twice before use, to 
remove fine particles.
The separating buffer was poured into the assembled funnel and air 
bubbles expelled by gently tapping the side of the funnel. A filter paper 
(Whatman No. 1) was placed on the surface of the buffer and by slowly 
allowing the buffer to run through the funnel, the filter paper tightly fitted onto 
the grid by suction pressure. Into this, the prepared separating cellulose was 
poured gently and packed to the required depth by adding buffer and allowing it 
to run through several times.
Heparinised blood from infected animals was carefully and evenly 
spread on the surface of the packed column. The buffer was then allowed to run 
through the column and collected into a beaker with continuous monitoring by 
light microscopy for the appearance of trypanosomes. The trypanosomes and 
buffer were then collected into centrifugation tubes, placed on ice, and 
centrifuged at 3,500 xg at 4° C for 20 min. The supernatant was carefully
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discarded and fresh buffer was added to the pellet and the centrifugation 
procedure repeated again. This washing process was repeated at least three 
times before the trypanosomes were used. The trypanosomes collected at the 
bottom of the tubes as a pellet, were stored at -20°.
6.7. PREPARATION OF TRYPANOSOME PRODUCTS
6.7.1. Whole Trypanosome Lysate
For the preparation of trypanosome lysate, whole trypanosomes were 
disrupted by repeated freeze-thawing. The trypanosomes in tubes were placed 
in liquid nitrogen for 10 min and then allowed to thaw at room temperature 
followed by vortexing and repeatedly passing through a fine 26 gauge needle. 
This procedure was repeated until no entire trypanosomes could be observed 
under the microscope.
6.7.2. Membrane-Enriched Trypanosome Fraction
The preparation of membrane enriched fraction from the trypanosome, 
was performed by the method of Rovis and Baekkeskov (1980). All the steps 
were performed at 0-4° C.
Two ml of packed volume of the separated trypanosomes was re­
suspended in 10 ml of PBSG in a 30 ml centrifuge tube into which was added 2 
ml volume equivalent of solid glass beads that had been pre-rinsed with PBSG. 
The mixture was homogenised in a motor for at least 2 min, maintaining the 
tube on ice. Into this homogenate was added 10 ml of HEPES sucrose mixture 
(10 mM 4-(hydroxyethyl)-l-piperazinyl-ethane-2-sulphonic acid, pH 7.4, 0.25 
M sucrose, 1 mM ethylenediamine tetra acetic acid (EDTA), 1 mM 
benzamidine, 1 mM aprotinine).
A sample was then taken and examined under the microscope for the 
presence of entire trypanosomes. If any entire trypanosomes were observed, the
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homogenisation procedure was repeated. The homogenate was then spun for a 
few seconds at 4° C to pellet the beads and the supernatant collected and kept 
on ice. Into the beads was added 5 ml of HEPES/sucrose and spun again for a 
few seconds and the supernatant collected. This extraction of the beads was 
repeated two more times.
The different supernatants were pooled and centrifuged at 5,000 xg for 
20 min at 4° C, and the pellet containing mainly the nuclei and unbroken cells 
discarded.
The supernatant was then centrifuged at 50,000 xg at 4° C, for 50 min 
and the supernatant was discarded. The pellet obtained was re-suspended in 25 
ml of HEPES/sucrose and the centrifugation procedure repeated as above.
The pellet (membrane-enriched fraction) was re-suspended in 2.5 ml 
HEPES/magnesium sulphate buffer, pH 8.6 (1 mM HEPES, 1 mM magnesium 
sulphate, 1 mM benzamidine and aprotinine), per ml of starting packed cell 
volume and transferred to a dialysis bag and dialysed for 20 min against 1 litre 
of cold HEPES/magnesium sulphate containing benzamidine and aprotinine.
A 26% (w/v) dextran solution (Sigma Chemical Company) in 
HEPES/magnesium sulphate buffer was prepared, and 11 ml of this was placed 
into a swing-out tube and overlaid with 2.5 ml of the dialysed membrane- 
enriched fractions. This was centrifuged at 35,000 xg in a swing-out rotor for 
1.3 hr. This separates the plasma membranes from the golgi, endoplasmic 
reticulum and lysosomes which are retained by the dextran. The top layer was 
carefully removed, made up to 30 ml with HEPES/sucrose buffer and spun at 
48,000 xg for 1 hr. The pellet was re-suspended in 0.5-2 ml in HEPES/sucrose 
containing protease inhibitors. The concentration of protein was then measured 
by the biuret method as described in Chapter 2, and the samples stored at -70° 
C.
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6.8. BIOCHEMICAL ASSAYS
6.8.1. Endotoxin Assay
Endotoxin activity was measured using the quantitative chromogenic 
Limulus amoebocyte lysate test (LAL test) (Coatest Endotoxin Kit; Quadratech 
Ltd) as described in Chapter 2.
The standards were prepared to cover the range 0.15-1.2 EU/ml and the 
trypanosome lysate and trypanosome protein rich membrane were used as the 
starting materials.
6.8.2. Protein Assay
The protein content of the trypanosome products was estimated by the 
biuret method utilising a automated analyser (Cobas Mira).
6.9. SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS
Samples were solubilized in an equal volume of lysis buffer containing 
4% dodecyl sulphate lauryl sulphate (SDS), 10% DL-dithiothreitol (DDT), 20% 
glycerol, 1 M Tris-Cl (pH 6.8), 40 mM EDTA, and 0.01% bromophenol blue. 
The lysates were then heated at 100° C for 10 min.
For protein digestion, 25 jag of proteinase-K (PK) (Sigma Chemical 
Company) solubilized in 10 p.1 of lysis buffer was added to each boiled lysate 
and incubated at 60° C for a further 60 min.
Where whole trypanosome or membrane pellets were used, the pellet 
was either solubilized with an equal volume of lysis buffer and thereafter 
treated as the lysates above or was mixed with lysis buffer containing the PK 
and incubated at 60° C for 60 min.
As well as trypanosome products, control material consisting of bacterial 
LPS (48 EU/ml) and lipid-A (5 ng) preparations was subjected to SDS-PAGE
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electrophoresis with and without proteinase K digestion, using the 
discontinuous SDS-PAGE system as described by Laemmli (1970). 
Electrophoresis was performed in a vertical slab gel apparatus (SE-250) 
(Hoeffer Scientific Ltd., San Francisco, USA), in buffer comprising 25 mM 
Tris-HCl and 192 mM glycine (pH 8.3). The slab gel (140 x 100 x 0.75 mm) 
incorporated a 4% acrylamide stacking gel and 15% acrylamide separating gel.
Samples were subjected to electrophoresis at 20 miliamperes (mA) per 
gel until the bromophenol blue migrated to the edge of the tank buffer. The gels 
were prepared in duplicate and one was stained by the silver stain method and 
the other used for immunoblot transfer.
Effectiveness of protein transfer in the immunoblot was demonstrated by 
staining the gels from which protein had been transferred by the Coomassie 
blue stain method.
6.10. STAINING TECHNIQUES
6.10.1. Silver Stain
The gels were stained using the LPS sensitive silver stain method of Tsai 
and Frasch (1982). This staining method preferentially stains for LPS and not 
proteins by including 29.4% ammonium hydroxide in the staining reagent and 
keeping the staining solution at an optimal temperature of 25 °C (Hitchcock 
and Brown, 1983).
After electrophoresis, the LPS on the gel was fixed by placing the 
polyacrylamide gels in a clean glass dish containing 200 ml of a 40% ethanol- 
5% acetic acid solution and incubating overnight. The solution was then 
replaced with 0.7% periodic acid in 40% ethanol-5% acetic acid solution to 
oxidise the LPS for 5 min. This was followed by three, 15 min washes in a 
second container with 500-1000 ml distilled water per wash. The water was 
drained off and 150 ml of freshly prepared staining reagent (2 ml concentrated
173
ammonium hydroxide (29.4%), 28 ml of 0.1 M sodium hydroxide, 5 ml of 20% 
silver nitrate (w/v), and 115 ml distilled water) was added and kept under 
continuous vigorous agitation for 10 min. At the end of the above procedure, 
the staining solution was decanted and the gels washed three times in distilled 
water for 10 min per wash as above. The gels were then developed by replacing 
the water with 200 ml formaldehyde developer solution containing 50 mg citric 
acid and 0.5 ml formaldehyde per litre. Development was stopped when the 
stain reached the desired intensity or the clear gel showed the first sign of 
discoloration. The gels were then washed and stored in distilled water or dried 
using a vacuum pump dryer as described in section 6.10.3.
6.10.2. Coomassie Stain
The gels were stained in Coomassie blue stain (0.125% Coomassie blue 
in 50% methanol, 10% acetic acid) for 30 min after which they were washed 
with destaining solution 1 (50% methanol, 10% acetic acid) for 5 min and later 
this was decanted and replaced with destaining solution 2 (5% methanol and 
7% acetic acid). The gels were allowed to destain to give minimal background 
colour of the gels while retaining an intense protein stain. The gels were then 
dried as described in section 6.10.3.
6.10.3. Gei Drying
The gels were dried under vacuum at a temperature of 80° C for 1 hr 
using a vacuum pump (Biorad). Prior to drying, the gels were soaked in 500 ml 
of a 3% glycerol (w/v), 40% methanol, 10% ethanol solution for about 3 hr with 
constant gentle agitation on a rotary table to ensure crack-free drying. A final 
10 min soak in a 3% glycerol (w/v) solution was performed to rehydrate them 
back to their original size before drying.
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A fresh dry sheet of 3 MM filter paper (Whatman) was cut to the 
appropriate size and placed on the drying apparatus. The gels were placed on 
the filter paper and evenly spread out by rolling a test tube on top. This set up 
was then overlaid with a thin non porous plastic adhesive film (Saran® wrap 
plastic) (Genetic Instrumentation Company) and evenly spread out again to 
eliminate any trapped air bubbles. The transparent covering gasket was placed 
evenly on top, the lid closed, and the vacuum turned on resulting in the 
formation of a vacuum seal. This was run for 1 hr and at the end of the cycle, 
the heating was turned off to let the gels cool before disrupting the vacuum seal, 
and thus prevent the gels from cracking.
6.10.4. Western Blot
6.10.4.1. Protein transfer
Immunoblotting after SDS-PAGE was performed according to the 
method of Towbin et al (1979). Prior to protein transfer, the nitrocellulose 
sheets (Biorad Laboratories., Hercules, USA), filter papers and pads were 
equilibrated in transfer buffer (25 mM Tris, 192 mM glycine, 20% (v/v) 
methanol in distilled water, pH 8.3) for 10 min with gentle agitation. The 
polyacrylamide gels after SDS-PAGE electrophoresis were placed on the 
nitrocellulose membrane sandwiched between filter papers and scotbrite pads. 
Protein transfer was carried out using a Bio-rad transfer apparatus at 8° C using 
a constant current of 8 mA overnight, with the nitrocellulose membrane on the 
anodal side and gels on the cathode side.
Effectiveness of the transfer was evaluated by staining the gels after the 
transfer with Coomassie blue.
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6.10.4.2. Immunostain technique
Immunostaining was performed by the method of Mutharia et al (1984), 
with slight modifications. After the protein transfer overnight, the membranes 
were blocked for 2 hr at room temperature with 3% bovine serum albumin 
(BSA) (Sigma Chemical Company) in assay buffer without Tween 20 (TBS) 
(50 mM Tris-HCl-buffer saline, pH 7.4). This was followed by three washes in 
assay buffer (50 mM-Tris-HCl, 0.05%-Tween 20, pH 7.4) (TBS-Tween 20) 
containing 1% BSA. The membranes were then incubated overnight at room 
temperature (23° C), with monoclonal anti-Lipid-A as primary antibody (8A1, 
Centorcor) diluted 1:500 in 1% BSA in assay buffer. This was followed by 
three 10 min washes in TBS-Tween and a further 1 hr incubation in secondary 
antibody, anti-mouse IgG horseradish peroxidase conjugate (Law Hospital, 
Lanark, UK.), at a dilution of 1:1000 in 1% BSA in TBS-Tween 20. After three 
10 min washes as above, the membranes were incubated in freshly prepared 
chromogen solution. The chromogen was prepared by dissolving 20 mg of 3- 
amino-9-ethyl carbazole (AEC) (Sigma Chemical Company) in 2.5 ml dimethyl 
formamide, thoroughly mixing with 47.5 ml acetate buffer (50 mM sodium 
acetate buffer, pH 5.5), followed by filtration through Whatman No. 1 filter 
paper. Into the eluent was added 25 pi of hydrogen peroxide (30% (v/v)) 
(Sigma Chemical Company). The reaction was allowed to continue until the 
desired intensity of brown colour of the protein in the membranes was achieved. 
The reaction was terminated by washing the nitrocellulose membranes in 
distilled water followed by air-drying at room temperature.
To determine the cross reaction of secondary antibody to rat plasma 
proteins, rat serum was included as one of the samples and treated as above.
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6.11. RESULTS
6.11.1. Endotoxin Activity
The protein content and endotoxin activity of four aliquots of 
trypanosome lysate and trypanosome enriched membrane proteins are presented 
in Tables 6.1 and 6.2, respectively. The protein content of the trypanosome 
lysates and the trypanosome enriched membrane proteins was 33.3 ± 4.0 mg/ml 
and 27.7 ± 4.1 mg/ml (mean ± SD) respectively. These gave LPS endotoxin 
activity equivalent of 59.4 ± 12.3 and 35.9 ± 6.7 EU/ml (mean ± SD) for the 
trypanosome lysate and trypanosome-enriched membranes respectively as 
measured by the LAL assay after serial dilution to fit the standard curve range.
6.11.2. Silver Stain
The sensitivity of the silver stain method for LPS following SDS PAGE 
was determined. This was done by taking a sample containing 6144 EU/ml of 
E. coli LPS, serially diluting it and using this as the starting material. The 
samples were treated and the gels stained as described in the materials and 
methods section. This showed that the silver stain was very sensitive and was 
able to detect as low as 24 EU/ml in the serially diluted E. coli LPS (Fig. 6.1).
During the running of the trypanosome samples, E. coli LPS and S. 
minnesota Lipid-A were included in each gel as the positive controls while 
distilled water was used as the negative control. Results are summarised in table
6.3. In all the gels stained with the silver stain, the lanes loaded with E. coli 
LPS (L) showed the classical ladder-like bands characteristic of smooth gram 
negative bacteria LPS. This was observed in samples before and after the PK 
digestion step. All the lanes loaded with endotoxin free water (W) and lipid-A 
(A) did not stain with the silver stain with or without the PK digestion step.
The silver stain for the trypanosome lysate is presented in figure 6.2a 
befcre PK digestion and figure 6.2 after PK digestion. The silver stain did not
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stain the lanes loaded with trypanosome lysate (TL) before or after PK 
digestion.
To determine whether the lack of any staining in the trypanosome lysate 
samples was due to low concentration of endotoxin in the samples or loss of 
LPS during preparation of samples, whole trypanosome pellets were used as the 
starting material. This did not stain indicating that the pre analytical loss or 
concentration of LPS in samples was not a reason for the failure to stain these 
samples by the silver stain.
Similar to the trypanosome lysates, the trypanosome membranes (TM) 
did not stain by the silver stain before (Fig. 6.3a) or after (Fig. 6.3b) PK 
digestion. Attempts to increase the detection by the use of trypanosome 
membrane pellet as the starting material did not improve the staining.
6.11.3. Western Blot
To determine the presence of lipid-A in the trypanosome products, the 
Western blot technique using the monoclonal antibody 8A1 was used following 
SDS-PAGE and results are summarised in Table 6.4.
In each gel LPS and lipid-A were used as the positive controls while 
endotoxin free water was used as the negative control. In all the Western blots, 
monoclonal antibody 8A1 stained the lanes loaded with LPS (L) and lipid-A 
(A) as a single first migrating broad band of high mobility with the same 
molecular weight in both the LPS and lipid A. This was observed in the samples 
before and after PK digestion step.
The wells containing trypanosome lysates (TL) showed several slow 
migrating light staining bands only when loaded with samples without the PK 
digestion step (Fig. 6.4a). These bands were not detectable in any trypanosome 
lysate samples that were treated with PK (Fig. 6.4b) even when pellets from 
trypanosome lysate were used as the starting material.
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The monoclonal antibody 8A1 stained several slow migrating bands in 
the lanes loaded with trypanosome membranes (TM), before the PK digestion 
step (Fig. 6.5a). The samples immunoblotted after PK digestion, did not 
indicate the presence of any bands even when trypanosome membranes pellet 
was used (Fig 6.5b).
To determine the crossreaction of the monoclonal antibody with plasma 
proteins in the trypanosome products, a serum sample from a normal rat was 
treated by the SDS-PAGE electrophoresis and immunostained as before. The 
protein sample did not stain with the monoclonal antibody indicating that the 
observed bands were not due to non-specific protein binding.
6.12. DISCUSSION
These results demonstrate that trypanosome lysate and membranes 
contain molecule(s) with endotoxin-like activity as measured by the LAL assay, 
although the endotoxin-like activity was low compared to the gram negative 
bacteria LPS.
After electrophoresis and staining, with a silver stain, the lanes 
containing trypanosome products and lipid-A, did not stain whereas the E. coli 
lipopolysaccharide used as the positive control, gave the classical ladder-like 
spread of different bands in the lanes loaded with LPS before and after the 
proteinase K digestion step. The distinctive ladder-like pattern is caused by the 
separation of a mixture of molecules of increasing molecular mass representing 
additional O-antigen units added to the basic lipid-A core oligosaccharide 
structure (Davies et al, 1991).
Sensitivity of the silver stain for LPS following SDS PAGE 
electrophoresis was high being able to detect LPS down to 24 EU/ml, and thus 
at the endotoxin levels detected by the LAL assay in the trypanosome products 
(> 26 EU/ml). LPS if present in the products should have been identified by the
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silver stain. These findings indicate that the molecules(s) responsible for the 
endotoxin-like activity in trypanosomes are not of similar chemical structure to 
the gram negative bacteria LPS.
After Western blotting with the monoclonal antibody 8A1, the lipid-A 
and lipopolysaccharide stained as a single fast migrating broad band of similar 
size in both the PK digested and non PK digested samples. However, the 
trypanosome lysates and membranes lanes, showed lighter staining of several 
bands of higher molecular weight compared to that of lipid-A and LPS with the 
monoclonal antibody 8A1. This was only visible in the non PK digested 
trypanosome samples, whereas, in the PK digested samples, all these bands 
disappeared. This indicated that the molecule(s) being stained were destroyed 
by the PK treatment procedure suggesting that they were protein in nature or 
were associated with protein. Increasing the concentration of the PK treated 
trypanosome samples by using whole trypanosome and membrane pellets as the 
starting material did not improve the detectability, whereas bacterial LPS and 
lipid-A were both detectable at low concentration by the silver stain and 
Western blot staining techniques.
Detection of LAL activity in trypanosome lysate and membranes 
confirm that they contain endotoxin-like molecule(s) and likely to be the source 
of the increased levels of endotoxin-like activity in T. b. brucei infected mice 
demonstrated in vivo by Alafiatayo et al (1993) and in Chapter 5 of this thesis. 
Results from this study indicate the levels of activity were low compared to the 
LPS in Trypanosoma cruzi and gram negative bacteria LPS, confirming the 
observations of Pentreath, (1995).
The chemical nature of the molecule(s) responsible for the LAL activity 
in trypanosomes is not known. Although the LAL assay is activated by and is 
generally accepted as being specific for lipid-A, it has previously been shown to 
give positive reactions with non-endotoxin molecules including Streptococcal
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exotoxin (Brunson and Watson, 1976), Streptococcus faecalis lipoteichoic acid 
(Fine, Kessler, Tabak and Shockman, 1977), and Mycoplasma lipoglycans 
(Seid, Smith, Guevarra, Hochstein and Barile, 1980; Weinberg et al, 1980). The 
LAL test has also detected the biological activity of endotoxin-like molecules 
purified from membranes of various organisms including Chlamydia psittaci 
(Lewis et al, 1979) Plasmodium falciparum  (Jakobsen et al, 1988), and 
Micropolyspora faeni (Smith, Hill, Snyder and Burrel, 1978).
The finding that the monoclonal antibody 8A1 which is lipid-A specific 
(Mutharia et al, 1984; Bogard et al, 1987), reacted with trypanosome lysate 
without PK digestion suggests that trypanosomes contain molecule(s) with 
lipid-A or lipid-A-like epitopes. The visible bands on the immunoblots could 
not have been due to non-specific reaction of the monoclonal antibody with rat 
plasma proteins since the immunoblot treatment of normal rat serum did not 
give similar bands.
The molecule(s) giving the positive LAL and immunoblot reaction did 
not have a structure or chemical properties similar to gram negative bacteria 
lipopolysaccharide. The molecule(s) did not stain by the silver stain and also 
were unable to withstand PK digestion, unlike the T. cruzi LPS which has been 
shown to stain with the silver stain (de Simone et al, 1991), and also has been 
shown to be LPS (Ketteridge, 1978; Golberg et al, 1983). The possibility that 
the endotoxin was in very low amount, leading to decreased detectability, was 
unlikely since similar low levels of E. coli LPS were demonstrated on the gels 
by silver stain. The results of this study strongly suggest that endotoxin-like 
activity of T. b. brucei is not based on lipid-A and is therefore not of a similar 
chemical nature as bacterial lipopolysaccharide.
The observation that the trypanosome molecule(s), identified by the 
monoclonal antibody 8A1 by the Western blot, could not withstand PK 
digestion, suggests that the molecule(s) responsible for this activity could be
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protein in nature or associated with protein. Indeed treatment of mice with 
variable surface glycoprotein (Cross, 1975), produces effects such as non­
specific polyclonal B-cell activation, which are thought to be produced by an 
endotoxin molecule(s) released by trypanosomes (Greenwood, 1974).
Bacterial LPS, which is the most studied endotoxin, is known to be 
among the strongest inducers of cytokines (Mathison, Wolfson and Ulevitch,
1988). It is generally accepted that the inner core region of LPS is mainly 
responsible for the manifestation of endotoxicity, with lipid-A conveying the 
critical contribution (Kotani, Takada, Takahashi, Ogawa, Tsujimoto, 
Shimauchi, Ikeda, Okamura, Tamura, Harada, Tanaka, Shiba, Kusumoto and 
Shimamoto, 1986; Rietschel et al , 1987), and also being responsible for the 
adjuvant effects of endotoxin, including increased resistance to infection and 
cancer (Rietschel and Brade, 1992).
Cytokines are increasingly being recognised to be involved in the 
initiation of the pathological changes observed during parasitic infections 
(Rouzer and Cerami, 1980; Beutler and Cerami, 1987; Titus et al, 1991). 
During these parasitic infections, which include trypanosomiasis, increased 
serum cytokine levels have been demonstrated (Bancroft et al, 1983; Reincke et 
al, 1993).
Although the pathogenesis of African trypanosomiasis is yet to be fully 
understood, the production of cytokines during the infection is likely to be 
responsible for the production of some of the pathological changes observed, 
e.g. hypertriglyceridaemia (Rouzer and Cerami, 1980), and CNS inflammation 
(Hunter et al, 1991; Hunter et al, 1992a), common features of African 
trypanosomiasis. The mechanism of their production by the parasite is not well 
understood although the possible release of active trypanosome molecule(s) has 
been suggested and the endotoxin-like activity demonstrated in the present 
study, is likely to be involved in this process. Indeed in vitro trypanosome
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products have been demonstrated to stimulate several cell types to release 
cytokines (Olsson et al, 1991; Gichuki, 1994), and similarly cells from infected 
hosts are known to show increased ability to release cytokines when stimulated 
(Sileghem et al, 1989; Sileghem et al, 1993). In vivo administration of 
trypanosome products have also been shown to stimulate the release of active 
molecules including granulocyte-macrophage stimulating activity (Oka et al,
1989).
Among the molecules present in protozoan parasites such as 
trypanosomes, and known to be able to stimulate the production and release of 
cytokines is glycosyl phosphatidylinositol (Masterson, Raper, Doering, Hart 
and Englund, 1990; Bate and Kwiatkowski, 1994). The molecule is also found 
in trypanosomes but from this source was not found to stimulate cytokine 
production (Bate, Taveme, Roman, Moreno and Playfair, 1992; Jakobsen et al, 
1995). Other phospholipids from malaria exoantigens have been shown to 
stimulate the production of TNF (Bate et al, 1992), these are also major 
constituents of the trypanosome plasma membrane (Dixon and Williamson, 
1970; Rovis and Baekkeskov, 1980). The non lipid-A endotoxin-like activity 
demonstrated in trypanosomes in the present study, could be the same or similar 
to the molecule(s) responsible for the stimulation of cytokine release in the 
above publications.
The lack of a protective vaccine or safe non-toxic drugs for the treatment 
of trypanosomiasis, justify the search for detailed information concerning the 
interaction between the parasite and the host. The present work indicates that 
the characterisation of the trypanosome molecules is central to the 
understanding of the pathogenesis of African trypanosomiasis and thus may 
lead to the development of better disease management.
Further work that may lead to the understanding of the chemical nature 
of the molecule(s) responsible for the endotoxin-like activity in trypanosomes
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should include the measurement of 2-keto-3-deoxy octulosonic acid (KDO) 
levels, a molecule found in most LPS linking the lipid-A and polysaccharide 
moieties via a ketosidic linkage. The cross reactivity of the monoclonal 
antibody 8A1 with non bacterial lipid-A could be confirmed by performing 
Western blots with T. cruzi LPS which has been characterised (Goldberg et al, 
1983). Research could also be extended to analysis of other molecules purified 
from trypanosomes with biological activity such as the TLTF. Attempts should 
also be made to extract the endotoxin-like activity from purified trypanosomes 
by the standard techniques which have been applied in gram negative bacteria 
and T. cruzi and to then characterise the bioactive molecule(s).
6.13. CONCLUSION
This results suggest that trypanosomes contain molecule(s) with 
endotoxin-like activity. Although the molecule(s) responsible for this activity 
activate the proenzyme in the LAL assay as the lipid-A of gram negative 
bacteria, they are not chemically or structurally similar to the LPS of gram 
negative bacteria. These molecule(s) should be isolated and characterised as it 
is likely that they could play a central role in the pathogenesis of the disease 
process in African trypanosomiasis.
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SAMPLES PROTEIN
CONCENTRATION
(mg/ml)
ENDOTOXIN 
ACTIVITY (EU/ml)
1 33.4 65.3
2 38.2 46.8
3 28.4 73.6
4 33.3 51.9
MEAN ± SD 33.3 ±4.0 59.4 ± 12.3
Table 6.1. The protein concentrations and endotoxin activity levels in 
Trypanosoma brucei brucei lysate.
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SAMPLES PROTEIN
CONCENTRATION
(mg/ml)
ENDOTOXIN 
ACTIVITY (EU/ml)
1 25.2 35.1
2 33.1 38.9
3 23.9 26.9
4 28.4 42.6
MEAN ± SD 27.7 ±4.1 35.9 ±6.7
Table 6.2. The protein concentrations and endotoxin activity levels in 
Trypanosoma brucei brucei membranes.
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Fig. 6.1. Silver stain SDS-PAGE gel loaded with serially diluted E. coli LPS. The 
arrow indicates the direction of decreasing concentration of LPS. A-highest 
concentration and B- lowest concentration.
Fig. 6.2. Silver stain SDS-PAGE gel loaded with LPS (L), Lipid-A (A), saline 
(S) and trypanosome lysate (TL). Figure 6.2a samples were not treated with PK 
prior to electrophoresis while in Figure 6.2b the samples were treated with 25 p 
g of PK for 60 min. Note the ladder-like staining of the E. coli LPS.
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Fig. 6.2
Fig. 6.3 Silver stain SDS-PAGE gel loaded with LPS (L), Lipid-A (A), saline 
(S) and membrane-enriched trypanosome fraction (TM). Fig. 6.3a samples were 
not treated with PK prior to electrophoresis while in Fig. 6.3b the samples were 
treated with 25 jig of PK for 60 min. Note the classical ladder-like staining of 
bacterial LPS.
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Fig. 6.3
SAMPLES BEFORE PK AFTER PK
DIGESTION DIGESTION
Water N N
LPS ++ ++
Lipid-A N N
Trypanosome membranes N N
Trypanosome lysate N N
Table 6.3. The summary of the silver stained SDS PAGE gels following 
electrophoresis of bacterial and trypanosome products. N-No visible bands; +- 
Single band; ++-More than one band.
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Fig. 6 4. Western blot analysis of LPS (L), lipid-A (A), saline (S) and 
trypanosome lysate (TL). Figure 6.4a the samples were not treated with PK 
before electrophoresis while Figure 6.4b the samples were pre-treated with 25 p 
g of PK for 60 min before electrophoresis. Note the staining of E. coli LPS and 
lipid-A from S. minnesota with or without PK digestion, and trypanosome 
lysate without PK digestion.
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Fig. 6 4
F ig . 6 .5 . Western blot analysis of LPS (L), lipid-A (A), saline (s) and 
membrane enriched trypanosome fractions (TM). Figure 6.5a the samples were 
not treated with PK while in Figure 6.5b the samples were pre-treated with 25 \i 
g of PK before electrophoresis. Note the staining of LPS and lipid-A with or 
without PK digestion and trypanosome enriched membranes without PK 
digestion.
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SAMPLES BEFORE PK AFTER PK
DIGESTION DIGESTION
Water N N
LPS + +
Lipid-A + +
Trypanosome membranes ++ N
Trypanosome lysate ++ N
Table 6.4. The summary of the Western blot from SDS PAGE gels following 
electrophoresis and transfer of bacterial and trypanosome products. N-No 
visible band; +-Single band; ++-More than one band.
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CHAPTER 7 
GENERAL DISCUSSION AND CONCLUSION
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This thesis is a study on the pathogenesis of African trypanosomiasis 
using mice infected with either Trypanosoma brucei brucei or T. congolense, 
with particular reference to the acute phase response (APR). Previous studies 
have shown that trypanosome infections cause pathological changes in a wide 
range of organs and tissues accompanied by alterations of biochemical levels of 
different blood components. However, only a few studies have been carried out 
on the APR in trypanosomiasis (Thomasson et al, 1973; Cook, 1979; Esievo et 
al, 1984; Pluschke et al, 1986; Ndungu et al, 1991; Shapiro and Black, 1992), 
and little is known about the possible pathophysiological role of acute phase 
proteins (APP) during the disease process (Shapiro and black, 1992).
The working hypothesis of the present investigations is that 
trypanosomes contain and release an endotoxin-like molecule(s) which, through 
the over-stimulation of endogenous cytokines, leads to the production of the 
observed pathological changes such as the APR.
The objectives of this investigation were to develop a direct ELISA for 
measurement of serum amyloid P-component (SAP), a major murine APP, 
assess the APR during a tissue invasive and non-invasive trypanosome 
infection, and to identify the origin of the endotoxin-like molecule(s) released 
during the course of a trypanosome infection.
Chapter 3 describes the development of the ELISA for the estimation of 
SAP. The advantage of this assay was that it utilised only small amounts of test 
plasma making it possible to assay SAP serially in small animals such as the 
mouse. The assay was also sparing in the use of antigen and antibodies.
This ELISA was used to measure the plasma levels of SAP in normal 
and trypanosome-infected mice (Chapters 4 and 5). The results obtained 
showed that both T. b. brucei (invasive) and T. congolense (non-invasive) 
infections in mice, induced an increase in the plasma levels of the APP,
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haptoglobin and SAP (Chapter 4). This response was accompanied by cellular 
infiltration and damage to the liver, spleen and the brain in the T. b. brucei 
infections. In T. b. brucei infections, both APP increased rapidly reaching peak 
levels within 10 DAI; thereafter SAP decreased to about baseline levels, while 
Hp remained elevated at 50% peak levels. Similarly, following T. congolense 
infections, both APP increased and reached peak levels early in the infection. 
Thereafter, SAP decreased but then increased around 30 DAI before starting to 
fall. Haptoglobin, on the other hand, increased rapidly to peak levels, decreased 
by a 50% and thereafter remained at this elevated level.
The finding that both invasive and non-invasive trypanosome infections 
resulted in increased plasma levels of APP, indicated that the trypanosomes do 
not induce the release of cytokines and APP, solely through the invasion and 
damage of tissue. Indeed, in T. b. brucei infections, APP started to increase 
before trypanosomes could be demonstrated in circulation and peaked before 
any severe tissue damage had occurred; later in the infection, severe pathology 
was concomitant with a decrease of 50% in haptoglobin and a near baseline 
concentration of SAP.
Following treatment of T. congolense-infected mice with trypanocidal 
drug diminazine aceturate, which is curative in this infection, haptoglobin 
concentrations decreased rapidly. In contrast in T. b. brucei-infected mice in 
which the treatment is subcurative with trypanosomes persisting in the brain, 
haptoglobin concentrations remained elevated, indicating that the trypanosomes 
and/or the pathology in the CNS of the mice might still be playing a part in the 
continuing stimulation of the hepatic APR. This observation needs to be further 
investigated in a more extensive study with follow-up of the animals for a 
longer period after a curative and subcurative treatment.
Acute phase proteins reflect a complex cytokine reaction but remain in 
the circulation longer than cytokines. Acute phase proteins therefore, provide an
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indicator of cytokine activity during the disease process. Indeed in mice, a 
strong correlation between the ability to produce IL-1 and the SAP response has 
been demonstrated (Mortensen et al, 1983).
Although increased endotoxin-like activity has been previously 
demonstrated in plasma of T. b. brucei-infected mice, and trypanosomes are 
documented to contain molecules with endotoxin-like activity, the source and 
pathological significance of this serum endotoxin-like activity during 
trypanosome infection has not yet been elucidated. Chapter 5 describes a series 
of studies on mice infected with T. b. brucei and kept under an umbrella cover 
with the antibiotics norfloxacin, a systemic broad spectrum antibiotic, or 
polymyxin-B an antibiotic that binds to and inactivates LPS. The levels of 
plasma endotoxin-like activity remained elevated and were not affected by 
treatment with either antibiotics. This finding suggests that the increased 
endotoxin-like activity is of parasite origin. Similarly, pathological changes 
assessed by APP, Hp and SAP, and by histological examination of tissues, were 
not affected significantly by the antibiotic treatments. In one study a slight 
decrease in the Hp concentration occurred in the norfloxacin-treated mice 
during late infection, and a decrease in the cellular infiltration of the liver was 
observed in norfloxacin-treated mice during the early stages of infection. These 
results suggest that although secondary bacterial infections might influence the 
pathological changes during trypanosomiasis, the trypanosome parasites are 
likely to be responsible for the initiation of the pathological changes observed 
during infection in mice.
The study also attempted to characterise the chemical nature of the 
molecule(s) responsible for endotoxin-like activity in trypanosomes (Chapter 
6). The lipid-A moiety of gram negative bacteria LPS is responsible for the 
pathogenic effects of LPS and in activating the LAL assay. Trypanosomes were 
therefore analysed for the presence of LPS by a silver stain that preferentially
stains LPS, and for the lipid-A moiety by Western blotting with a monoclonal 
antibody. Results suggested that the parasites contain molecule(s) with 
endotoxin-like activity and might have epitopes similar to lipid-A, but are in 
structure different from the LPS of gram negative bacteria. Further studies need 
to be undertaken to purify and characterise the molecules with endotoxin-like 
activity and compare with other non-bacterial LPS molecules of known 
chemical structure such as T. cruzi a close relative of the African trypanosome 
which is reported to contain an LPS structure (Goldberg et al, 1983).
These studies have shown that the African trypanosomes T. b. brucei and 
T. congolense, induce an APR in mice. As the mouse model is an excellent 
reflection of the disease in man and the major animal species, it is probable that 
the response also occurs in these hosts. The APR is associated with an increase 
in plasma endotoxin-like activity and APP. These results have several clinical 
implications in trypanosomiasis.
The APP might be used as markers in different aspects of 
trypanosomiasis and in examining the effect of trypanocidal and non- 
trypanocidal drugs on the host during an active infection. With the emerging 
evidence that some of the APP might be playing an active role in the host 
response, further studies need to be conducted to ascertain this possibility. For 
example, haptoglobin at acute phase concentrations is known to be 
immunosuppressive, whereas, ot2 -macroglobulin is known to inhibit the 
proliferative response of lymphocytes and also the antibody-dependent cell- 
mediated cytotoxicity and natural killer cell activity. Serum amyloid-P has been 
shown to augment in vitro listericidal activity of macrophages and thus might 
act as a mediator of the increased phagocytic activity observed during 
trypanosomiasis. C-reactive protein and SAP are known to induce cytokine 
production from monocytes/macrophages, while a 2 -macroglobulin binds to IL- 
6 and IL-1, an effect that protects IL-6 from degradation by proteases and thus
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could prolong its half-life and possibly its effect on the host. These acute phase 
proteins might thus be involved in the production of the cytokines and also 
affect their plasma half-life and thus could influence the course of the disease. 
Haptoglobin in circulation binds free haemoglobin released during haemolysis, 
thus preventing glomerular filtration of haemoglobin which could lead to 
kidney damage and irreversible loss of iron from the body. Thus this action 
might conserve iron during haemolytic anaemia and reduce the severity of 
anaemia during infections.
In conclusion, this study has provided evidence that the induction of the 
disease process in African trypanosomiasis might be the result of an endotoxin­
like cytokine-inducing molecule(s) present in the trypanosome, a molecule(s) 
with similar activity to the LPS found in gram negative bacteria.
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APPENDIX 1:
Stock Solutions for SDS-PAGE Buffers and Gel Mixes
Stock Acrylamide (Monomer solution-30%, 2.7% Bis)
Acrylamide 29.2 g
Methylene-bisacrylamide 0.8 g
Distilled water 100 ml
Separating Gel Buffer (1.6 M Tris-HCL pH 8.8)
Tris-HCL 18.15 g
Distilled water 100 ml
Stacking Gel Buffer (0.5 M Tris-HCL pH 6.8)
Tris-HCL 3.0 g
Distilled water 50 ml
10% SDS
SDS 50 g
Distilled water 500 ml
Initiator (10% ammonium persulphate)
Ammonium persulphate 0.5 g
Distilled- water 5 ml
Resolving GeL Overlay (0.375 M Tris-HCL pH 8.8, 0.1% SDS)
Resolving gel buffer 25 ml
256
10% SDS 1 ml
Distilled water 74 ml
15% SDS-PAGE Separating Gel
Stock acrylamide 15 ml
1.6 M Tris-HCL (pH 8.8) 7.5 ml
10% SDS 300 fil
Distilled water 7 ml
Ammonium persulphate 150 pi
TEMED 15 pi
4% Stacking Gel
Stock acrylamide 1.34 ml
0.5 M Tris-HCL (pH 6.8) 2.5 ml
Distilled water 6 ml
10% SDS 100 pi
TEMED 15 pi
Protein Treatment Buffer (Sample buffer)
2.5% SDS
2.5% dithreioerythriol 
0.1 M Tris-HCL (pH 6.8)
10% glycerol
0.01% bromophenol blue
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APPENDIX 2:
LPS Treatment Buffer 
Treatment Buffer (Sample buffer)
2.5% SDS
2.5% dithreioerythriol 
0.1 M Tris-HCL (pH 6.8)
10% glycerol 
40 mM EDTA 
0.01% bromophenol blue
Electrophoresis Tank Buffer
SDS-PAGE Tank Buffer(0.025 M Tris, pH 8.3, 0.I9M glycine, 0.1% SDS)
Glycine 14.4 g
■1 g 
• 0 g  
L
Tris base 3
SDS 1
Distilled water 1
APPENDIX 3:
Coomassie Blue Staining and Destaining Solutions 
Coomassie Blue Staining Solution
Coomassie blue 0.5 g
Methanol 300 ml
Glacial acetic acid 100 ml
Distilled water-to 1 L
Destaining Solution
Methanol 300 ml
Glacial acetic acid 100 ml
Distilled water to 1 L
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APPENDIX 4:
Western Blot Buffers
Transfer Buffer (25 mM Tris, 192 mM glycine, 5 % methanol, pH 8.3)
Tris-HCL 6.055 g
Glycine 28.33 g
20 % Methanol 0.5 L
Distilled water to 2 L
Western Blot Assay Buffer (20 mM Tris-HCL, 150 mM NaCl, 0.05 % 
Tween-20, pH 7.4)
Tris-HCL 2.422 g
Sodium chloride 8.766 g
Tween-20 0.5 ml
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A L W A Y S  R E M E M B E R  T H A T  T H E  F E A R  O F  
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